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The neuromuscular junction (NMJ) connects the motor neuron and the skeletal 
muscle cell. In mammals, the neurotransmitter acetylcholine (ACh) is released from 
presynaptic terminals upon activation of  the motor neuron. Subsequently, ACh will 
bind and activate postsynaptic ACh receptors (AChRs) leading to membrane depo-
larization and contraction of  the muscle fiber. Proper function of  the NMJ is of  
crucial importance for the survival of  the organism. Several paralytic neuromuscular 
diseases are known to be caused by either post- or presynaptic NMJ dysfunction.
The NMJ has been of  key importance in our understanding of  chemical synaptic 
transmission. Since Katz and colleagues first measured synaptic events at the NMJ 
of  frog some 60 years ago (Fatt and Katz, 1950) the NMJ has remained an impor-
tant model system. It is technically easier to measure the synaptic signals in vitro at 
this peripheral synapse compared to synapses in the brain. Another advantage over 
central synapses is that it is a ‘one-to-one synapse’, in contrast to the central nervous 
system (CNS) where many presynaptic nerve terminals are present at one postsyn-
aptic neuron. This allows for direct assessment of  the physiological parameters of  
a single synapse.
Chemical transmission involves the highly controlled fusion of  transmitter-filled 
vesicles with the presynaptic plasma membrane, leading to exocytosis of  the trans-
mitter into the synaptic cleft. Many presynaptic proteins important for the tight 
regulation of  this process have been identified in the last two decades. This research 
has been greatly facilitated by the generation of  transgenic mice lacking or over ex-
pressing specific proteins. The roles of  neuro-exocytotic proteins hitherto have been 
experimentally characterized mainly in mouse brain slice preparations and cultured 
brain synapses.
This thesis investigates whether the neuro-exocytotic proteins identified in the 
CNS also serve this role at the presynaptic NMJ. Besides being of  neurobiological 
importance, characterization of  such roles might be relevant to primary and second-
ary presynaptic phenomena in diseases with NMJ dysfunction, such as (congenital 
forms) of  presynaptic myasthenic syndromes and myasthenia gravis (MG)
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General Introduction
The neuromuscular junction: a model-synapse
The NMJ is one of  the most thoroughly studied synapses. Using the NMJ, Sir Henry 
Dale demonstrated the principle of  chemical transmission of  an electrical signal 
from one cell to another (Dale et al., 1936), for which he and Otto Loewi were 
awarded the Nobel Prize in Physiology or Medicine. In 1966 Katz reported the 
quantal and vesicular properties of  ACh release (Katz, 1966). Since then, the cholin-
ergic NMJ has proven a highly suitable experimental synapse model that has enabled 
detailed analysis of  neurotransmission.
Cellular components
The NMJ comprises parts of  the motor neuron, skeletal muscle fiber, and Schwann 
cell (Figure 1) (reviewed in Couteaux, 1973; Ogata, 1988; Engel, 1994). The motor 
axon, myelinated by Schwann cells, originates from the nerve cell body within the 
ventral horn of  the spinal cord, and projects to the target muscle through the pe-
ripheral nerve. The terminal branches of  the motor axon, which are each up to 100 
μm long, can contact up to tens to hundreds of  muscle fibers. The combination of  
a motor neuron and all of  the muscle fibers it innervates is called a motor unit. The 
place of  synaptic contact is at a site near to the middle of  the muscle fiber, where 
invaginations in the postsynaptic membrane (primary clefts) harbor the axon ter-
minals. The nerve terminal is covered by perisynaptic Schwann cells. They insulate 
the nerve terminal from the environment, support the long-term maintenance of  
the synapse and are capable to modulate neurotransmitter release. Schwann cells 
guide regeneration after injury as well and are play a crucial role during development 
(Sanes and Lichtman, 1999; reviewed by Feng and Ko, 2007). 
The synaptic cleft between the nerve terminal and the postsynaptic membrane 
is about 50 nm wide and is lined with basal lamina, a thin layer of  connective tissue 
that sheaths the muscle fiber. It consists of  collagen IV, laminin, entactin, and hepa-
ran sulfate proteoglycans. The synaptic basal lamina also contains a collagen-tailed 
form of  acetylcholinesterase, important for the degradation of  ACh (Krejci et al., 
1997).
The nerve terminal contains many mitochondria, microtubules and actin micro-
filaments. The most noticeable characteristic in electron microscopic images is the 
presence of  many synaptic vesicles with a diameter of  about 50 nm. Some of  these 
are clustered at specialized sites at the presynaptic membrane, called ‘active zones’, 
appearing as electron-dense regions of  the cytoplasm. Upon Ca2+ influx through 
voltage-gated Ca2+ channels (Cav2.1, also called P/Q type), these vesicles undergo 
exocytosis.
Localized opposite to the pre-synaptic membrane, the post-synaptic muscle 
membrane exhibits an eight-time increased surface area due to extensive folding 
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(‘secondary folds’). Voltage-gated Na+ channels are localized in the depths of  the 
folds. Several myonuclei with associated Golgi apparatus lie just beneath the post-
synaptic membrane. On the surface of  the secondary folds exposed to the synaptic 
cleft, large numbers of  ACh-gated receptor-channels (AChRs) are present at high 
density (10000/μm2). Upon binding of  ACh, these channels open and cause a net 
inward ion current (see below). Extrasynaptically, the AChR density drops to 10/
μm2 (Fertuck and Salpeter, 1976).
The acetylcholine receptor
The endplate AChR is a ligand-gated ion channel of  the nicotinic class. Binding of  
two ACh molecules results in a short opening of  the pore, allowing influx of  Na+ 
and efflux of  K+ ions. This leads to a net inward electrical current. The discovery 
of  α-bungarotoxin (α-BTx), a peptide component of  the venom of  the snake Bun-
garus multicinctus, enabled the purification and subsequent structural analysis of  
the AChR (reviewed in: Karlin, 2002). α-BTx is a highly specific irreversibly binding 
ligand that has been applied to extract AChRs from the Torpedo electric organ in 












Figure 1. Motor neuron and NMJ
Schematic representation of  the motor neuron, making synaptic contact with a number of  muscle fibers, together 
forming the motor unit. The nerve endings are positioned in the primary folds of  the muscle fiber membrane and 
are covered with perisynaptic Schwann cells. The nerve terminal contains synaptic vesicles filled with ACh. Upon 
arrival of  a presynaptic action potential, the vesicles fuse with the presynaptic cell membrane at the active zones, 
thereby releasing ACh in the synaptic cleft. AChRs located on top of  the secondary folds open after binding of  
ACh, permitting an ion current to flow which underlies a depolarization that activates voltage gated Na+ channels 
located in the depths of  the folds. This results in a muscle action potential that eventually induces contraction of  
the fiber. Modified from Plomp et al., 2003.
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polypeptides subunits: α, β, γ, and δ with a stoichiometry of  α2βγδ. X-ray crystal-
lography analysis shows a structure that resembles a chalice, with a large extracellular 
‘mouth’ of  65 Å, and a smaller intracellular vestibule of  20 Å, connected by a 30 
Å wide pore. The binding sites for ACh and α-BTx are located on the α-subunits. 
Embryonic mammalian NMJs possess AChRs with the same subunit composition 
as the Torpedo AChR; however, during the first postnatal week the γ-subunit is re-
placed by an ε-subunit. This yields a channel with a shorter opening duration and a 
larger electrical conductance (Mishina et al., 1986; Gu and Hall, 1988; Missias et al., 
1996). 
Function 
The function of  the NMJ is to transmit signals from the motor neuron to the muscle 
fiber, which is achieved by action potential-induced ACh release from the nerve 
terminal. ACh is synthesized from choline and acetyl coenzyme A (AcCoA) by the 
enzyme choline-acetyltransferase (ChAT) which transfers an acetyl group from Ac-
CoA onto choline. In the synaptic cleft, ACh is rapidly hydrolyzed by acetylcholin-
esterase into choline and acetate, thereby terminating the ACh signal. Subsequently, 
choline is transported back into the nerve terminal and re-used for ACh synthesis. 
Cytoplasmic ACh is transported into synaptic vesicles by a vesicle specific proton 
pump (V-ATPase), packing about 10,000 molecules of  ACh into one single vesicle. 
Upon arrival of  an action potential at the presynaptic terminal, voltage-gated 
Ca2+ channels open. These are Cav2.1 (P/Q-type) channels, also widely expressed in 
the CNS (Wheeler et al., 1995). In the PNS, Cav2.1 channels are mainly restricted to 
the NMJ (Uchitel et al., 1992). The opening of  Ca2+ channels results in a short Ca2+ 
influx, causing a transient local elevation of  the Ca2+ concentration, from 100 nM 
to 200-300 μM. The Ca2+ signal is transmitted to the exocytotic protein machinery 
and induces rapid fusion of  vesicles from the readily-releasable pool (RRP) with 
the plasma membrane, thereby releasing ACh in the synaptic cleft. Vesicle fusion 
increases with [Ca2+]n, with n = 3-4, interpreted as three to four Ca
2+ ions to work 
cooperatively in inducing fusion (reviewed by Meir et al., 1999). 
ACh binds to the postsynaptic AChRs which in turn open and permit a net 
inward current of  positive ions, the endplate current (EPC). The EPC underlies a 
depolarization, the endplate potential (EPP) (Fatt and Katz, 1951). Using electro-
physiological techniques, EPPs can be measured in vitro (Figure 2, also see below). 
Next to the action-potential evoked EPPs, small depolarizations of  ~1 mV can be 
observed at ~1/s, the miniature endplate potentials (MEPPs) (Fatt and Katz, 1952). 
MEPPs are the result of  the spontaneous release of  one single quantum of  ACh. 
Typically, in the NMJ (depending on species, muscle-type and age), the quantal con-
tent of  endplates (i.e., the number of  vesicles that fuse upon a presynaptic action 
































Figure 2. NMJ electrophysiology
Schematic representation of  a hemidiaphragm, pinned out in a dish (A). The phrenic nerve has been placed on a 
bipolar stimulation electrode that delivers electrical pulses which trigger nerve-action potentials. Under microscopic 
inspection a muscle fiber is impaled with a microelectrode to monitor the membrane potential which typically is 
around -75 mV. Stimulation of  the nerve (indicated with a black dot) will eventually result in a muscle action po-
tential (B), which in most cases will disrupt the recording since it induces contraction of  the muscle. μ-Conotoxin-
GIIIB is used to block the muscle Na+ channels in order to prevent muscle action potentials, enabling undisturbed 
measurement of  the EPPs (C). Spontaneous release events can be monitored as MEPPs (D). The quantal content, 
which is the number of  vesicles that have fused to give rise to an EPP is calculated by dividing the EPP amplitude 
by the MEPP amplitude. (Modified from (Kaja, 2007) with permission).
The precise function of  MEPPs has not been established yet, but might involve 
regulation of  local postsynaptic protein synthesis (Sutton et al., 2004). Otherwise, 
it may be an intrinsic property of  the molecular machinery that mediates synaptic 
vesicle function (Lou et al., 2005). However, since spontaneous and evoked release 
seem to originate from distinct vesicle pools a functional relevance for spontaneous 
release cannot be excluded.
The EPP activates voltage-gated Na+channels, which initiate a muscle action 
potential that leads to contraction of  the muscle fiber. (Fatt and Katz, 1951). In 
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general, the EPP amplitude is several times higher than minimally required to excite 
the muscle fiber. This safety factor ensures that during prolonged, high-frequency 
activation of  muscles, when the amount of  transmitter released per nerve impulse 
declines substantially, transmission does not fail. (Wood and Slater, 2001).
 
In vitro electrophysiological analysis of  ACh release at the 
NMJ 
Several mouse nerve-muscle preparations can be used for studying NMJ electro-
physiology. In this thesis, the diaphragm-phrenic nerve preparation was mainly used, 
as well as the soleus-tibialis nerve preparation. The diaphragm preparation has the 
advantage that it is a flat, thin muscle (typically 10-15 fibers thick) and that its fibers 
can be easily visualized and are well accessible by microelectrodes. In addition, NMJs 
are localized in a central band along both hemi-diaphragms that can be easily visually 
identified. A further advantage is the length of  the phrenic nerve which can be dis-
sected, so that it can be placed over a bipolar electrode for stimulation (Figure 2A). 
The diaphragm is a mixture of  both slow- and fast-switch fibers. The soleus muscle 
is a technically somewhat more demanding preparation, as the NMJ region is not 
very well identifiable and nerve stimulation requires a suction electrode configura-
tion. Soleus muscles consist of  slow-twitch fibers. After dissection, the muscles are 
pinned on a silicone rubber-coated dish containing a physiological Ringer’s solu-
tion. 
A glass micro electrode (1 μm tip diameter), coupled to an amplifier, is impaled in 
the muscle cell near the endplate-region using a micromanipulator. The membrane 
potential is then measured, which is in rest around -75 mV. MEPPs can be recorded; 
typical values for diaphragm are 1 mV, occurring at a frequency of  1 s-1. Using a 
stimulus generator, the nerve can be electrically stimulated and the ensuing EPPs 
can be recorded. Because the measured resting membrane potential varies between 
the multiple muscle fibers sampled, amplitudes at each NMJ are normalized to -75 
mV.
Measures have to be taken to prevent muscle action potentials, since these ob-
scure the EPP and cause contraction which in general will disrupt the recording. 
Several methods exist to prevent muscle action potentials; the most straight-forward 
of  these is selectively blocking the muscle Na+ current by μ-conotoxin-GIIIB, a ma-
rine snail venom component. Other methods involve reducing the EPP amplitude 
to sub-threshold values for Na+ channel activation by blocking part of  the AChRs 
using the reversible antagonist d-tubocurarine. The drawback of  this method is that 
MEPPs will become too small to be measured.
From the EPP and MEPP values recorded, the quantal content at an endplate can 
be calculated by dividing the EPP amplitude by the MEPP amplitude. Beforehand, 
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the EPP amplitude needs to be corrected for non-linear summation (McLachlan and 
Martin, 1981). 
Some of  the experiments described in this thesis have been carried out on em-
bryonic or one day old mice. In addition to a slightly more complicated dissection, it 
appeared that muscle action potentials could not be blocked by μ-conotoxin-GIIIB. 
In these experiments, a depolarization-induced inactivation of  the Na+ channels was 
used to prevent muscle action potentials. To this end, diaphragm muscle fibers were 
shortened by cutting away some length from the central tendon side until depolar-
ization of  the muscle fibers to about -40 mV was reached, preventing the triggering 
of  action potentials by EPPs.  
Myasthenia gravis
Clinical symptoms
MG is a prototype for both synaptic and autoimmune disorders, with a prevalence 
of  around 20-500 per million (reviewed by Lindstrom, 2000; Vincent et al., 2001). 
The disorder is characterized by a painless, fatigable weakness. At onset, patients 
often have ptosis (eyelid drooping) and diplopia (double-vision) arising from levator 
palpebrae and extraocular muscle weakness. Typically within one year, 75% of  the 
patients will develop bulbar weakness (for example, facial weakness, difficult chew-
ing and defective articulation) and/or extremity weakness. Weakness can remain 
localized to one group of  muscles for many years (commonly in the eye-muscles, 
termed ‘ocular myasthenia’) or spread to affect other skeletal muscles (generalized 
MG). Myasthenic crises (life threatening episodes of  respiratory or bulbar paralysis) 
may occur.
MG is often accompanied by thymic abnormalities, and around 10% of  patients 
suffer from a lymphoepithelial thymoma (Oosterhuis, 1989). 
Histological analysis of  intercostal biopsies from myasthenic patients show a 
reduction or disappearance of  functional folds, with widened secondary folds and 
synaptic cleft (Vincent, 1987).
Mechanism
The majority (85%) of  patients with MG is seropositive for antibodies against 
the nicotinic AChR. The titers of  antibodies are highly variable amongst patients, 
and do not correlate well with severity of  the clinical symptoms between individu-
als. However, individual patient titers correlate well with clinical scores after plasma 
exchange, thymectomy and/or immunosuppressive treatment. The remaining 15% 
of  the patients is classified as seronegative MG. In a subset of  this group antibodies 
against muscle specific kinase (MuSK) have been found. The proportion of  sero-
negative MG patients with antibodies against MuSK seems to vary (60-70% in sera 
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from Oxford (Hoch et al., 2001) and Italy, 30-40% in sera from the USA and Japan, 
and none has yet been identified in Norway (reviewed in: Vincent and Leite, 2005).
The autoantibodies decrease the ACh sensitivity of  the NMJ, thereby reducing 
the safety-factor of  neuromuscular transmission. In healthy NMJs, the EPP ampli-
tudes decrease during repetitive stimulation (i.e. during voluntary muscle contrac-
tion) which is probably the result from depletion of  the vesicle pool in the presyn-
aptic terminal in combination with the behaviour of  Cav2.1 channels during high 
frequency stimulation. However, due to the safety-factor of  the NMJ, the EPPs 
will remain supra-threshold and will all elicit muscle action potentials. However, the 
reduced safety factor of  MG NMJs results in sub-threshold EPPs during repetitive 
stimulation which results in the observed (fatigable) weakness of  patients. 
There are three mechanisms by which the autoantibodies to the AChR lead to 
decreased ACh sensitivity at the NMJ: 1) complement-mediated damage of  the post-
synaptic membrane by antibodies, 2) increased internalization due to cross-linking 
by antibodies and 3) AChR block by direct binding of  antibodies (reviewed by: 
Boonyapisit et al., 1999). Complement-mediated lysis is by far the most important 
effect.
Depending on the type of  MG and the severity of  the symptoms several treat-
ments are given. These include the administration of  acetylcholinesterase inhibitors 
(in order to prolong the life-time of  ACh in the synaptic cleft), thymectomy, plasma-
exchange and immune-suppressive therapy.
Clinical and in vitro electrophysiology
Electromyographical methods are used in the diagnosis of  MG (reviewed in Merig-
gioli and Sanders, 2004). The two tests that are used are repetitive nerve stimulation 
(RNS) and single-fiber electromyography (SFEMG). In RNS the peripheral nerve 
is stimulated supramaximally and the compound muscle action potential (CMAP) is 
recorded with surface electrodes. In healthy muscles, the amplitudes of  the CMAPs 
will remain constant during the repetitive stimulation. In MG muscles however, the 
CMAP amplitude decreases during the train of  stimuli because an increasing num-
ber of  fibers no longer contracts due to EPPs that become sub-threshold for ac-
tion potential generation. In SFEMG, a needle is used to record from an individual 
muscle fiber during contraction of  a muscle (voluntary or stimulated). There is a 
small variation in the delay between the stimulation and the recorded muscle action 
potential between the successive stimuli. This ‘jitter’ phenomenon is caused by the 
variation in the time it takes for the EPP to reach the threshold and the initiation of  
the muscle action potential. Increased jitter is reflecting a defect in neuromuscular 
transmission, EPPs being peri-threshold. Sometimes an EPP will not be able to gen-
erate a muscle action potential at all, which is termed a ‘blocking’. 
18
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In vitro electrophysiological recording from muscle biopsies from MG patients 
showed a decreased MEPP amplitude (Elmqvist et al., 1964), indicating a decreased 
postsynaptic sensitivity for ACh. EPPs, measured at low frequency stimulation, 
showed a decreased amplitude, which is however higher than would be expected 
based on the MEPP amplitude reduction. This is caused by an increase in the quan-
tal content (Cull-Candy et al., 1980; Plomp et al., 1995), resulting from a homeostatic 
presynaptic response of  the NMJ in attempt to maintain successful transmission 
(see below). During high frequency stimulation of  the nerve, EPPs show increased 
rundown of  amplitude, compared to normal. 
Experimental models of  myasthenia gravis
Several animal models of  MG have been developed in order to study the pathophys-
iological mechanisms and possible treatments of  this disease.
The first model of  MG comprised injections of  rabbits with AChR purified 
from the Torpedo electrical organ, which caused paralytic symptoms. This experi-
mental auto-immune myasthenia gravis (EAMG) model provided much information 
about the pathophysiological mechanisms of  MG but the condition of  the animals 
proved to be difficult to control. After an initial phase with mild muscle weakness a 
more generalized MG follows, including breathing problems which ultimately lead 
to death of  the animals.
A more controllable model is toxin-induced MG (TIMG), in which the decreased 
ACh-sensitivity is achieved by repeated intraperitoneal injections with low doses 
of  α-BTx (Figure 3). Initially developed for rats (Molenaar et al., 1991), it has been 
changed and re-evaluated for the use in mice. 
Homeostatic upregulation of  neurotransmitter release at 
(neuromuscular) synapses
As outlined in the previous section, myasthenic synapses aim to compensate for the 
decreased sensitivity of  the postsynaptic cell to ACh by releasing more ACh upon 
nerve stimulation. This compensatory increase of  quantal content has been found 
in NMJs from MG patient muscle biopsies (Molenaar et al., 1979; Cull-Candy et al., 
1980), and has been confirmed by recordings in NMJs from animal models for MG 
(Molenaar et al., 1979; Cull-Candy et al., 1980; Takamori et al., 1984; Molenaar et al., 
1991; Plomp et al., 1992; Plomp et al., 1995). The increase in quantal content is cor-
related with the reduction of  the MEPP amplitude, indicating that regulation takes 
place at individual endplate level (Plomp et al., 1992; Plomp et al., 1995).
The increase of  neurotransmitter release in the myasthenic NMJ suggests that 
the neural activity in the NMJ is under homeostatic control (Davis and Bezprozvan-
ny, 2001; Burrone and Murthy, 2003). Homeostatic regulation of  transmitter release 
in response to decreased postsynaptic sensitivity in the NMJ has been described in 
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additional models. For example, in mice heterozygous knock-out for the Ig-contain-
ing isoform of  neuregulin the AChR density was reduced. This was compensated 
for by increased quantal content (Sandrock, Jr. et al., 1997). A similar phenomenon 
was seen in studies at the glutamatergic Drosophila NMJ. In one of  these studies 
mutations were induced in the glutamate receptor subunit GluRIIA (Petersen et al., 
1997). Expression of  a dominant negative form of  GluRIIA resulted in the decrease 
Figure 3. Toxin-induced myasthenia gravis
Toxin-induced myasthenia gravis (TIMG) is a non-immunogenic model of  MG, where reduced ACh sensitivity of  
the NMJ is induced by injection of  the nAChR-blocker α-BTx into mice.
(A) For 3 weeks, mice receive every 48 h an injection with either a 0.8 μg dose α-BTx (‘T’) or control vehicle (‘C’). 
(B) Reduced MEPP amplitudes in TIMG reflect the reduced ACh sensitivity due to block of  part of  the AChRs 
by α-BTx at the NMJ. Typically, the EPP amplitudes in TIMG NMJs are only slightly reduced, hence the quantal 
content of  these NMJs has been increased to compensate for the reduced ACh sensitivity. High rate (40 Hz) evoked 
release in TIMG NMJs typically shows increased rundown. (C) Schematic representations of  control and TIMG 
NMJs (star indicates α-BTx.). Arrows indicate unknown pathways that are being employed to increase vesicle fusion 
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of  the response to single quantum. However, the response to nerve stimulation was 
the same due to an increase in quantal content. In another study a constitutively ac-
tive catalytic subunit of  protein kinase A (PKA) was expressed (Davis et al., 1998) 
to achieve decreased postsynaptic sensitivity. In a third Drosophila study the excit-
ability of  the postsynaptic muscle was decreased by postsynaptic expression of  the 
Kir2.1 K
+ channel (Paradis et al., 2001). In all these cases the reduced postsynaptic 
sensitivity for the transmitter was (partly) counteracted by a compensatory increase 
in presynaptic transmitter release.
 Homeostatic control of  presynaptic release requires retrograde signaling to pro-
vide the presynapse with feedback on the current state of  neurotransmission. Many 
candidate retrograde messengers have been proposed, including soluble factors like 
brain-derived neurotrophic factor (BDNF), neurotrophins, nitric oxide, and endo-
cannabinoids (Fitzsimonds and Poo, 1998; Tao and Poo, 2001). Especially BDNF 
has been given much attention (Lohof  et al., 1993; Lessmann et al., 1994; Berninger 
and Poo, 1996; Lessmann, 1998; Schinder et al., 2000; Tyler et al., 2002). Magby and 
colleagues described the action of  BDNF as a retrograde messenger in cultured 
hippocampal neurons (Magby et al., 2006). It was proven by pharmacological means 
that BDNF was released from postsynaptic neurons upon depolarization, and that 
this had a direct enhancing effect on the spontaneous transmitter release of  the 
presynaptic cell. This process was dependent on activation of  presynaptic tyrosine 
kinase B (trk-B) and the postsynaptic intracellular Ca2+ concentration. 
Direct cell-cell contact by transsynaptic protein complexes may be employed as 
well in retrograde signaling (Davis and Bezprozvanny, 2001; Dean and Dresbach, 
2006; Futai et al., 2007). An example of  these trans-synaptic protein complexes that 
mediate presynaptic release in the CNS is a neuroligin-neurexin complex, formed 
by presynaptic Neurexin-β and the postsynaptic complex PSD-95-Neuroligin. Futai 
and colleagues described an experiment performed in cultured hippocampal neu-
rons where the levels of  postsynaptic PSD-95 and neuroligin were found to affect 
presynaptic release. This mechanism was dependent on the presence of  presynaptic 
β-neurexin (Dean and Dresbach, 2006; Futai et al., 2007). 
Studies in Drosophila have revealed the bone morphogenic protein (BMP) glass 
bottom boat (Gbb) as a retrograde signal in homeostatic synaptic plasticity. As men-
tioned above, expression of  a dominant negative of  GluRIIA induced a compen-
sational increase of  transmitter release, but this was not the case in mutants lacking 
the BMP receptor wishful thinking (Wit) (Haghighi et al., 2003). Gbb is a good 
candidate for the retrograde signal because it is expressed by developing muscle 
fibers, and Gbb deletion mutants have a similar phenotype as Wit deletion mutants 
(Keshishian and Kim, 2004). However, more recent evidence seems to contradicts 
this because both post- and presynaptic expression of  Gbb restores synaptic ho-
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meostatis in Gbb deletion mutants (Goold and Davis, 2007). Thus, the identity of  
the retrograde signal remains unknown. 
Another Drosophila study on a specific motoneuron-interneuron synapse de-
scribes a Gbb-Wit indendent example of  synaptic homeostatis. Deleting Dp186, 
one of  the Drosophila isoforms of  Dystrophin increases evoked presynaptic release. 
Mutants can be restored to wild-type levels by postsynaptic (but not presynaptic) 
expression of  Dp186 (Fradkin et al., 2008), indicating that the protein is involved in 
the retrograde signaling pathway. Interestingly, another Dystrophin isoform (DLP2) 
has shown to be involved in a similar manner in synaptic homeostasis in the NMJ 
(van der Plas et al., 2006). Recently, yet another protein, Dysbindin, was found to 
play a role in homeostatic modulation of  neurotransmission (Dickman and Davis, 
2009). Dysbindin is necessary on the presynaptic side in synaptic homeostasis. It 
colocalizes with synaptic vesicle proteins, indicating that it functions at or near the 
synaptic vesicle pool. Dysbindin has been linked to schizophrenia in humans, sug-
gesting that a defect in synaptic homeostasis is possibly contributing to this disease. 
However, this remains to be investigated.
Synaptic exocytosis
Exocytosis is defined as the process by which molecules are secreted from eukary-
otic cells through fusion of  membrane-bound vesicles with the plasma membrane. 
The most extensively studied example of  exocytosis is chemical synaptic transmis-
sion, used intensively by cells in the nervous system to transduce electrical signals. 
Upon arrival of  an electrical signal in the presynaptic terminal, fusion of  vesicles 
takes place. The released transmitter substance binds to receptor molecules on the 
postsynaptic cell, which in turn generates an electrical signal that travels onwards.
 
Vesicle pools and life cycle
Synaptic vesicles in the nerve terminal are organized in different pools, depending 
on their level of  fusion-readiness (Rizzoli and Betz, 2004). Vesicles in the readily 
releasable pool (RRP) are primed for fusion and await the Ca2+ trigger, in contrast 
to vesicles in the reserve pool (RP). Vesicles in this pool have to undergo several 
maturation steps in order to ‘prime’ them to make them readily releasable. These 
pools together are called ‘recycling pool’. There is a third pool, the ‘resting pool’ 
of  vesicles. The latter pool most likely provides the vesicles that undergo spontane-
ous release, while the RRP is responsible for regulated release (Fredj and Burrone, 
2009) 
Vesicles that take part in regulated exocytosis have a life cycle, starting with the 
synthesis of  the lipids and membrane proteins in the endoplasmatic reticulum and 
modification in the Golgi apparatus. The vesicle then is translocated from the soma 
to the nerve terminal, where neurotransmitter molecules are transported in the lu-
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reserve pool of  vesicles, or it will be directed to the active zone. At the active zone 
the vesicle docks at the plasma membrane and undergoes priming steps, making it 
ready (‘competent’) for Ca2+-triggered fusion-pore opening. 
Three endocytotic modes have been proposed (Figure 4) (reviewed by Smith 
et al., 2008). One mode is the ‘kiss-and-run’ pathway, where vesicles are retrieved 
before full collapse has occurred, maintaining the vesicle identity. Another mode is 
full-collapse fusion, where complete fusion of  the vesicle with the membrane takes 
place, the vesicle membrane has become part of  the cell membrane. Retrieval of  
the membrane occurs via clathrin coated pits. Alternatively, retrieval can take place 
via ‘bulk endocytosis’ where an endosomal structure is formed. In this case new 
vesicles are formed by budding from the endosomal structure. Most likely, these 
three modes coexist in synapses. 
Neuro-exocytotic proteins
A large number of  different proteins is implicated in the regulation of  the different 
stages of  the synaptic vesicle life cycle. Whereas some of  them are essential, others 
may have auxiliary or regulatory functions. The basic mechanism of  exocytosis is 
conserved from yeast to man and in different cell-types. Although homologous pro-
teins acting in specific steps in exocytosis have been identified across many species, 
Figure 4. Endocytotic pathways
Three different pathways have been proposed 
for endocytosis as depicted in this figure. (A) 
“Kiss and run”, where the vesicle fuses, is emp-
tied and closes again, and refilling takes place 
after it has been relocated from the site of  fu-
sion. (B) The vesicle fuses completely with the 
membrane, loosing its identity. The membrane 
is retrieved by clathrin coated pits (Clathrin is 
depicted by black bars) (C) A larger amount of  
membrane can be retrieved in bulk endocyto-
sis. An endosomal structure is formed, from 
which vesicles can bud.
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it has become clear that there is a wide variety of  differences in the specific steps of  
exocytosis, and homologous proteins may have distinct roles in different cell types 
or organisms. Therefore, many conflicting reports on the precise roles of  some of  
the exocytotic proteins exist. To discuss the detailed roles of  all existing neuro-exo-
cytotic proteins is beyond the scope of  this thesis Introduction. I will limit myself  
to a description of  the soluble N-ethylmaleimide-sensitive factor attachment protein 
receptors proteins (SNAREs) (Figure 5), which are believed to be the key-role play-
ers of  fusion and, in addition, the proteins studied in the experimental chapters of  
this thesis (Figure 6). 
SNAREs
At present, it is widely accepted that SNAREs are the key players in the final stages 
of  docking and subsequent fusion of  synaptic vesicles (Jahn and Sudhof, 1999; Chen 
and Scheller, 2001; Rizo and Sudhof, 2002; Jahn et al., 2003). They are small proteins 
(10-35 kDa), characterized by the SNARE motif, which comprises of  a stretch of  60 
to 70 amino acids, often localized next to a C-terminal transmembrane anchor. Most 
SNARE proteins contain one SNARE motif. However, the soluble NSF attach-
ment proteins (SNAPs) SNAP-25, SNAP-29 and SNAP-23 contain two of  them. 
SNAREs can be functionally divided into vesicle-associated (v-), and target-associ-
ated (t-) SNAREs (Sollner et al., 1993). However, as these functional categories do 
not apply to all types of  fusion reactions (e.g. fusion of  yeast vacuoles), a categoriza-
tion based on a single key residue in the SNARE motif, being either arginine (R) or 
glutamine (Q) was developed (see below).
Unstructured in solution, SNAREs can assemble into ‘SNARE-complexes’, 
which are formed by four SNARE motifs adopting an α-helical configuration in the 
center of  which there are four conserved, interacting amino acids (three glutamines, 
one argine). Based on this, a new classification has been made, Qa-SNAREs (or syn-
taxins), Qb-, and Qc- SNAREs (homologs of  the N- and C-terminal SNARE motif, 
respectively, of  SNAP-25), and R-SNAREs (vesicle-associated membrane proteins, 
VAMPs, also called synaptobrevins) (Fasshauer et al., 1998).  The four α-helices zip 
together from the N-terminal end of  the SNARE motifs toward the C-terminal 
membrane anchors, thereby pulling the membranes close together (Hanson et al., 
1997; Lin and Scheller, 1997). 
It is generally accepted that SNAREs provide the energy necessary to overcome 
the energy barrier for membrane fusion through their assembly into SNARE com-
plexes. These are extraordinarily stable, indicating that a lot of  energy was released 
upon assembly (Fasshauer et al., 2002). 
In neuronal exocytosis, the t-SNARES syntaxin 1a (Qa) and SNAP-25 (Qb and 
Qc) are predominantly located on the plasma membrane, whereas the v-SNARE 
VAMP/synaptobrevin (R) is located on the synaptic vesicle (Figure 5). If  the com-
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plex is located on both the vesicle and plasma-membrane, it is called a trans-SNARE 
complex. After fusion however, the complex is located only on the plasma mem-
brane, in ‘cis-configuration’, and needs to be disassembled. Disassembly is achieved 
by action of  the ATP-ase N-ethylmaleimide-sensitive fusion protein (NSF). In order 
to recruit NSF, binding of  the co-factors SNAPs is required. ATP hydrolysis by NSF 
leads to disassembly of  the complex (Sollner et al., 1993). After this, v-SNAREs are 
recycled to synaptic vesicles, while the t-SNAREs are re-organized for new rounds 
of  docking and fusion events (Figure 5)
Using in vitro assays of  liposome fusions, it has been shown that SNARE pro-
teins alone are sufficient for the actual fusion of  membranes, although the kinet-
ics of  this reaction are very slow (Weber et al., 1998). However, several observa-
tions argue against their exclusive role in membrane fusion. First, deletion of  the 
R-SNARE synaptobrevin in mice does not completely abolish synaptic exocytosis 
(10% remains) in mice (Schoch et al., 2001). Similar results were obtained from 
mice lacking the t-SNARE SNAP-25 (Washbourne et al., 2002). Second, deletion of  
the non-SNARE protein Munc18-1 abolished exocytosis completely (Verhage et al., 
2000). This shows that SNARE proteins alone are not sufficient for fusion. Thus, 
although being the core proteins of  membrane fusion, other factors in addition to 
SNAREs are required for exocytosis in vivo. 
Synaptic communication of  neuronal cells is a very delicate and precise process, 
which is highly tuned in time and space. Precise control of  synaptic exocytosis has 
evolved, in which many proteins play a role in the several aspects of  exocytosis. 
Below, a subset of  these is discussed, with relevance to the experimental studies of  
this thesis. For more information see the following reviews:  (Jahn and Sudhof, 1999; 
Chen and Scheller, 2001; Rizo and Sudhof, 2002; Jahn et al., 2003; Sudhof, 2004; 
Sudhof  and Rothman, 2009).
Munc18
Munc18-1 is a member of  the Sec1/Munc18 protein family, referred to as SM pro-
teins (Toonen and Verhage, 2003), consisting of  highly conserved cytosolic proteins 
of  ~60 to 80 kD. Deletion of  SM proteins generally leads to an impairment of  
vesicle trafficking and fusion, and is lethal in most organisms (reviewed in Toonen 
and Verhage, 2003). Although all SM proteins have shown to be important in vesicle 
trafficking and fusion, it appeared difficult to pinpoint their exact roles (Weimer and 
Jorgensen, 2003; Toonen and Verhage, 2003; Weimer and Richmond, 2005). 
Munc18-1 was first discovered as a binding-partner of  syntaxin-1 (Hata et al., 
1993) and was found to be the mammalian homologue of  the C. elegans protein 
Unc18, deletion of  which gives an uncoordinated movement phenotype (Hosono et 
al., 1992). Deletion of  Munc18-1 in mice resulted in a lethal phenotype at birth and 
a complete blockade of  synaptic vesicle fusion (Verhage et al., 2000). Munc18-1 is 
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one of  the seven SM proteins discovered in mammals and is exclusively expressed in 
neurons (Toonen and Verhage, 2003). 
SM proteins are arch-shaped molecules consisting of  three domains that form a 
central V-shaped cleft (Bracher et al., 2000; Misura et al., 2000). The interaction with 
syntaxin-1 is a common feature of  SM proteins (reviewed in Toonen and Verhage, 
2003).
Munc18-1 binds to syntaxin in two different modes, namely to the ‘open’ and 
the ‘closed’ form of  syntaxin. In the ‘closed’ form of  syntaxin, the N-terminal Habc 
domain of  syntaxin folds back on the C-terminal SNARE motif  and blocks SNARE 
complex assembly (Dulubova et al., 1999). Munc18-1’s arch shaped form clasps this 
‘closed’ conformation of  syntaxin (Misura et al., 2000). Munc18-1 can also bind via 

























Figure 5. Vesicle fusion protein machinery
Conformational cycle of  SNARE proteins. Syntaxin in ‘open’ state is able to form a trans SNARE complex with 
SNAP25 and synaptobrevin, releasing enough energy to induce membrane fusion. After fusion, αSNAP and NSF 
bind, and after ATP hydrolysis induce disassembly of  the cis SNARE complex. Munc18-1 binds to the ‘closed’ 
state of  syntaxin and needs to unbind to induce the open state. Not depicted here is the relocation of  synaptobre-
vin, most likely upon retrieval of  the vesicle membrane. The top panels include a schematic representation of  the 




open.  This cavity then can be used to bind the assembling four-helical structure of  
the SNARE complex (see Sudhof  and Rothman, 2009).
There has been a lot of  debate about SM proteins being either positive or nega-
tive regulators of  release. Genetic deletion of  SM proteins results in a strong impair-
ment or abolishment of  release, suggesting a positive role of  SM proteins. However, 
data on increasing SM protein levels (overexpression, injection) has led to conflicting 
results, suggesting either a positive or a negative role for the SM protein in exocy-
tosis (Schulze et al., 1994; Dresbach et al., 1998; Wu et al., 1998; Voets et al., 2001). 
The most likely explanation is that the dual mode of  interaction of  the SM proteins 
and their cognate SNARE proteins represents two roles of  the SM proteins. In 
membrane fusion, SM proteins have positive role (Shen et al., 2007) via the binding 
to the ‘open’ form of  syntaxin and providing selectivity as well since binding only 
occurs to the cognate syntaxin. In addition, SM proteins can have a chaperone role 
to protect syntaxin during intercellular transport via binding to the ‘closed’ form of  
syntaxin (Medine et al., 2007).
Munc13
Unc13 was discovered in a classical genetic screen for C. elegans aiming at identifying 
mutant genes responsible for ‘uncoordinated movements’ (Brenner, 1974). It has 
one Drosophila homologue, Dunc13 (Aravamudan et al., 1999). Three Munc13 iso-
forms function in synaptic exocytosis (Munc13-1, bMunc13-2/ubMunc13-2 (splice 
variants of  the Munc13-2 gene), and Munc13-3). Two other, ubiquitously expressed 
isoforms, presumably act in non-synaptic forms of  exocytosis (Munc13-4 (Feld-
mann et al., 2003) and BAP-3 (Shiratsuchi et al., 1998)). 
Munc13 proteins are large multidomain proteins with variable N-terminal se-
quences, but conserved central and C-terminal domains: a C2B (Ca2+ binding) do-
main, a large Munc13-homology region (the MUN domain) and a Ca2+-independent 
C2C domain. 
Deletion of  Munc13 proteins in C. elegans, Drosophila, and mice showed severely 
reduced evoked and spontaneous release, but a normal number of  docked vesicles 
(Aravamudan et al., 1999; Augustin et al., 1999; Richmond et al., 1999). The read-
ily releasable pool of  vesicles is strongly reduced, indicating that Munc13 acts after 
docking but prior to acquisition of  ‘fusion competence’, called priming. 
Munc13 interacts with syntaxin via its MUN domain, overexpression of  which 
rescues synaptic transmission in Munc13 deletion (Stevens et al., 2005). Unc13 binds 
syntaxin at the same binding site as Unc18, and is even able to replace Unc18 (Sassa 
et al., 1999). 
Munc13 and Munc18 have overlapping binding sites in the regulatory Habc do-
main of  syntaxin. Munc13 could potentially displace Munc18 when it is clamping 
syntaxin in the ‘closed’ conformation to enable transition to the ‘open’ conforma-
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tion, thereby enabling SNARE complex formation. Correspondingly, expression of  
a constitutively ‘open’ mutant of  syntaxin (but not wild-type) rescued the release 
properties of  a C. elegans Unc13 mutant (Richmond et al., 2001).
Munc13 participates in a tripartite complex with Rab3 and RIM, presumably to 
bring vesicles to the fusion machinery (Dulubova et al., 2005). Recent data suggests 
that this complex might be much more complex, also involving big presynaptic ac-
tive zone proteins like Bassoon, Acyonin/Piccolo and CAST. The N-terminus of  
Munc13 seems to be site where all binding converges (Wang et al., 2009).
Next to being involved in basic release of  neurotransmission, Munc13 has been 
shown to play a role in plasticity as well. The N terminal C1 domain is involved, 
which binds phorbol ester [4ß-phorbol-12, 13-dibutyrate (PDBu)] and diacyglycerol 
(DAG). This interaction is crucial for short term plasticity in the mouse hippocam-
pus (Rhee et al., 2002). In addition, recently it was shown that the C2B domain of  
Munc13 functions as a Ca2+ regulator of  short-term synaptic plasticity as well (Shin 
et al., 2010). 
α-Neurexin
Neurexin1α was originally discovered as a neuronal cell-surface protein that binds 
the neurotoxin α-latrotoxin (Ushkaryov et al., 1992; Petrenko et al., 1993). The latter 
stimulates synaptic vesicle exocytosis and induces massive neurotransmitter release 
(reviewed in: Sudhof, 2001). Neurexin1α is a member of  the neurexin protein family, 
which in mammals is encoded by three large genes (neurexin1, -2, and -3) (Tabuchi 
and Sudhof, 2002).  Each of  these genes contains a separate promoter for α- and 
β-neurexins. Neurexin genes are subject to intensive alternative splicing, potentially 
giving rise to thousands of  isoforms (Missler and Sudhof, 1998).
α-Neurexins are transmembrane proteins, containing an N-terminal signal pep-
tide followed by a three times repeated domain. Intracellularly, α-neurexins bind 
structural proteins with PDZ domains, Ca2+/calmodulin-dependent serine protein 
kinase (CASK), Munc interacting protein (Mint) and the SNARE synaptotagmin. 
Extracellularly, α-neurexins bind to the postsynaptic cell-adhesion proteins dystro-
glycan (Missler and Sudhof, 1998; Sugita et al., 2001), neurexophilin (Missler et al., 
1998) and neuroligin (Boucard et al., 2005).
Based on their structure and binding partners, neurexins have been suggested 
to function as cell-adhesion molecules that play an active role in the functional or-
ganization of  the presynaptic machinery (Missler et al., 1998; Missler and Sudhof, 
1998; Sudhof, 2001; Tabuchi and Sudhof, 2002; Missler et al., 2003). Deletion of  
α-neurexins in mice, however, showed morphologically normal synapses in brain. 
Interestingly, mutants lacking all three isoforms of  α-neurexin display reduced syn-
aptic N-type Ca2+ channel function, but unchanged numbers of  cell-surface Ca2+ 
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channels, suggesting that α-neurexins play a role in functionally coupling Ca2+ chan-
nels to the exocytotic machinery. 
As mentioned above, β-neurexin has been implicated in a transsynaptic retro-
grade signaling pathway with neuroligin (Futai et al., 2007). α-Neurexins potentially 
could act in a similar pathway with a specific splice variant of  neuroligin (Boucard 
et al., 2005).
Rab3A
Rab3A, B, C and D are small GTP-binding proteins that are involved in regulating 
membrane traffic (reviewed by Darchen and Goud, 2000). Rab3A, the most abun-
dant brain isoform (Geppert et al., 1994), is associated with synaptic vesicles, but 
dissociates upon GTP-to-GDP hydrolysis during, or shortly after the fusion event 
(Fischer von Mollard et al., 1991; Star et al., 2005). Rab3A is therefore alternating 
between a GTP- and a GDP-bound form, which may function as a molecular switch 
regulating interaction with binding partners. 
Rab3A binds to rabphilin (Shirataki et al., 1993), Rab-interacting molecule (RIM) 







Figure 6. Exocytotic proteins studied in this thesis
Depicted here are the proteins that have been studied in this thesis (indicated with an asterisk), along with some key-
role players in the process of  exocytosis. Arrows indicate interactions, see main text for further details.
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only leads to a mild synaptic phenotype that includes altered short-term synaptic 
plasticity, and the absence of  PKA-dependent long-term potentiation (Castillo et 
al., 1997; Geppert et al., 1997), suggesting a modulatory role for Rab3A. Mice that 
lack Rab3A, B, C, and D (quadruple knock-outs) are not viable, while the individ-
ual knock-outs display no or only a mild phenotype, indicating that Rab3 proteins 
are indispensable but individually are functionally redundant (Schluter et al., 2004). 
Analysis of  cultured hippocampal neurons from these quadruple knock-out mice 
showed impaired evoked neurotransmitter release, whilst leaving spontaneous re-
lease unchanged (Schluter et al., 2004). The C. elegans Rab3 homologue interacts with 
the RIM homologue and this interaction is likely to play a role in placing the vesicle 
in the proximity of  the presynaptic calcium channels (Gracheva et al., 2008). 
RIM1α
Rab interacting molecule-1α (RIM1α) is located presynaptically at the active zone 
and plays an important role in neurotransmitter release (Wang et al., 1997; Schoch et 
al., 2002; Schoch et al., 2006). It is a large multi-domain scaffolding protein that was 
originally discovered as a binding partner of  GTP-Rab3A, hence its name (Wang 
et al., 1997). So far, four genes (Rim1-4) encoding RIMs have been discovered in 
the mammalian genome. They encode six isoforms (RIM1α, 2α, 2β, 2γ, 3γ, and 4γ) 
(Wang et al., 2000; Wang and Sudhof, 2003). 
RIM1α interacts with Rab3 and Munc13 (Wang et al., 1997; Betz et al., 2001; 
Wang et al., 2001). Originally it was thought that this binding was mutually exclu-
sive (Betz et al., 2001). However, simultaneous binding can occur (Dulubova et al., 
2005). In addition to Rab3 and Munc13, RIM1α interacts with ELKS proteins (also 
known as Rab6-interacting protein or CAST, also abbreviated as ERC), α-liprins, 
synaptotagmin and RIM-binding protein (reviewed by Kaeser and Sudhof, 2005). 
Via the latter, RIM may in turn bind to voltage-gated Cav1 and Cav2.2 Ca
2+ chan-
nels (Hibino et al., 2002), although immunoprecipitation experiments with Cav2.2 
antibodies failed to show co-immunoprecipitation (Khanna et al., 2006; Wong and 
Stanley, 2010). 
RIM1α and Rab3A seem to jointly participate in several forms of  presynaptic, 
PKA dependent LTP (Castillo et al., 2002; Lonart et al., 2003; Huang et al., 2005; 
Simsek-Duran and Lonart, 2008). RIM1α is likely to be the PKA substrate in the 
signaling pathway and therefore might function as a phosphoswitch.
Aims and outline of  this thesis
This thesis characterizes the function of  several neuro-exocytotic proteins in ACh 
release at the mouse NMJ. For a selection of  these proteins it has been investigated 
whether they play a role in the mechanism underlying homeostatic upregulation 
of  presynaptic ACh release resulting from reduction of  the density of  functional 
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postsynaptic AChRs, such as present under myasthenic condition. To this end, NMJ 
electrophysiology and morphology of  several strains of   mice genetically deficient 
for one or more members of  neuro-exocytotic protein families has been investigated 
under normal conditions as well as after inducing experimental myasthenia gravis 
using α-BTx to block part of  the AChRs. 
Combined elimination of  Munc13-1 and Munc13-2 genes leads to a lethal phe-
notype around birth. This prevents analysis of  Munc13 function in the adult NMJ. 
In Chapter 2, a study of  NMJ function and morphology is therefore performed on 
Munc13-1/2 double knock-out mouse embryos. In Chapter 3 the effect of  genetic 
deletion of  single or multiple isoforms of  α-neurexin is reported. Morphological 
and electrophysiological studies have been performed on soleus muscle NMJ from 
adult mice and diaphragm NMJs from adult and one day-old mice. This chapter 
also describes the effect on ACh release homeostasis following application of  the 
toxin model of  myasthenia gravis on mice lacking both α-neurexin1 and -2. Chapter 
4 reports on the effect of  deleting Rab3A on neuromuscular transmission in so-
leus and diaphragm NMJs. Chapter 5 describes the effect of  reducing or increasing 
Munc18-1 protein levels on exocytotic parameters at the NMJ, in comparison with 
the effects on cultured glutamatergic and GABAergic central synapses. In view of  its 
modulatory roles, Munc18-1 might be a presynaptic target of  the retrograde signals 
involved in transsynaptic homeostatic upregulation of  transmitter release following 
reduction of  postsynaptic AChRs at the NMJ. In chapter 6, the effect of  reducing or 
increasing Munc18-1 protein levels on ACh release homeostasis was investigated in a 
mouse model for myasthenia gravis. Chapter 7 investigates basic transmitter release 
properties at NMJs of  mice lacking RIM1α as well as the homeostatic response of  
ACh release to toxin-induced myasthenia gravis. Chapter 8 provides the reader with 
a general discussion on the findings presented in this thesis and raises some ideas 
for future research.
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In cultured hippocampal neurons, synaptogenesis is largely independent of  synaptic 
transmission, while several accounts in the literature indicate that synaptogenesis 
at cholinergic neuromuscular junctions in mammals appears to partially depend on 
synaptic activity. To systematically examine the role of  synaptic activity in synap-
togenesis at the neuromuscular junction, we investigated neuromuscular synapto-
genesis and neurotransmitter release of  mice lacking all synaptic vesicle priming 
proteins of  the Munc13 family. Munc13 deficient mice are completely paralyzed 
at birth and die immediately, but form specialized neuromuscular end-plates that 
display typical synaptic features. However, the distribution, number, size, and shape 
of  these synapses, as well as the number of  motor neurons they originate from and 
the maturation state of  muscle cells are profoundly altered. Surprisingly, Munc13 
deficient synapses exhibit significantly increased spontaneous quantal acetylcholine 
release, although fewer fusion-competent synaptic vesicles are present and nerve 
stimulation-evoked secretion is hardly elicitable and strongly reduced in magnitude. 
We conclude that the residual transmitter release in Munc13 deficient mice is not 
sufficient to sustain normal synaptogenesis at the neuromuscular junction, essential-
ly causing morphological aberrations that are also seen upon total blockade of  neu-
romuscular transmission in other genetic models. Our data confirm the importance 
of  Munc13 proteins in synaptic vesicle priming at the neuromuscular junction but 
indicate also that priming at this synapse may differ from priming at glutamatergic 
and GABAergic synapses and is partly Munc13-independent. Thus, non-Munc13 
priming proteins exist at this synapse or vesicle priming occurs in part spontane-
ously, i.e. without dedicated priming proteins in the release machinery.  
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Transmitter release from presynaptic terminals is mediated by the exocytotic fu-
sion of  transmitter filled synaptic vesicles. Fusion of  these vesicles is triggered by 
membrane depolarization and concomitant influx of  Ca2+ ions, and is dependent 
on the SNARE proteins synaptobrevin/VAMP 2, syntaxin 1, and SNAP-25, whose 
assembly into a highly stable SNARE complex (Sutton et al., 1998) is thought to 
drive the fusion reaction  (Reviewed in: Rettig and Neher, 2002; Jahn et al., 2003; 
Fasshauer, 2003).
Before fusion can be initiated, synaptic vesicles must be primed into a fusion-
competent state (for review, see: Brose et al., 2000; Rettig and Neher, 2002; Rosen-
mund et al., 2003). Members of  the Munc13 family, mammalian homologues of  C. 
elegans Unc-13 (Brose et al., 1995), play an essential role during this priming reaction 
(Aravamudan et al., 1999; Richmond et al., 1999; Ashery et al., 2000; Rhee et al., 
2002; Rosenmund et al., 2002). At the molecular level, synaptic vesicle priming is 
thought to depend on a conformational switch of  the SNARE protein syntaxin 1 
from a closed conformation, which prevents SNARE complex assembly, to an open 
conformation, which permits it (Dulubova et al., 1999). It is believed that Munc13 
plays an important role during this conformational switch, since the overexpression 
of  an open syntaxin mutant in C. elegans bypassed the strict requirement for Unc-13 
(Richmond et al., 1999). In C. elegans, Unc-13 is essential for vesicle priming at both 
cholinergic and GABAergic synapses (Brenner, 1974; Richmond et al., 1999; Lack-
ner et al., 1999).
In mammals, the Munc13 protein family comprises three highly homologous 
members, Munc13-1, bMunc13-2/ubMunc13-2 (splice variants of  the Munc13-2 
gene), and Munc13-3 (Brose et al., 2000), which are differentially distributed in the 
brain (Augustin et al., 1999a) and confer differential short-term plasticity charac-
teristics to the synapses they equip (Rosenmund et al., 2002; Junge et al., 2004). 
Transmitter release from both glutamatergic and GABAergic neurons in the hip-
pocampus is strictly dependent on Munc13 function. In the absence of  Munc13-1 
and Munc13-2, these neurons show neither spontaneous nor evoked synaptic release 
events, yet develop normal numbers of  synapses which contain an electrophysi-
ologically normal postsynaptic AMPA and GABA receptor complement, but exhibit 
a broader active zone (Varoqueaux et al., 2002). These findings led to the conclusion 
that genesis and assembly of  synapses between hippocampal nerve cells are largely 
independent of  synaptic activity. Rather, synaptogenesis in the central nervous sys-
tem may follow a default developmental program that is only modulated, stabilized, 
and refined by synaptic activity (Varoqueaux et al., 2002).
In many aspects, the neuromuscular synapse, which uses acetylcholine as a neu-
rotransmitter, is similar to central synapses and therefore a widely used model for 
the study of  synaptogenesis. The formation and maturation of  the neuromuscular 
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junction (NMJ) is known to rely in part on activity-dependent signals. Initially, evi-
dence in support of  this view was obtained in studies where the developmental role 
of  synaptic transmission at the NMJ had been examined using anti-cholinergic or 
activity-blocking drugs (reviewed in: Misgeld et al., 2002; Brandon et al., 2003). More 
recently, genetic studies on mutant mice lacking choline acetyltransferase (ChAT), 
the enzyme responsible for producing acetylcholine, provided compelling evidence 
for the requirement of  neurotransmitter release in NMJ formation (Misgeld et al., 
2002; Brandon et al., 2003). 
Based on our observations in the central nervous system (Varoqueaux et al., 
2002), and the fact that Munc13 deficient mice are completely paralysed, we ex-
pected to find a total blockade of  transmitter release at the NMJ in the absence 
of  Munc13s. We report here the unexpected finding that neuromuscular synaptic 
transmission is not entirely abolished in the absence of  Munc13s. Nevertheless, the 
morphology of  the NMJ shows abnormalities comparable to those seen in ChAT 
deletion mutant mice. We characterize the features of  the neuromuscular apparatus 
in Munc13 deficient NMJs and discuss the role of  different types of  synaptic activ-
ity in regulating synaptogenesis at NMJs, and the function of  Munc13s at peripheral 
and central synapses. 
Materials and Methods
Mouse lines
Single deletion mutant mice lacking Munc13-1, Munc13-2, or Munc13-3 were pub-
lished previously (Augustin et al., 1999b; Augustin et al., 2001; Varoqueaux et al., 
2002). Double and triple mutant mice were obtained by interbreeding of  the single 
mutant lines. Prior to experiments, mice heteroyzygous for the lethal Munc13-1 de-
letion and heterozygous or homozygous for the Munc13-2 deletion, and in some 
cases also for the Munc13-3 deletion were mated for 24 h (embryonic day E0). At 
embryonic day E18.5, the pregnant mothers were sacrificed by cervical dislocation. 
Embryos were recovered by hysterectomy and further processed on ice. Homozy-
gous Munc13-1/2 double mutant and Munc13-1/2/3 triple mutant embryos were 
easily recognizable in the litter due to their complete paralysis and exhibited identical 
phenotypes in all subsequent experiments. Embryos heterozygous for the Munc13-1 
and Munc13-2 deletion, or heterozygous for the Munc13-1 deletion and homozy-
gous for the Munc13-2 deletion were indistinguishable from wild type animals (not 
shown) and served as littermate controls in all subsequent analyses.
Animal preparation 
For spinal cord preparations, E18.5 embryos were fixed by perfusion with 4% para-
formaldehyde in phosphate buffer. The spinal cord (cervical levels 3-5) was then 
dissected out under a binocular. For diaphragm preparations, E18.5 embryos were 
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decapitated, and the ribcage was quickly isolated and fixed by immersion (2-12 h). 
Subsequently, the diaphragm muscle was taken out and further processed for stain-
ing.
Histology 
In toto staining of  E18.5 embryos for bone and cartilage was performed by im-
mersion fixation of  the eviscerated embryo in absolute ethanol (4 days) and then 
acetone (3 days). After several washes in water, embryos were stained for 10 days in 
a solution containing 0.015% alcian blue, 0.005% alizarin red, 5% acetic acid, and 
93% ethanol. After washes in water, samples were kept in 20% glycerol/1% KOH 
for 16 h at 37°C, and then at room temperature until cleared. Samples were stored 
in 20% glycerol.
Western blotting 
The presence of  Munc13 isoforms at the NMJ was assessed by Western blotting 
of  muscle membranes that were prepared as follows. The diaphragm muscles from 
20 newborn mice were dissected out under a binocular and flash-frozen in liquid 
nitrogen. Diaphragms were then thawed, homogenized in buffer containing 20 mM 
HEPES pH 7.4, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 300 mM sucrose, 0.2 
mM PMSF, and 1 µg/ml Aprotinin, and centrifuged at 1,000 x g, 4°C for 10 min. The 
supernatant was further centrifuged at 15,000 x g, 4°C for 20 min, and the result-
ing pellet was resuspended in Laemmli sample buffer and analyzed in parallel with 
newborn mouse brain or lung homogenates (positive control) by SDS-PAGE (10 to 
20 μg per lane). Blots were probed with Munc13 isoform-specific rabbit polyclonal 
antibodies that were raised against recombinant protein fragments (Munc13-1, resi-
dues 3-317; bMunc13-2, residues 1-305; ubMunc13-2, residues 182-407; Munc13-3, 
residues 294-574; BAP3, residues 9-181; Munc13-4, residues 889-1088). 
Immunocytochemistry
50 µm-thick free-floating vibratome sections of  the spinal cord were made at the 
cervical level and either stained for the vesicular acetylcholine transporter (vAChT) 
using a rabbit polyclonal antibody (1:500, Chemicon) or Nissl-stained. Free-floating 
diaphragms from mutant and control mice were incubated with α-Bungarotoxin-
Alexa 568 (1:2000, Molecular Probes) or with antibodies against synapsin (rabbit 
polyclonal, 1:500, Synaptic Systems), or S-100 (Mouse monoclonal, 1:500, DAKO), 
to visualize acetylcholine receptors, presynaptic terminals, and Schwann cells, re-
spectively. Acetylcholinesterase activity was visualized histochemically by incubation 
of  the fixed diaphragms for 30 min at 37°C in 0.5 mM 5-bromoindoxyl acetate (23). 




Fluorescent images were acquired on a Zeiss Axiovert 200-LSM 510 confocal laser 
scanning microscope, and bright-field images were obtained with a Camedia (Olym-
pus) digital camera fixed on a Leica Binocular (for embryos) or a Zeiss Axiophot 
upright microscope (for Nissl staining). Alternatively, fluorescent and bright-field 
images were acquired on an Olympus BX61 microscope with an F-View (EsiVision) 
digital camera coupled to an image acquisition and analysis software (EsiVision).
Ultrastructural analysis
Ultrastructural investigation of  the right phrenic nerve and whole diaphragm muscle 
synapses was carried out on samples that had been fixed by immersion with 4% 
paraformaldehyde and 0.5% glutaraldehyde and classically processed for epoxy-em-
bedding with Durcupan (ACM, Fluka). 50-nm thick sections were contrasted and 
observed in a LEO912AB transmission electron microscope, and digital pictures 
taken with a Proscan CCD camera coupled to the EsiVision Software which was also 
used for quantitative analysis.
Electrophysiology 
Ex vivo electrophysiological measurement of  acetylcholine release was performed 
at 26-28°C on NMJs of  diaphragm nerve-muscle preparations from Munc13-1/2-
DKO, Munc13-1/2/3-TKO and control E18 embryos. Muscles were dissected 
and mounted in Ringer’s medium (containing in mM: NaCl 116, KCl 4.5, CaCl2 2, 
MgSO4 1, NaH2PO4 1, NaHCO3 23, glucose 11, pH 7.4, pre-bubbled with 95% O2 / 
5% CO2). Muscle fibres were impaled at the endplate region with a 20-40 MΩ glass 
capillary micro-electrode, connected to standard recording equipment (Plomp et al., 
1992). Intracellular recordings of  miniature endplate potentials (MEPPs), the spon-
taneous depolarizing events due to uniquantal acetylcholine release, were made at 
different NMJs within the muscle. The phrenic nerve was stimulated supramaximal-
ly via a suction electrode. The resulting muscle contraction was visually monitored 
and muscle action potentials, if  present, were recorded. To be able to record evoked 
synaptic responses (endplate potentials, EPPs) in control preparations, muscle fibres 
were cut alongside the endplate region to induce depolarization to -20 - -40 mV 
(Barstad and Lilleheil, 1968). This inactivates Na+ channels, so that muscle action 
potentials and the ensuing contractions no longer occur and the underlying EPP 
can be recorded. In Munc13-DKO/TKO muscles this procedure was not neces-
sary because depolarization to -20 to -40 mV often occurred spontaneously after 
impalement with the micro-electrode. Munc13-DKO/TKO fibres were more fragile 
and thinner than controls and probably became damaged by the impalement. Also, 
synaptic recordings were much less disturbed by contraction of  neighbouring fibres, 
because these were much less vigorous than in control muscles. From each NMJ 11-
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144 responses to nerve stimulation at 0.3 Hz were recorded. The mean amplitudes 
of  EPP and MEPP recorded at each NMJ were linearly normalized to -75 mV rest-
ing membrane potential. From the grand-mean values of  each muscle, the number 
of  acetylcholine vesicles released per nerve impulse, i.e. the quantal content, was 
calculated by dividing the mean EPP amplitude by the mean MEPP amplitude.
In intact control and Munc13-DKO/TKO muscles, MEPPs were recorded be-
fore and after application of  2.5 nM α-latrotoxin (Alomone Laboratories, Jerusalem, 
Israel) or 0.5 M sucrose, to probe the acetylcholine vesicle pool available for im-
mediate release. In these experiments tetrodotoxin (1 µM, Sigma-Aldrich, Zwijn-
Figure 1. Munc13 isoforms at the neuromuscular junction and phenotypic alterations in the Munc13-1/2-
DKO mouse mutant.
(A), Immunoblot analysis of  muscle membrane extract (“M”) with anti-Munc13-1, -b/ubMunc13-2, -Munc13-3, 
-Munc13-4 and -BAP3 isoform-specific antibodies. Brain (“B”) or lung (“L”) homogenates were used as positive 
control. (B,C), E18.5 Munc13-1/2-DKO mutant and control littermate mice gross morphology (B) and skeleton 
(C; bones are stained in blue and cartilage in pink). White arrow points to a broadened rib cage, black arrow to a 
stiffened neck and a compacted spinal cord. Scale bar: 3 mm.
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drecht, The Netherlands) was added to reduce the spontaneous contractions of  
fibers which can occur in embryonic muscle. All electrophysiological data are given 
as group mean values ± S.E.M. with n as number of  muscles per group and 1-20 
NMJs sampled per muscle.
Results
Macroscopic phenotype of  Munc13-1/2 double deficient mutants
Munc13-2 and Munc13-3 single mutant mice are viable, fertile, and show no abnor-
malities (Augustin et al., 2001; Varoqueaux et al., 2002), while Munc13-1 deficient 
mice die within a few hours after birth (Augustin et al., 1999b).
The Munc13-1/2 double deletion mutant mice (Munc13-1/2-DKO) and 
Munc13-1/2/3 triple deletion mutant mice (Munc13-1/2/3-TKO) studied here 
showed even stronger phenotypic alterations, whereas Munc13-2/3 double mutant 
mice (Munc13-2/3-DKO) were viable and fertile, indicating a dominant role of  
Munc13-1 in mice. Munc13-1/2-DKOs and Munc13-1/2/3-TKOs were morpho-
logically indistinguishable from each other, and had identical phenotypes with re-
spect to neuromuscular synaptic structure and function (see below). This could be 
due to the fact that NMJ axon terminals contain Munc13-1 and ubMunc13-2, but 
neither bMunc13-2 nor Munc13-3, as determined by Western blot analysis of  mus-
cle membrane preparations (Figure 1A). Therefore, results obtained from Munc13-
1/2-DKOs and Munc13-1/2/3-TKOs were pooled and subsequently referred to 
as ‘Munc13-1/2-DKO’ for clarity. More distantly related Munc13 homologues are 
either faintly (Munc13-4; MW 112 kDa) or not detectable (BAP3; MW 125 kDa) 
in muscle membrane preparations (Figure 1A). Because Munc13-1/2-DKOs were 
often born dead, all experiments were carried out on E18.5 embryos, whose central 
and peripheral nervous systems are developed extensively and which can be recov-
ered alive upon hysterectomy. Munc13-2-KO and Munc13-2/3-DKO littermates 
were used as controls as they were indistinguishable from wild type animals with 
respect to neuromuscular synaptic transmission. 
Munc13-1/2-DKO embryos were completely paralyzed, did not breathe or re-
spond to tactile stimulation, and had a very fragile appearance. They had a hunched 
posture (Figure 1B), and often showed hematomes along the spinal cord and on 
the skull. In the Munc13-1/2-DKO (Figure 1C), no developmental defect of  the 
skeleton was detectable after in toto staining for bone and cartilage. However, the 
ribcage appeared larger and the vertebra more compact at the cervical level, prob-
ably reflecting a permanent paralysis of  the embryo throughout development. 
The total paralysis we observed in Munc13-1/2-DKO embryos indicated a pro-
found defect at the NMJ in addition to the central nervous system dysfunction seen 
in these mice (Augustin et al., 1999b; Varoqueaux et al., 2002). To examine this in 
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more detail, we investigated the structure and function of  the NMJ using the well 
characterized phrenic nerve/diaphragm muscle preparation as a model system.
Muscle morphology in Munc13-1/2 double deficient mutants
The fragile appearance of  the Munc13-1/2-DKOs was paralleled by an abnormally 
thin musculature. In E18.5 embryos, the diaphragm muscle appeared fully developed 
along its rostro-caudal axis, but its outermost edges indicated an impaired lateral ex-
tension of  myotubes (Figure 2A). Moreover, muscle fibers were not strictly aligned 
and formed intermingled bundles (Figure 2A). Muscle cells were more loosely at-
tached to each other, on average smaller than in diaphragms of  control littermates 
(muscle cell area: 389 ± 25 µm2, n=104, control, vs. 136 ± 5 µm2, n=227, Munc13-
1/2-DKO), and exhibited centrally localized nuclei that had apparently not migrated 
to the cell periphery (Figure 2B), indicating a maturation delay or defect of  some of  
the myotubes. In addition, many mostly oversized blood vessels ran throughout the 
diaphragm (Figure 2B), possibly due to a lack of  muscle tone. 
Figure 2. Impaired morphology of  the Munc13-1/2-DKO diaphragm muscle.
 (A,B), Detail of  wholemount (A) and Nissl-stained semithin cross-section (B) of  Munc13-1/2-DKO mutant and 
control littermate. Black arrows indicate oversized blood vessels, white arrows poorly differentiated myotubes. Scale 
bar:  100 μm in A, 30 μm in B.
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Diaphragm innervation in Munc13-1/2 double deficient mutants
The diaphragm is innervated by the left and right phrenic nerves, each of  which 
branches and forms synapses that are typically organized in a discrete end-plate 
band within the central region of  the respective hemidiaphragm. Using a whole-
mount enzymatic staining for acetylcholinesterase, which is particularly abundant 
at the synaptic cleft, we observed regularly distributed synapses in both hemidi-
aphragms of  control mice (Figure 3). In Munc13-1/2-DKOs however, the phrenic 
nerves exhibited an abnormally extensive branching throughout the muscle, and its 
terminal arborizations covered a much broader surface of  the muscle (Figure 3). 
The acetylcholinesterase staining intensity in Munc13-1/2-DKO diaphragms, which 
correlates with the amount of  acetylcholineesterase present at a given synapse, was 
slightly reduced as compared to control levels. 
To further analyze the neuromuscular connectivity in Munc13-1/2-DKOs, 
combined immunostainings for synapsin-containing presynaptic terminals, 
α-bungarotoxin-binding acetylcholine receptors, and S-100-expressing Schwann cells 
were carried out. In control as well as in Munc13-1/2-DKO diaphragms, all axon 
terminals were juxtaposed to acetylcholine receptor clusters, and vice versa, and 
all terminals were ensheated by Schwann cells (Figure 4). However, acetylcholine 
receptor and synapsin stainings showed that motor endplate units in the Munc13-
1/2-DKO diaphragm were only poorly aligned along the midline of  the diaphragm 
and no longer confined to it, but rather distributed as a large array of  clusters (Figure 
4). Quantitative analyses showed that the area occupied by endplates (as defined by 
α-bungarotoxin labeled acetylcholine receptor clusters) at the midline of  the dia-
phragm was larger in the Munc13-1/2-DKO than in the control mice (4984 ± 1150 
Figure 3. Impaired branching and endplate distribution of  the Munc13-1/2-DKO phrenic nerve termi-
nating onto the diaphragm surface.
(A,B), Detail of  the left (A) and right (B) hemidiaphragms of  Munc13-1/2-DKO mutant and control littermate, 
stained for acetylcholinesterase. Scale bar: 180 μm.
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µm2 per 0.2 mm2, n=5, in Munc13-1/2-DKOs vs. 2144 ± 436 µm2 per 0.2 mm2, 
n=5, in control mice, p<0.05). In addition, the number of  synapses was clearly in-
creased in the Munc13-1/2-DKO diaphragms mouse (not shown). 
Cytoarchitecture of  the spinal cord and morphology of  the phrenic nerve in Munc13-1/2 
double deficient mutants
The phrenic motor neuron cell bodies that innervate the diaphragm are located at 
cervical levels C3-C5 of  the spinal cord, and typically undergo massive apoptosis 
around E15-17 in the rat and mouse embryo (Harris and McCaig, 1984; Allan and 
Greer, 1997). We analyzed the number of  the large cell body phrenic motor neu-
rons in control and Munc13-1/2-DKO mice in Nissl-stained vibratome sections. 
We found that at all cervical levels these motor neuron groups in the ventral horn 
were larger in Munc13-1/2-DKOs and contained more cells than the correspond-
ing areas in control sections (Figure 5A). No sign of  degeneration was detectable in 
dorsal root ganglia (not shown). Motor neuron somata receive a specific recurrent 
cholinergic innervation which we visualized by immunostaining for the vesicular 
acetylcholine transporter vAChT. Cholinergic terminals in the ventral horn of  cervi-
cal levels C3-C5 in the Munc13-1/2-DKO showed a density that was comparable 
to that in control sections, but were covering a larger area of  the ventral horn, again 
indicating an abnormally large population of  motor neurons in the mutant (Figure 
5B). Low magnification ultrastructural analysis of  phrenic nerves showed that as a 
result of  the increased motor neuron number in Munc13-1/2-DKOs, the nerves 
were larger and contained more axons (367 ± 27, n=6, in Munc13-1/2-DKO vs. 
213 ± 16, n=8, in controls, p<0.001) (Figure 5C,D). This mutant phenotype was 
accompanied by an increased number of  Schwann cell bodies (44 ± 5.8, n=3, in 
Munc13-1/2-DKO vs. 27 ± 1.5, n=3, in controls, p<0.05), but the extent of  axon 
myelinization was similar in control and Munc13-1/2-DKO nerves (not shown).
Figure 4. Normal apposition of  presynaptic, postsynaptic, and glial elements at the Munc13-1/2-DKO 
motor endplate.
(A, B), Confocal micrographs of   Munc13-1/2-DKO mutant and control littermate, double-immunostained for 
α-bungarotoxin (to visualize  acetylcholine receptors) and synapsin (as a marker for presynapses) (A) or S-100 (as a 
marker for Schwann cells) (B). Scale bar: 90 μm in A, 190 μm in B.
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Figure 5. Increased number of  motor neurons in the Munc13-1-
/2-DKO mutant spinal cord.
(A), Groups of  large-bodied motor neurons are easily identified in the 
ventral horn of  Nissl-stained cervical spinal cord sections of  Munc13-1-
/2-DKO mutant and control littermate. (B), Detail of  the motor neuron-
specific cholinergic innervation obtained by immunostaining for vAChT 
in the ventral horn of  the spinal cord of  Munc13-1/2-DKO mutant 
and control littermate. (C), Low-magnification electron micrographs of  
transversally cut right phrenic nerves of  Munc13-1/2-DKO mutant and 
control littermate; insert shows a detail of  a myelinated axon; (D), Quan-
tification of  the number of  motor neuron axons in the phrenic nerve of  
control littermate (n=8) and Munc13-1/2-DKO mutant embryos (n=6). 




Electrophysiological properties of  neuromuscular synaptic transmission in Munc13-1/2-
DKO mice
We investigated the characteristics of  synaptic transmission at the NMJ of  Munc13-
1/2-DKOs and Munc13-1/2/3-TKOs. As predicted by the lack of  Munc13-3 
immunoreactivity in NMJ terminals, our analyses showed no difference between 
Munc13-1/2-DKOs (n=13) and Munc13-1/2/3-TKOs (n=3). Therefore, as for 
morphological observations, data from Munc13-1/2-DKOs and Munc13-1/2/3-
TKOs were subsequently pooled. 
Surprisingly, and in contrast to glutamatergic and GABAergic synapses in hip-
pocampal neurons, intracellular recordings of  MEPPs revealed that neurotransmit-
ter release is not completely abolished at the NMJs of  Munc13-1/2-DKOs. MEPP 
amplitude (2.89 ± 0.28 mV, n=15 muscles) was not statistically significantly different 
from control embryos (2.96 ± 0.28 mV, n=15, p=0.86), and MEPP frequency was 
more than doubled in Munc13-1/2-DKOs (4.42 ± 0.60 per min, n=15), as com-
pared to controls (1.80 ± 0.34 per min, n=15, p<0.001, Figure 6A). α-Latrotoxin 
elicits massive asynchronous uniquantal acetylcholine release through exocytosis 
from all synaptic vesicles that are fusion-competent and therefore are probably in 
a primed state. Application of  this toxin revealed that this type of  neurotransmit-
ter release is strongly impaired at NMJs of  Munc13-1/2-DKO embryos. MEPP 
frequency was 591 ± 137 per min (n=8) in Munc13-1/2-DKO and 1996 ± 500 per 
min (n=7, p<0.05) in control NMJs (Figure 6B). MEPP amplitudes were similar 
in Munc13-1/2-DKO (4.00 ± 0.6 mV, n=6) and controls (2.81± 0.30 mV, n=7, 
p=0.09). Like α-latrotoxin, application of  hypertonic sucrose solution, which trig-
gers the release of  fusion-competent synaptic vesicles, induced much lower MEPP 
frequencies in Munc13-1/2-DKO  (144 ± 66 per min, n=5) as compared to controls 
(619 ± 100 per min, n=7, p<0.01) (Figure 6C). Unexpectedly, sucrose treatment re-
duced MEPP amplitude to 1.33 ± 0.24 mV, n=5, compared to 3.35 ± 0.23 mV, n=7, 
in the controls. Thus, the asynchronous uniquantal acetylcholine release induced by 
α-latrotoxin or hypertonic shock is severely reduced at Munc13-1/2-DKO NMJs.
We stimulated the phrenic nerve at 0.3 and 20 Hz through a suction electrode 
to evoke acetylcholine release by nerve impulses. The resulting muscle contractions 
were monitored visually through the microscope. We observed a robust contraction 
of  the whole control muscle preparation, involving all muscle fibres, which was well 
sustained at 20 Hz. However, contraction of  Munc13-1/2-DKO preparations was 
much weaker because not all fibres contracted and was not very well sustained at 20 
Hz. This indicated that presynaptic transmitter release can at least to some extent 
induce postsynaptic action potentials in these mutants (Figure 6D). EPPs were re-
corded in depolarized fibres. In 77.1 ± 4.0% of  the cases (n=12), evoked stimulation 
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trols, only 0.7 ± 0.7% (n=6) failures were observed (Figure 6D, E). In the Munc13-
1/2-DKO, stronger variability in the delay between the time of  nerve stimulation 
and EPP-ocurrence was observed (Figure 6D).  The amplitude of  the evoked EPP 
was significantly smaller in Munc13-1/2-DKO (5.52 ± 0.46 mV, without failures 
taken into account; 1.34 ± 0.26 mV, with failures taken into account; n=12) than in 
control NMJs (21.40 ± 2.10 mV, n=6, p<0.001) (Figure 6F). The calculated quantal 
content was decreased by 81%, from 6.09 ± 0.74 (n=6) in control NMJs to 0.56 ± 
0.20 (n=6) in the Munc13-1/2-DKO NMJ (Figure 6G). Thus, nerve impulse-evoked 
acetylcholine release is dramatically reduced at Munc13-1/2-DKO NMJs.
Figure 6. Strongly reduced acetylcholine release evoked by nerve impulses, α-latrotoxin, or hypertonic 
medium at Munc13-1/2-DKO NMJs. 
Bar graphs display the group mean values ± S.E.M (n=5-15 embryos, 1-21 NMJs sampled per muscle). (A), Spon-
taneous uniquantal acetylcholine release, MEPPs, recorded in normal Ringer's medium. Superimposed example 
traces show the MEPPs observed during a 135 s measuring period. (B), MEPPs recorded in the presence of  2.5 nM 
α-latrotoxin. (C), MEPPs recorded in the presence of  0.5 M sucrose-Ringer. (D), Examples of  nerve stimulation 
evoked responses. The moment of  phrenic nerve stimulation is indicated with a black triangle. At relative hyper-
polarized membrane potentials, a full-size muscle action potential is elicited in control muscle (upper left), leading 
to contraction that is visible as an artifact on the signal (indicated by open triangle). At Munc13-1/2-DKO NMJs, 
subthreshold and delayed EPPs and failures were observed (upper right), sometimes leading to delayed muscle 
action potentials. Subsequent traces (0.3 Hz stimulation) have been superimposed. At depolarized muscle fibres, 
EPPs become unmasked. At control NMJs, no failures were observed at 0.3 Hz stimulation (bottom left), while at 
Munc13-1/2-DKO NMJs there were many failures and very small, delayed EPPs. (E), Percentage of  stimuli leading 
to failures. F, EPP amplitude, normalized to  75 mV membrane potential, failures taken into account. (G), Quantal 
content, i.e. the number of  acetylcholine quanta release upon a single nerve impulse.
Figure 7. Immature but well-formed neuromuscular synapses in the Munc13-1/2-DKO mutant. 
Electron micrographs of  representative motor endplates in Munc13-1/2-DKO mutant and control littermate. At 
low magnification (A), Munc13-1/2-DKO motor endplates are always composed of  more presynaptic elements, 
containing numerous small synaptic vesicles, than the littermate ones. In either case, magnified areas of  the synaptic 
active zone (B) allow to recognize small synaptic vesicles docked at the active zone membrane, large dense-core 
vesicles, clathrin-coated vesicles, and an intact basal lamina. However, the postsynaptic membrane of  the Munc13-
1/2-DKO muscle cell fails to develop secondary folds that normally accompany the maturation process of  neuro-





Ultrastructural characteristics of  NMJs in Munc13-1/2 double deficient mutants
At the ultrastructural level, well-formed synapses were observed in both control ani-
mals and Munc13-1/2-DKOs. Synapses in the mutants tended to contain more bou-
tons than control synapses, which may be a correlate of  the increased complexity of  
innervation and the larger endplate size observed in the mutants at the light micro-
scopic level (Figure 4). Synaptic boutons at NMJs of  Munc13-1/2-DKOs contained 
normal sized small synaptic vesicles, but also dense core and clathrin-coated vesicles 
(Figure 7). Boutons in mutant synapses were aligned with postsynaptic densities in 
muscle cells and exhibited clusters of  small synaptic vesicles that were occasionally 
observed along the plasma membrane or docked at the active zone (Figure 7, insert). 
Pre- and postsynaptic membranes were continuously juxtaposed to each other and 
separated by a well-developed basal lamina. In the control samples, many synapses 
showed junctional folds reflecting a normal maturation process. In contrast, small 
invaginations, but no deep folds were observed at the postsynaptic membranes of  
NMJs in Munc13-1/2-DKOs (Figure 7, insert).
Discussion
The functional relevance of  differential Munc13 protein expression at the NMJ 
Munc13-1, -2, and -3 are essential for synaptic vesicle priming in central synaps-
es. Data on the priming activity of  N-terminally truncated Munc13-1 fragments 
(Ashery et al., 2000) indicate that the evolutionarily conserved domain structure in 
Munc13-1, -2, and -3 and the related Munc13-4 (Koch et al., 2000) and BAP3 (Shi-
ratsuchi et al., 1998) proteins, which consists of  two Munc13-homology domains 
(MHDs) flanked by two C2 domains, acts as the minimal priming module. This 
module covers most of  the C-terminal two thirds of  Munc13-1/2/3 (Brose et al., 
2000), and is thought to mediate Munc13 priming activity by binding to (Betz et al., 
1997) and regulating the function of  syntaxins (Richmond et al., 2001). Differences 
between members of  the Munc13 protein family with respect to their priming ac-
tivity or the fusion reaction they regulate could be due to the type of  syntaxin-like 
SNARE protein their minimal priming module interacts with. 
We found the murine NMJ to contain Munc13-1 and ubMunc13-2, but not 
bMunc13-2, Munc13-3, or the more distantly related BAP3, and only trace amounts 
of  Munc13-4. The two Munc13 isoforms expressed at the NMJ are the most closely 
related Munc13 variants. In contrast to other family members, they do not only 
share the highly conserved C-terminal region but also have highly homologous N-
terminal regions which contain a C2 domain that binds the active zone components 
RIM1 and RIM2 (Betz et al., 2001) and a calmodulin binding site (Junge et al., 2004). 
Thus, Munc13-1 and ubMunc13-2 may interact with the same protein partners and 
have similar basic functions, and mutual compensation upon loss of  one of  the two 
isoforms is highly likely at the NMJ, as was also reported for hippocampal GABAer-
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gic synapses (Varoqueaux et al., 2002). Nevertheless, Munc13-1 and ubMunc13-2 
differentially modulate short-term plasticity at hippocampal synapses (Rosenmund 
et al., 2002; Junge et al., 2004), and their coexpression at the NMJ may allow for the 
tuning of  presynaptic molecular mechanisms over a wide range of  synaptic activity 
rates in order to guarantee high fidelity of  synaptic transmission. 
Using the diaphragm NMJ as a model system, we found that upon genetic dele-
tion of  Munc13s (Munc13-1, -2, and -3) and in the absence of  significant levels of  
the related Munc13-4 and BAP3 proteins, evoked synaptic transmission is strongly 
reduced while spontaneous release persists, and the NMJ system exhibits all classi-
cal developmental aberrations that are typically observed upon complete block of  
spontaneous and evoked synaptic transmission (Misgeld et al., 2002; Brandon et al., 
2003). In the light of  previous studies on the function of  Munc13s at central synaps-
es, two of  our findings at the NMJ are very unexpected: (i) Synaptic vesicle priming 
in the NMJ appears to be partially independent of  bona fide Munc13s (Munc13-1, 
-2, and -3), and (ii) despite the quite large spontaneous transmitter release activity 
at Munc13-1/2-DKO NMJs, the innervation of  the diaphragm exhibits the same 
developmental aberrations that are also observed in the complete absence of  NMJ 
synaptic transmission (Misgeld et al., 2002; Brandon et al., 2003).
Munc13 independent synaptic vesicle priming at the NMJ 
Synaptic transmission at glutamatergic and GABAergic synapses of  murine hip-
pocampal neurons is strictly dependent on the presence of  Munc13-1 and -2. 
Munc13-3, Munc13-4 or BAP3 do not functionally replace Munc13-1 and -2 in 
these synapses (Varoqueaux et al., 2002). Likewise, spontaneous and evoked trans-
mitter release at the cholinergic NMJ in C. elegans is entirely blocked in worms car-
rying the complete loss-of-function allele of  unc-13, unc-13(s69) (Richmond et al., 
1999), although an Unc-13 homologue similar to BAP3 and Munc13-4 (Koch et al., 
2000) is most likely present. In contrast, at murine NMJs lacking Munc13s, sponta-
neous transmitter release persists and some evoked transmitter release is elicitable. It 
is unlikely that trace amounts of  Munc13-4 or BAP3 mediate the residual synaptic 
vesicle priming at these mutant NMJs because even robust levels of  BAP3 are not 
sufficient to ameliorate the Munc13 deficient mutant phenotype in hippocampal syn-
apses (Varoqueaux et al., 2002), and Munc13-4 does not bind to RIM (Koch et al., 
2000). Apart from Munc13-4 and BAP3, CAPS proteins (i.e. CAPS1 and CAPS2 in 
mammals) have been proposed to be priming proteins (Berwin et al., 1998; Tandon 
et al., 1998; Koch et al., 2000; Renden et al., 2001). However, CAPS proteins do not 
compensate the loss of  Munc13s from hippocampal neurons in spite of  strong ex-
pression at their synaptic terminals (Varoqueaux et al., 2002; Speidel et al., 2003), and 
are therefore also unlikely to support synaptic vesicle priming in NMJs. 
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As the murine and human genomes do not contain any additional genes with 
homology to Munc13s, our findings indicate that some vesicle priming at the NMJ 
occurs in the absence of  Munc13s and that therefore either non-Munc13 priming 
proteins must exist or vesicle priming at the NMJ can occur in part spontaneously 
without priming proteins. Vesicle priming independent of  Munc13-1, -2, and -3 has 
previously been suggested to occur in chromaffin cells (Ashery et al., 2000). Ac-
cording to the current molecular model, Munc13s mediate synaptic vesicle priming 
by stabilizing the open conformation of  the SNARE syntaxin 1, thereby allowing 
the formation of  SNARE dimers containing syntaxin 1 and SNAP25 or of  trans 
SNARE complexes (Brose et al., 2000; Richmond et al., 2001; Fasshauer, 2003). 
Constitutive SNARE-mediated intracellular and secretory membrane fusion reac-
tions do not require a Munc13-like priming step, Saccharomyces cerevisiae does not 
express homologues of  Munc13-1, -2, -3, -4 or BAP3 (Koch et al., 2000), and bona 
fide Munc13s first appear during evolution in organisms with a central nervous sys-
tem (Koch et al., 2000), indicating that Munc13 independent spontaneous SNARE 
priming does occur. It is likely that synaptic vesicle exocytosis at the mouse NMJ 
involves in part a syntaxin variant or other SNARE complex components such as 
SNAP23 that are less dependent on Munc13s stabilizing the open conformation of  
syntaxin, with the consequence that some vesicle priming indeed occurs spontane-
ously. 
The SNARE protein complement of  murine NMJs is only partially known. NMJs 
lacking SNAP25 exhibit increased spontaneous transmitter release but lack evoked 
release (Washbourne et al., 2002). It is possible that spontaneous release in SNAP25 
KO mutants is due to the presence of  SNAP23, which can partly replace SNAP25 
but has strikingly different functional features (Sorensen et al., 2003). Essentially, 
our data and the published account in the literature are best compatible with a sce-
nario according to which Munc13-mediated vesicle priming is essential for a major-
ity of  synaptic vesicles at NMJs, while a small subpopulation of  vesicles can undergo 
spontaneous priming. This would explain why in the absence of  Munc13-1, -2, and 
-3 evoked transmitter release is strongly reduced while spontaneous release persists. 
The increase in the frequency of  spontaneous release events seen in SNAP25 KO 
(Washbourne et al., 2002) and Munc13-1/2-DKO NMJs may then simply be due to 
the increased number of  synapses formed in these mutant NMJs.
The importance of  synaptic activity for NMJ formation
The phenotypic alterations seen at the Munc13-1/2-DKO NMJ are similar to those 
reported for the ChAT-deficient mouse NMJ, in which synaptic vesicles are no longer 
loaded with acetylcholine (Misgeld et al., 2002; Brandon et al., 2003). The same type 
of  abnormal nerve arborizations and disorganized termination areas with more/
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larger synaptic endplates is also seen in SNAP25-deficient NMJs (Washbourne et 
al., 2002).
Functionally, the Munc13-1/2/3 and SNAP25 KO mice differ from ChAT KO 
mutants in various aspects. In the ChAT KO, transmission is blocked at the NMJ, 
while motor neuron cell bodies receive functionally normal synaptic inputs. In the 
Munc13-1/2-DKO and SNAP25 KO, synaptic transmission at spinal cord synapses 
is either abolished (not shown) or strongly reduced. This situation is similar to that 
described for Munc18-1 deletion mutant mice which are characterized by a complete 
lack of  spontaneous and evoked transmitter release at the NMJ as well as at central 
snyapses (Verhage et al., 2000; Heeroma et al., 2003; Bouwman et al., 2004). In these 
mutants, motor neurons form synaptic contacts very transiently in early embryonal 
life and soon thereafter degenerate and retract axonal processes (Jahn et al., 2003). 
This phenomenon, which is not seen in ChAT KOs (Misgeld et al., 2002; Brandon 
et al., 2003) or Munc13-1/2-DKOs, was explained by the lack of  synaptic signaling 
onto motor neurons in Munc18-1 mutants (Heeroma et al., 2003). However, given 
the fact that in Munc13-1/2-DKOs no motor neuron degeneration is seen despite a 
complete shut-down of  synaptic transmission onto these neurons, this explanation 
may be wrong. Rather, the role of  Munc18-1 may extend to the regulation of  intra-
cellular membrane trafficking events necessary for neuronal survival or of  develop-
mentally earlier and more general secretory events whose impairment dramatically 
compromises neuronal survival (e.g. neurotrophin signaling). As a consequence, 
Munc18-1 may exert a more stringent control of  exocytosis at the NMJ, abolishing 
not only fast synaptic transmission but also the secretion of  neuroactive peptides, 
neurotrophic factors, or hormones. In contrast, Munc13-1/2/3 deletion still allows 
for the fusion of  a small population of  synaptic and peptidergic vesicles, and ChAT 
deletion still permits the release of  transmitter-deficient vesicles that contain neu-
roactive or neurotrophic peptides. These may influence synapse formation, synapse 
maintenance, and neuronal survival (Misgeld et al., 2002; Brandon et al., 2003).
The increased number of  motor neurons in the spinal cord of  Munc13-DKOs 
is presumably due to a cessation of  their apoptosis, which occurs normally around 
E15-E17 (Harris and McCaig, 1984; Allan and Greer, 1997). As mentioned above, 
this blockade of  apoptosis is unlikely to result from a block of  synaptic signaling in 
the spinal cord. Instead, it might be due to the local malfunction of  the NMJ, thus 
influencing the well-described process of  embryonic synapse elimination that usual-
ly leads to the consolidation of  only one axon/endplate per muscle fiber (Lichtman 
and Colman, 2000; Buffelli et al., 2002; Buffelli et al., 2003; Kasthuri and Lichtman, 
2003). 
Spontaneous action potentials, which typically occur in motor neurons during 
development (Hanson and Landmesser, 2003), are likely to be important for shap-
ing nerve-muscle connectivity. They originate from either the spiking of  premotor 
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interneurons or the coordinated quantal neurotransmitter release from motor neu-
rons, which is unlikely to occur in Munc13-1/2-DKO embryos. Thus, muscle action 
potentials and contractions driven by action potentials in motor neurons are unlikely 
to take place in vivo in the Munc13-DKO embryo, despite the fact that stimulation 
of  the cut phrenic nerve can elicit action potentials and evoke some contractile 
response. Similarly, ChAT and SNAP25 deficiencies presumably lead to the elimina-
tion of  muscle activation driven by motor neuron action potentials. Given that all 
three mutants exhibit the same phenotype with respect to motor neuron survival 
and refinement of  NMJ connectivity, we conclude that the proper development 
of  motor neurons and NMJs does not depend on a trophic action of  spontaneous 
quantal acetylcholine release. Rather, successful and reliable action potential driven 
postsynaptic depolarizations, which can even occur spontaneously during develop-
ment, appear to be necessary to regulate motor neuron survival and shape mature 
NMJs. 
It is likely that retrograde signaling from the muscle to the innervating motor 
neuron is involved in the effects of  these action potential driven synaptic events on 
motor neuron number and NMJ morphology. Interestingly, a pattern of  connectiv-
ity similar to the one found in Munc13-1/2-DKO NMJs is seen in MyoD deficient 
mice. Here, the abnormal branching must be due to an impaired retrograde signal-
ing because MyoD is a muscle-specific transcription factor (Wang et al., 2003). In 
addition, the phenotypes of  Rapsyn- and MuSK-deficient mice, which show the 
same aberrant motor neuron survival seen in Munc13-1/2-DKOs and ChAT KOs 
(Terrado et al., 2001; Banks et al., 2001), indicate a role of  retrograde signaling from 
muscle in motor neuron survival. By analogy, it is possible that impaired transmis-
sion at the Munc13-, ChAT-, or SNAP25-deficient NMJ affects muscle electrical 
activity, thereby influencing the levels of  myogenic regulatory factors or other signal-
ing molecules and, in turn, retrograde signalling. 
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α-Neurexins are required for 
efficient transmitter release and 





Neurotransmission at chemical synapses of  the brain involves α-neurexins, neuron-
specific cell-surface molecules that are encoded by three genes in mammals. Dele-
tion of  α-neurexins in mice previously demonstrated an essential function, lead-
ing to early postnatal death of  many double-knockout mice and all triple mutants. 
Neurotransmitter release at central synapses of  newborn knockouts was severely 
reduced, a function of  α-neurexins that requires their extracellular sequences. Here, 
we investigated the role of   α-neurexins at neuromuscular junctions, presynaptic 
terminals that lack a neuronal postsynaptic partner, addressing an important ques-
tion because the function of  neurexins was hypothesized to involve cell-adhesion 
complexes between neurons. Using systems physiology, morphological analyses and 
electrophysiological recordings, we show that quantal content, i.e. the number of  
acetylcholine quanta released per nerve impulse from motor nerve terminals, and 
frequency of  spontaneous miniature endplate potentials at the slow-twitch soleus 
muscle are reduced in adult α-neurexins double-knockouts, consistent with earlier 
data on central synapses. However, the same parameters at diaphragm muscle neu-
romuscular junctions showed no difference in basal neurotransmission. To reconcile 
these observations, we tested the capability of  control and α-neurexins-deficient 
diaphragm neuromuscular junctions to compensate for an experimental reduction 
of  postsynaptic acetylcholine receptors by a compensatory increase of  presynaptic 
release: Knockout neuromuscular junctions produced significantly less upregula-
tion of  quantal content than synapses from control mice. Our data suggest that 
α-neurexins are required for efficient neurotransmitter release at neuromuscular 
junctions, and that they may perform a role in the molecular mechanism of  synaptic 
homeostasis at these peripheral synapses.
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Neurexins constitute a family of  highly variable neuronal transmembrane pro-
teins (for review, Missler and Südhof, 1998), that were discovered as a receptor for 
α-latrotoxin (Ushkaryov et al., 1992; Ushkaryov and Südhof, 1993, Ushkaryov et 
al., 1994, Geppert et al., 1998; Sugita et al., 1999), a neurotoxin from black-widow 
spiders that causes massive transmitter release from central and peripheral synapses, 
including neuromuscular junctions (NMJs) (Valtorta et al., 1984). In mammals, neur-
exins are encoded by three genes, each of  which includes independent promoters 
for the long α-neurexins and the shorter β-neurexins (Rowen et al., 2002; Tabuchi 
and Sudhof, 2002). α-Neurexins contain substantially more extracellular sequenc-
es than β-neurexins, but share with α-neurexins the same C-terminal extracellular 
domain, transmembrane region, and short intracellular tail (Missler et al., 1998a). 
Consequently, earlier biochemical studies have revealed shared intracellular binding 
partners (Hata et al., 1996; Butz et al., 1998; Biederer and Südhof, 2000; Biederer and 
Sudhof, 2001), but distinct extracellular interactions for α- and β-neurexins (Itchenko 
et al., 1995; Missler et al., 1989b; Sugita et al., 2001, but see Boucard et al., 2005).
To determine the function of  neurexins, we previously generated knockout mice 
that lack one, two or all three α-neurexins (Missler et al., 2003). Double-knockout 
mutants (DKO) with different combinations of  knockout alleles as well as triple-
knockout mice (TKO) mostly died prematurely due to respiratory problems. Analy-
ses of  newborn mice deficient for multiple α-neurexins revealed almost no changes 
in brain architecture or synapse structure but uncovered a severe reduction in neu-
rotransmitter release. As the presumptive cause for the inefficient exocytosis in mu-
tant mice, we suggested that voltage-dependent Ca2+-channels (VDCCs) were im-
paired because the response pattern of  synaptic transmission to specific Ca2+-chan-
nels blockers was altered, and whole-cell Ca2+-currents were reduced (Missler et al., 
2003). The regulation of  VDCCs by α-neurexins predominantly affects N- (CaV2.2) 
and P/Q-type (CaV2.1) Ca
2+-channels but leaves L-type (CaV1.3) channels unscathed 
(Zhang et al., 2005). In addition, another Ca2+-permeable channel, the N-methyl-
D-aspartate receptor (NMDAR) at neocortical synapses also appears to be affected 
because NMDAR-mediated currents were reduced in α-neurexin triple-knockouts 
(Kattenstroth et al., 2004). Transgenic rescue experiments furthermore showed that 
the effect on neurotransmission and Ca2+-currents is specific for α-neurexins and 
requires their extracellular domains (Zhang et al., 2005). These studies established 
a role for α-neurexins as organizer molecules of  the synaptic release machinery. 
However, an additional aspect of  their function exists: As originally proposed when 
neurexins were discovered as highly variable cell-surface receptors (Ushkaryov et 
al., 1992), they may be involved in cell-adhesion and/or cell-recognition function 
via their highly variable extracellular sequences (Missler and Südhof, 1998). This 
hypothesis was subsequently supported when neuroligins were discovered as post-
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synaptic binding partners of  α-neurexins (Ichtchenko et al., 1995; Ichtchenko et 
al., 1996; Nguyen and Südhof, 1997; Song et al., 1999), and has recently attract-
ed considerable attention by numerous laboratories, proposing that the neurexin/
neuroligin cell-adhesion complex can promote the formation of  de novo synapses 
and differentiation of  postsynaptic receptors at least in vitro (Scheiffele et al., 2000; 
Dean et al., 2003, Graf  et al., 2004; Chih et al., 2005; Chubykin et al., 2005; Sara et 
al., 2005). Since analyses of  α-neurexin and neuroligin knockout mice have not been 
published yet, it is presently impossible to decide if  the proposed aspects of  neur-
exin function, i.e. regulator of  neurotransmitter release/VDCCs or promoter of  
synapse formation/differentiation, represent (i) mutually exclusive roles, (ii) equally 
important roles, or (iii) functional specializations of  different neurexin isoforms, e.g. 
of  α- versus β-neurexins.
Here, we explored the α-neurexin function at neuromuscular junctions (NMJs) 
to better distinguish between the alternative roles. The NMJ appears as an excel-
lent model for many structural and functional aspects of  chemical synapses but 
important differences to central synapses exist, for example, presence of  a basal 
lamina in the synaptic cleft, absence of  a postsynaptic neuronal partner, capacity 
to regenerate after lesions, coverage by Schwann cells and the importance of  agrin 
signaling (Sanes and Lichtman, 1999). Neurotransmission and synaptogenesis have 
been studied intensely at NMJs of  invertebrate and vertebrate species, making it a 
widely used system for investigating the molecular mechanisms of  the presynaptic 
release machinery (e.g., Wu et al., 1998; Verhage et al., 2000; Misgeld et al., 2002; 
Urbano et al., 2003; Varoqueaux et al., 2005), and cell-adhesion molecules (Rafuse 
et al., 2000; Knight et al., 2003; Nishimune et al., 2004; Polo-Parada et al., 2004). 
Taking advantage of  the NMJs as a presynaptic terminal that lacks a neuronal post-
synaptic partner, we applied systems physiology, morphological analyses and elec-
trophysiological recordings to adult α-neurexin double-knockout mice. Our current 
data demonstrate that α-neurexins perform a role as regulators of  neurotransmitter 
release at synapses of  the peripheral nervous system, and contribute significantly 
to their synaptic homeostasis. These findings suggest that α-neurexins exert their 




α-Neurexin knockout mice were generated previously, and genotyped by short ge-
nomic PCR as described (Missler et al., 2003). Mice were housed under a 12-h light/ 
dark regime with access to food and water ad libitum. Animal procedures were car-
ried out according to German and Dutch laws and ethical guidelines set by the 
Universities of  Göttingen and Leiden. All experiments were performed with adult 
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DKOs deficient for either neurexins 1α and 2α (DKO1/2), or neurexins 2α and 3α 
(DKO2/3), respectively. Littermate single-knockout mice deficient only for neurex-
in 2α (SKO2) and a wild-type (WT) background line served as controls as described 
before (Missler et al., 2003, Zhang et al., 2005). Initial experiments were done on 
strictly separated genetic groups. As no significant differences were observed in the 
NMJ experiments between WT and SKO2, and DKO2/3 and DKO1/2 animals, 
respectively, mice were pooled into two groups for statistical analysis (control and 
DKO). Reagents were obtained from Sigma-Aldrich (Taufkirchen, Germany) or 
VWR (Darmstadt, Germany), except where stated otherwise.
Systems physiology
Auditory brainstem recordings.
Animals were deeply anaesthetized at 8 weeks of  age using ketamine/xylazine. Tone 
bursts (4, 6, 8, 12, 16, 24, 32 kHz; 10 ms plateau phase with 1 ms cos2 onset and 
offset) or clicks of  0.03 ms were generated with a System 2 (Tucker Davis Tech, Ala-
chua, FL, USA) driving a high-frequency speaker (Monacor, Bremen, Germany). In-
tensities are presented as sound pressure level (dB root mean square for tone bursts, 
dB peak equivalent for clicks). The difference potential between vertex and mastoid 
was amplified, filtered and sampled at a rate of  50 kHz. Stimuli were presented 2000 
times at a rate of  20 Hz. The EEG was recorded for 20 ms and averaged to obtain 
mean ABR traces. Latencies of  ABR were analyzed following stimulation with 80 
dB clicks, and the thresholds were estimated with a 10 dB precision, essentially as 
described (Lacas-Gervais et al., 2004).
Treadmill running in a metabolic chamber.
Oxygen uptake (VO2) in mice was tested during running exercise on a custom-made 
single-lane treadmill placed in a metabolic chamber, essentially as published (Kemi 
et al., 2002). Briefly, ambient air was led through the chamber at a rate of  0.5 l/min, 
and 200 ml/min samples were diverted to the paramagnetic oxygen analyzer (type 
1155, Servomex) and the carbon dioxide analyzer (LAIR 12, M & C Instruments). 
The gas analyzers were calibrated with standardized gas mixtures before every test 
session (accuracy of  measurements is appr. ±2%). To keep mice from stepping off  
the treadmill lanes, stainless steel grids at the end of  the lines provided an electrical 
stimulus of  0.25 mA, 1 Hz, and 200-ms length. The exercise protocol for determi-
nation of  VO2max consisted of  a regular warm-up period followed by a stepwise 
increase of  treadmill velocity from 0.2 m/s by 0.05 m/s every third minute at 25° 
inclination. VO2max was reached when oxygen uptake remained constant despite 
further increasing running velocity. Tests were terminated when the mice were un-
able to continue, or refused to run further. 
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Whole-body plethysmography.  
Ventilation activity was assessed in awake animals using a custom-made closed cham-
ber connected to a transducer as described elsewhere (Missler et al., 2003).
Isometric contraction force of  hindlimb muscles. 
The measuring set-up was modified from published procedures (Ellrich and Wes-
selak, 2003). Briefly, anaesthesized animals (70 mg kg-1 pentobarbital i.p.) were fixed 
to a warmed aluminium plate, and their body temperature maintained between 37.5 
and 38.5 °C. The right jugular vein was cannulated to infuse 0.5 % methohexital 
solution (Brevimytal, Lilly, 40-60 mg kg-1 h-1) for continuation of  anaesthesia for up 
to 8 hr. The common carotids were ligated to stabilize blood circulation in the rest 
of  the body, and a tracheal tube was inserted for artificial ventilation if  necessary. 
Two recording needles (platinum wire, 0.3 mm) inserted into the lower fore legs 
monitored the ECG, and the heart rate was used to adjust anaesthesia. The left hind 
leg muscles and nerves were prepared as follows: skin on the dorsal surface was cut 
from the thigh down to the heel to expose the triceps surae and the posterior biceps 
muscle. The posterior biceps was removed and the sural nerve and the common 
peroneal were cut and removed from the sciatic nerve. The common tibial nerve was 
left intact and mounted on a stimulation electrode. The Achilles tendon was dissect-
ed from the calcaneus and connected with a strain gauge that allowed measuring the 
combined contraction force of  the gastrocnemius and soleus muscles upon nerve 
stimulation. Electromyogram (EMG) recording electrodes were fixed on the surface 
of  the GS muscle. For recordings, the tibial nerve was stimulated repetitively with 
rectangular pulses (duration 0.1 ms, stimulation strength 5 times above threshold 
strength as estimated from EMG responses). Repetitive stimulation was done using 
decreasing stimulation intervals at 1 s (stimulation frequency: 1 Hz), 500 ms (2 Hz), 
250 ms (4 Hz), 125 ms (8 Hz), 62.5 ms (16 Hz), 31.2 ms (32 Hz), 16 ms (62.5 Hz), 
8 ms (125 Hz), and 4 ms (250 Hz). Stimulation trials lasted for 30 s, and interrupted 
by a 2.5 min pause before the start of  the next trial. 
Electrophysiological recordings of  neuromuscular junctions
Measurements were performed on nerve/muscle preparations of  soleus and hemi-
diaphragm muscles of  control and DKO mice killed by carbon dioxide inhalation. 
We intracellularly recorded endplate potentials (EPPs) and spontaneous release of  
single quanta (miniature EPPs, MEPPs), essentially as described before (Plomp et 
al., 1994, Verhage et al., 2000, van den Maagdenberg et al., 2004). At least 10 NMJs 
were sampled per muscle, and at least 30 EPPs and MEPPs were measured per 
NMJ. Briefly, muscles with the nerve supply left intact were dissected, placed in 
oxygenated Ringer’s solution, and pinned flat in a Sylgard (Dow Corning, Midlang, 
MI)-coated recording chamber. Muscle fibers were impaled near the NMJ with a 10-
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20 MΩ glass capillary microelectrode filled with 3 M KCl. Recordings of  synaptic 
transmission at the NMJ ex vivo was performed at 26-28°C in Ringer’s medium 
containing (in mM): NaCl, 116; KCl, 4.5; MgCl2, 1; CaCl2, 2; NaH2PO4, 1; NaHCO3, 
23; glucose 11; pH 7.4, gassed with 95 % O2/5 % CO2. Muscle preparations were 
incubated with 3.1 µM µ-conotoxin GIIIB (Scientific Marketing Associates, Herts, 
UK) which specifically blocks voltage-gated sodium channels in muscle, preventing 
contraction. This allowed for the undisturbed recording of  EPPs during 0.3 and 40 
Hz electrical nerve stimulation delivered by a Master8 Stimulus Generator (AMPI, 
Jerusalem, Israel; supramaximal squared pulse, 0.1 ms) using either a bipolar stimu-
lation electrode (in case of  the phrenic nerve) or a Ringer’s medium-filled suction 
electrode (for the tibial nerve). The quantal content (i.e., the number ACh quanta 
released upon a single nerve impulse) at each NMJ was calculated from EPP and 
MEPP amplitudes after normalization to -75 mV membrane potential. The EPP 
amplitude was corrected for non-linear summation as described before (Plomp et 
al., 1994). During high-frequency stimulation, EPP amplitudes have the tendency to 
decrease to a plateau level. Therefore, the run-down level of  EPP amplitude during 
40 Hz stimulation for 1 s was determined by averaging the amplitudes of  the last 10 
EPPs in the train and has been expressed as percentage of  the amplitude of  the first 
EPP in the train. A GeneClamp 500B amplifier (Axon Instruments, Union City, CA, 
USA) was used for amplifying and filtering (10 kHz low-pass) of  the signals. The 
recordings were digitized and analyzed using a Digidata 1200 interface, Clampex 8.0 
and Clampfit 8.0 programs (Axon Instruments) and routines programmed in Matlab 
software (The MathWorks Inc., Natick, MA, USA).
Toxin-induced myasthenia gravis model
The toxin-induced myasthenia gravis model (TIMG) is based on repeated injections 
of  α-bungarotoxin (α-BTx), a treatment causing chronic reduction of  the number 
of  functional acetylcholine (ACh) receptors, resulting in a presynaptic homeostatic 
response, i.e. an upregulation of  quantal content. It was initially developed for rats 
(Molenaar et al., 1991, Plomp et al., 1994), and subsequently adjusted for mice (Sons 
et al., 2003). For a period of  four weeks, adult control and DKO mice were injected 
intraperitoneally with a low dose of  α-BTx (Biotoxins Inc., FA, USA) on Mondays, 
Wednesdays and Fridays. As a first dose, 1.2 μg α-BTx was injected. Thereafter, 
doses of  0.8 μg of  the toxin were administered three times a week. Three hours 
after an injection the mice showed slightly invaginated flanks, indicating mild muscle 
weakness which ususally disappeared during the intermittent (toxin-free) day. Treat-
ment control groups for both genotypes received injections of  saline solution (0.9% 
NaCl). After the treatment, isolated phrenic nerve-diaphragm preparations from 





To stain NMJs with labeled α-BTx and/or primary antibodies, teased fiber prepara-
tions of  soleus and diaphragm muscles were made (Wood and Slater, 1998), allowing 
en face pictures of  NMJs for quantification of  their area and perimeter. Muscles 
were pinned on Sylgard-coated petri dishes, fixed with 0.5% paraformaldehyde in 
0.1 M phosphate-buffered saline for 30 min, teased into bundles of  3-10 fibers in 
PBS, and incubated with 1% Triton-X100 in PBS for 30 min. After blocking in 5% 
normal goat serum/ PBS, muscle fibers were incubated with Alexa488-conjugated 
α-BTx alone or together with antisera, washed and mounted using Prolong Anti-
fade reagent (Molecular Probes, Eugene, OR, USA). Primary antibodies to synapsins 
(E028) and synaptotagmin 1 (W855) were characterized previously (Rosahl et al., 
1995, Butz et al., 1998), or obtained commercially: VAChT, anti-vesicular acetyl-
choline transporter (Chemicon, Temecula, CA, USA), and SMI32, anti-phospho-
rylated neurofilament (Sternberger Monoclonals Inc., Lutherville, ML, USA). All 
fluorescently-labeled secondary antibodies and neurotoxins, α-BTx and phalloidin 
(Phall-Alexa633), were puchased from Molecular Probes. In order to analyze the dis-
tribution of  immunostained proteins, images were digitally photographed via a Ax-
ioCam HRc camera system mounted on a Axioskop 2 microscope, and quantitated 
using AxioVision 3.0 software (all from Fa. Zeiss, Oberkochen, Germany). In situ 
hybridization was performed with DIG-labeled cRNAs as described (Ernsberger et 
al., 2005), using probes to detect α-neurexins (a 515 bp KpnI/XbaI fragment from 
pCMVL2) and the VAChT (Burau et al., 2004). Color reaction was allowed for 5 d 
for neurexin riboprobes, and specificity of  reactions was monitored with appropri-
ate antisense riboprobes. Any modifications to digitally acquired images were limited 
to changes in color brightness and contrast using Adobe Photoshop 8.0 (Adobe 
Systems, San Jose, CA), and applied similarly when genotypes were compared.
Statistical analysis
In the electrophysiological experiments, between 10 – 15 individual NMJs were mea-
sured per muscle, and for morphology between 40 – 70 NMJs were analyzed per 
mouse. Genotype mean values were calculated with n as the number of  mice in the 
respective group. Statistical significance was tested with a two-tailed Student’s t-test 
in Excel spreadsheets or with Prism 4.0 software (GraphPad, USA), and in case of  
TIMG treatment differences between genotypes were analyzed with the multivariate 
general linear model and the post-hoc Tukey test using SPSS 10.0 software (SPSS 




α-Neurexins play a role at peripheral synapses containing P/Q-type (CaV2.1) calcium 
channels
Knockout mice that lack all three α-neurexin genes (TKOs) die a few hours after 
birth (Missler et al., 2003), limiting the choice of  synaptic systems that can be ana-
lyzed at postnatal stages. Here, we took advantage of  the fact that a proportion of  
double-knockout mice deficient for either neurexin 1α and 2α (DKO1/2) or neur-
exin 2α & 3α (DKO2/3) survive into adulthood (about 5-10% of  DKO1/2, and 
40% of  DKO2/3; (Missler et al., 2003)). To explore if  surviving α-neurexin DKOs 
display a phenotype of  impaired neurotransmission and Ca2+-channel function in 
the peripheral nervous system similar to our previous observations in the central 
nervous system, we screened two different types of  peripheral synapses, one domi-
nated by L-type (CaV1.3) the other by P/Q-type (CaV2.1) VDCCs (Figure 1). In the 
auditory system, the inner hair cell ribbon synapse in the cochlea is entirely CaV1.3 
dependent, and any impairment of  neurotransmitter release at this synapse results in 
hearing loss (Platzer et al., 2000, Brandt et al., 2003). Auditory thresholds of  young-
adult α-neurexin DKO and littermate control mice were measured by recording au-
ditory brainstem responses (ABR) following click and tone burst stimulation (Figure 
1A-B). Figure 1A shows a large overlap of  ABR data for wave I, which reflects the 
synchronized activation of  spiral ganglion neurons by the hair cell ribbon synapses. 
Quantification of  the wave I latencies revealed no significant delays in the mutants 
(WT 1.33 ± 0.03 ms, n = 7 mice; DKOs 1.47 ± 0.06, n = 8, n.s.), and a normal 
auditory threshold was observed in mutant animals (Figure 1B). These data suggest 
that CaV1.3 channel-dependent synaptic release does not require α-neurexins which 
is consistent with our earlier observations in central synapses of  newborn mutants 
(Missler et al., 2003, Zhang et al., 2005).
In contrast, when we tested α-neurexin DKO and control mice during a running 
exercise that involves mostly CaV2.1 channel-dependent neuromuscular junctions 
of  limb and respiratory muscles (Day et al., 1997, Plomp et al., 2000), mutants per-
formed significantly worse than controls (Figure 1C). To avoid confounding effects 
of  the about 30% lower body weight of  α-neurexin DKOs on physical exercise, we 
used oxygen uptake (VO2) as the measure to monitor their performance. Although 
the maximum oxygen uptake (VO2max) during treadmill running was compatible 
between genotypes (control 69.5 ± 4.3 ml kg, 0.75 min-1, n = 6 mice; DKO 70.7 ± 
7.7, n = 11, n.s.), mutant mice reached VO2max values after shorter mean running 
times (control 28.8 ± 2.4 min, n = 6 mice; DKO 16.1 ± 1.7, n = 11, p<0.01; Figure 
1C), indicating that neurotransmission at NMJs of  DKOs is less efficient. To exclude 
that the early exhaustion is entirely due to an impaired respiratory rhythm generator 
in the central nervous system, we measured the ventilation frequency in both geno-
types using whole-body plethysmography but found no significant difference (con-
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Figure 1. α-Neurexins perform a significant role at synapses of  the peripheral nervous system that de-
pend on P/Q-type (CaV2.1) Ca
2+ channels.
(A) Graphic representation of  auditory brainstem responses (ABR) recorded from adult control (black line, control, 
n = 7) and α-neurexin double KO mice (red, DKO, n = 8) KO mice, and (black, n = 7). The waves were sampled 
following stimulation with 80 dB clicks. Roman numbers above the graph indicate the ABR voltage peaks according 
to Jewett (Jewett et al., 1970). The first peak (I) represents mainly the activation of  spiral ganglion neurons by the 
inner hair cell ribbon synapse. (B) Averaged hearing thresholds (in dB SPL) of  the same mice. Auditory thresholds 






























































































trol 3.3 ± 0.3 s-1, n = 11 mice, DKO 2.6 ± 0.3, n = 12; Figure 1D). To demonstrate 
the impaired function of  mutant nerve-muscle transmission in the intact animal, we 
next developed an in vivo preparation of  one of  the muscle groups involved in the 
running exercise (triceps surae, consisting of  gastrocnemius and soleus muscles). 
Repetitive stimulation of  the tibial nerve with increasing stimulation frequencies 
from 1 – 250 Hz caused single twitches at lower stimulation frequencies that fuse 
to tetanic contractions at frequencies faster 30 Hz both in control and α-neurexin 
knockout mice (data not shown). We used the higher stimulation frequencies (cor-
responding to 16 and 8 ms interstimulus interval) to compare the maximal forces 
elicited by the nerve-muscle transmission under condition of  tetanus (Figure 1E). 
We observed that α-neurexin DKO mice reach similar peak forces when normalized 
for body weight, however, mutant NMJs are not able to sustain the contraction as 
long as control preparations (Figure 1E). Together, these experiments suggest that 
neurotransmission at CaV2.1 channel-dependent NMJs is less effective and may ex-
haust earlier in the absence of  α-neurexins.
Neurotransmitter release at neuromuscular junctions is impaired in adult α-neurexin KO 
mice
To test directly if  neurotransmitter release from individual NMJs of  adult α-neurexin 
DKO mice is reduced, we studied release parameters with ex vivo electrophysiol-
ogy, using micro-electrode recordings of  MEPPs and nerve stimulus-evoked EPPs 
in µ-conotoxin-paralyzed tibial nerve/soleus muscle preparations. Compared to lit-
termate control animals, spontaneous release of  single ACh quanta appeared less 
frequent in α-neurexin DKO muscles as shown by representative traces of  MEPPs 
(Figure 2A). MEPP frequency at this slow-twitch muscle was reduced by almost 
30% in adult α-neurexin DKOs (control 2.1 ± 0.2 s-1, n = 21 mice; DKO 1.4 ± 0.1, 
n = 20; P<0.05; Figure 2B). Application of  the selective CaV2.1 blocker ω-agatoxin 
IVA (200 nM) reduced the MEPP frequency in both genotypes to similar levels 
(fMEPP ± ω-Aga, Table 1), indicating that only the Ca2+-sensitive fraction of  spon-
taneous release was diminuished in the mutant NMJs, which is consistent with the 
hypothesis of  impaired calcium channel function in absence of  α-neurexins (Missler 
et al., 2003, Zhang et al., 2005). To assess the evoked release of  ACh in response 
to a single action potential at soleus NMJs, we next recorded EPPs by supramaxi-
mal stimulation of  the tibial nerve at low rate (0.3 Hz). We observed that quantal 
differences between genotypes at this L-type VDCC-dependent synapse. Data shown are means ± SEM. (C) Oxygen 
uptake (VO2) was measured on a treadmill set-up in control (black line; n = 8 mice) and α-neurexin DKO animals 
(red; n = 11) with increasing running speed from 0.2 m/s with 0.05 m/s every 3 min until exhaustion. Note that 
similar VO2max values are reached but knockout mice fatigue much earlier at lower running velocities. Data shown 
are means ± SEM. (D) Whole-body plethysmography was used to determine the respiratory activity of  adult DKO 
and control mice. Data shown are means ± SEM. n.s. = not significant. (E) Time course of  tetanic contractions 
of  triceps surae muscle group from control (black line, average for n = 3 mice) and DKO mutants (red, n = 4) 
were normalized to their maximal force at 16 ms (E1, still incomplete tetanic contraction) and 8 ms (E2, complete 
tetanus) stimulation intervals. DKO muscles do not sustain contractions as long as controls.
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content, i.e. the number of  quanta released per nerve impulse), was also diminished 
at mutant NMJs to about 70% of  control values (control 60 ± 4, n = 21 mice; 
DKO 43 ± 3, n = 20; P<0.01, Figure 2C). The findings of  impaired spontane-
ous and evoked release at soleus NMJs are consistent with the earlier observation 
of  reduced mini frequency and evoked postsynaptic currents at central synapses 
of  newborn α-neurexin knockout mice (Missler et al., 2003). In contrast, the un-
changed ventilation activity in adult α-neurexin DKOs as reported above (Figure 
1D) is surprising because newborn α-neurexin knockouts breathed more slowly than 
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Figure 2. Basal spontaneous and 
evoked ACh release is reduced at so-
leus NMJs of  α-neurexin DKO mice 
but not at their diaphragm NMJs. 
(A) Representative traces show typical 
examples of  MEPP recordings from 
soleus muscle of  control (upper panel) 
and α-neurexin DKO mice (lower panel). 
Traces show 7x 1.5 s long recordings 
superimposed for each genotype. (B, 
C) Intracellular recordings from a tibial 
nerve/soleus muscle ex vivo preparation 
show a reduced spontaneous (MEPP 
frequency, panel B) and evoked (Quantal 
content, panel C) ACh transmitter re-
lease in α-neurexin mutants. (D, E) The 
frequency of  spontaneous release events 
(D) and evoked ACh release (E) does 
not differ between diaphragm NMJs of  
control and α-neurexin DKO mice. In all 
graphs, statistical significance is indicated 




demonstrated in the soleus (Figure 2B, C) was a general phenomenon of  all mutant 
NMJs. Since the central respiratory rhythm generator was largely intact in the few 
surviving adult knockouts as judged from the hypoglossal nerve output (data not 
shown), a reduced ACh release from NMJs at the diaphragm, a predominantly fast-
twitch muscle responsible for inspiration, should cause massive respiratory prob-
lems. Therefore, we explored neurotransmitter release from diaphragm NMJs, using 
the same methods and parameters as for the soleus NMJ recordings. However, the 
frequency of  MEPPs (control 1.5 ± 0.1 s-1, n = 16 mice; DKO 1.4 ± 0.1, n = 16; 
n.s.; Figure 2D) and quantal content (control 38 ± 2, n = 16 mice; DKO 35 ± 1, n 
= 16; n.s.; Figure 2E) appeared unchanged between control and α-neurexin DKO 
diaphragms. Since DKOs used in this study still contain the remaining third neur-
exin gene (Nrxn 2α), we reasoned that the unchanged release at the diaphragm may 
be due to the continued presence of  this single isoform, contributing to a presum-
ably higher safety factor at this particular NMJ (Wood and Slater, 2001). To explore 
this possibility experimentally, we obtained some NMJ recordings from diaphragm 
preparations of  newborn TKOs lacking all α-neurexins, applying the so-called cut-
fiber method (depolarization block) to record EPPs. Quantal content was calculated 













Figure 3.α-Neurexins are expressed in motorneurons innervating soleus and diaphragm muscles.
In situ hybridizations of  spinal cord sections derived from wild-type mice at the lower lumbar level (about L5, panels 
A-B) and at cervical segments (about C6, panels C-D) using probes against α-neurexin (A, C) and VAChT (B, D). 
Motoneurons (arrow heads) as well as most other neurons in the ventral horn express α-neurexin. Scale bar in D 
(for A-D), 150 µm.
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TKO diaphragm muscles (control 2.9 ± 0.5, n = 7 mice; TKO 2.4 ± 0.2, n = 3; n.s.). 
Similarly, MEPP frequences were unchanged (around 3-4 min-1; data not shown). 
As the phenotype was not more pronounced in the diaphragm and evoked release 
recordings from the soleus preparation in newborns proved technically impossible, 
all further analyses were restricted to the adult α-neurexin DKOs. To exclude the 
possibility that α-neurexins are absent in motorneurons innervating the diaphragm, 
we performed in-situ hybridization of  histological sections from different levels of  
the spinal cord, showing that α-neurexin mRNAs are present in the respective seg-
ments (Figure 3). These results prompted the question if  the difference between 
soleus and diaphragm physiology in α-neurexin DKOs reflects a different regulation 
of  the presynaptic release machinery.
To analyze if  the deletion of  α-neurexins affected Ca2+-independent steps of  
neurotransmission at the NMJ, we applied hypertonic solution (500 mM sucrose) to 
both soleus and diaphragm muscle preparations, and recorded MEPP frequencies. 
Consistent with previous results in central synapses (Missler et al., 2003), secretion 
of  the readily-releasible pool triggered by high sucrose solution did not differ be-
tween control and α-neurexin DKO NMJs of  both muscle preparations (Table 1). 
The lack of  reduced ACh release in diaphragm NMJs of  α-neurexin DKOs might 
be due to a compensation by other types of  voltage-gated calcium channels as found 
in calcium channels mutants (Muth et al., 2001; Urbano et al., 2003). In order to test 
Muscle preparation
Soleus Diaphragm
Genotype Control (n) DKO (n) Control (n) DKO (n)
fMEPP/± ω-Agaa (s-1) 0.57 ± 0.1 (6) 0.55 ± 0.1 (8) --- ---
fMEPP/sucrose (s-1) 60.7 ± 3.6 (13) 53.9 ± 3.4 (12) 41.0 ± 6.9 (10) 48.9 ± 5.5 (11)
QC (ratio ± ω-Aga)a 0.003 ± 0.001 (6) 0.004 ± 0.001 (6) 0.08 ± 0.01 (14) 0.02 ± 0.01 (15) ***
EPP rundown (%)b 75.5 ± 0.7 (16) 73.9 ± 0.9 (19) 82.9 ± 0.8 (16) 83.5 ± 0.5 (16)
EPP amplitude (mV) 26.8 ± 0.9 (20) 26.1 ± 0.8 (21) 25.4 ± 0.8 (16) 28.7 ± 1.1 (16) *
EPP halfwidth (ms) 3.1 ± 0.1 (15) 2.9 ± 0.1 (12) 3.1 ± 0.1 (16) 3.1 ± 0.1 (16)
MEPPamplitude (mV) 0.7 ± 0.1 (21) 0.9 ± 0.1 (20) ** 1.0 ± 0.1 (16) 1.3 ± 0.1 (16) **
MEPP halfwidth (ms) 2.9 ± 0.1 (15) 2.9 ± 0.1 (12) 2.8 ± 0.1 (16) 2.9 ± 0.1 (16)
TABLE 1.   Characterization of  neurotransmission at the NMJ of  α-neurexin double-knockout mice
Intracellular recording techniques were used to compare biophysical properties of  nerve-muscle transmission in 
soleus (slow-twitch) and diaphragm (mixed slow and fast-twitch) muscles prepared from 5-6 week old α-neurexin 
double-knockouts (DKO), and their respective controls. Data are means ± SEM; n = number of  animals used; 
10-15 NMJs tested per muscle/mouse. fMEPP, frequency of  miniature endplate potential (MEPP); QC, quantal 
content; EPP, endplate potential; ω-Aga, CaV2.1 specific calcium channel inhibitor ω-agatoxin IVA; ---, not done. 
* P<0.05; 
** P<0.01; 
*** P<0.001 (Student’s t-test). 
aRecordings were performed before and after addition of  200 nM ω-agatoxin IVA, and results expressed as the ratio 
of  agatoxin/control.
bExpressed as percent of  first EPP amplitude, recorded under high-rate (40 Hz) nerve stimulation.
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for possible compensation, we measured quantal content before and after applica-
tion of  the CaV2.1 blocker ω-agatoxin IVA (200 nM), but no apparent compensa-
tory upregulation was observed. The amount of  ACh released after removal of  the 
CaV2.1 component was even slightly lower in DKOs than in control mice (Table 1), 
possibly reflecting the likewise impaired function of  CaV2.2 channels in α-neurexin 
KOs (Zhang et al., 2005). 
Since NMJs on different types of  muscle fibers such as slow-twitch and fast-
twitch fibers differ in structure and function (Bewick, 2003), we further compared 
the biophysical parameters of  evoked and spontaneous ACh release at both prepara-
tions of  control and α-neurexin DKO mice. To test if  the difference between soleus 
and diaphragm NMJs in α-neurexin knockouts could be attributed to a change in the 
safety factor, we measured the EPP amplitude rundown at high-rate nerve stimula-
tion (40 Hz). However, no differences in rundown profiles (data not shown) and 
relative reduction of  rundown amplitudes could be observed (Table 1) between the 
genotypes under high intensity use. The halfwidth of  EPP and MEPP recordings re-
vealed also no changes in the activation kinetics of  ACh release and of  the postsyn-
aptic ACh receptors (Table 1).  Although the quantal content was reduced at mutant 
soleus NMJs (Figure 2C), their overall EPP amplitude was unchanged, and the EPP 
amplitude measured at mutant diaphragm NMJs was even slightly elevated (Table 
1). This effect can be explained by the about 20% reduced fibre diameter in DKO 











Figure 4. MEPP amplitudes are increased 
at soleus and diaphragm NMJs of  
α-neurexin DKO mice.
Single representative traces of  miniature end-
plate potentials (MEPPs) recorded from sole-
us (A) and diaphragm (B) ex vivo preparations 
show slightly higher amplitudes in mutant 
mice (DKO) as compared to control animals, 
most likely reflecting the overall reduced mus-
cle fiber diameter (see Table 2).
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about 25% increase in MEPP amplitude which can be observed on representative 
MEPP traces from both muscle preparations (Figure 4) and their quantifications 
(Table 1).
Effect of  the deletion of  α-neurexins on the morphology of  neuromuscular junctions
The reduced neurotransmitter release in the soleus muscle and the smaller muscle 
fibers in both soleus and diaphragm of  α-neurexin DKOs raised the question if  the 
localization or morphology of  NMJs were affected as well. Formation and matura-
tion of  NMJs are known to rely at least partly on activity-dependent signals, as evi-
denced, for example, by deletion of  choline acetytransferase, the enzyme responsible 
for the synthesis of  ACh (Misgeld et al., 2002). To address this issue, we performed 
histological experiments on NMJs of  both soleus and diaphragm muscles. Teased 
fibers were incubated with fluorescently-labeled α-BTx to visualize NMJs by their 
postsynaptic ACh receptors (Figure 5A1-A2). NMJs were normally distributed in 
their target field of  innervation in both muscles of  control and DKO mice (Figure 
Muscle preparation
Soleus Diaphragm
Genotype Control (n) DKO (n) Control (n) DKO (n)
Muscle Fibre  
Diameter (µm) 31.6 ± 1.1 (6) 25.4 ± 1.7 (6) * 29.8 ± 0.9 (6) 25.4 ± 1.6 (6) *
NMJ Area (µm2) 375 ± 17 (7) 293 ± 11 (6) ** 261 ± 14 (7) 224 ± 12 (7)
NMJ Perimeter (µm) 241 ± 15 (7) 199 ± 6 (6) ** 195 ± 9 (7) 171 ± 8 (7)
Complexity (µm-1)a 0.7 ± 0.04 (7) 0.7 ± 0.03 (6) 0.8 ± 0.04 (7) 0.8 ± 0.02 (7)
NMJs/fiber (No.)b 0.99 ± 0.01 (7) 0.98 ± 0.02 (6) 1.01 ± 0.01 (7) 0.99 ± 0.01 (6)
TABLE 2.   Neuromuscular junction morphology in α-neurexin double-knockout mice
Teased muscle fibers of  soleus and diaphragm were prepared from 5-6 week old mice (α-neurexin double-knockouts 
and littermate controls), and the outlines of  their fluorescently–labeled NMJs (see Figure 5) quantitated using an 
image analysis software (see Experimental Procedures). Data are means ± SEM; n = number of  animals used; 40-70 
NMJs analyzed per muscle/mouse.
* P<0.05;  
** P<0.01; (Student’s t-test)
a Complexity is a derived measure that represents the shape of  the pretzel-like NMJ, and was calculated by dividing 
Perimeter/Area. A lower value of  complexity would reflect more disc-like, immature NMJs.
b The number of  synaptic sites per muscle fiber was counted in double-labelings as described in Results.
Figure 5. Morphological analysis of  α-neurexin-deficient NMJs.
Teased fiber preparations (A1, differential interference contrast picture) were stained with fluorescently-labeled 
α-BTx to identify NMJs (A2) by visualizing postsynaptic ACh receptors. (B) Images of  randomly sampled NMJs 
were outlined interactively by an investigator unaware of  the genotype, and their area and perimeter quantitated by 
image analysis (results see table 2). (C, D) Double-labelings of  soleus muscle NMJs from control (C1) and mutant 
mice (D1) with antibodies against the synaptic vesicle protein synapsin, and α-BTx (C2, D2), showing precise over-
lap of  pre- and postsynaptic sites in merged images (C3, D3). (E, F) Similar experiment using antibodies againt the 
vesicular ACh transporter, VAChT, on NMJs of  control (E1) and mutant mice (F1), counter-stained with fluores-
cently-labeled α-BTx (E2, F2). (G) The number of  axons per synaptic site in control (G1) and DKO mice (G2) was 
estimated by co-labeling ACh receptor clusters (α-BTx, green) with antibodies against neurofilament (SMI32, red), 
and in some experiments with Alexa633-phalloidin to stain target cells (G3).











A2, and data not shown). Their en face images were outlined interactively (example 
in Figure 5B), and the area, perimeter and complexity quantitated by automated 
image analysis (Table 2). To ensure that the postsynaptic ACh receptor distribu-
tion visualized by fluorescent α-BTx is a true representative also of  the presynaptic 
terminal of  NMJs especially in mutant mice, we performed double-labelings with 





































Figure 6. Effect of  chronic α-BTx 
treatment on postsynaptic ACh 
receptor density in control and 
α-neurexin DKO mice.
(A) Representative traces of  single MEPP 
recordings from control and DKO 
diaphragm NMJs that received saline or 
α-BTx injections for four weeks, lead-
ing to a strong reduction of  amplitudes 
in both genotypes under toxin-induced 
myastenia gravis-like (TIMG) conditions. 
The slightly elevated amplitude in DKOs 
before injections is most likely due to a 
smaller muscle fiber diameter (see also 
Figure 4, and Table 2) (B, C) Histograms 
of  MEPP amplitude distributions follow-
ing saline (B) or α-BTx (C) treatment.
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(Figure 5E-F). Overlap of  pre- and postsynaptic markers was found in both control 
and mutant muscle preparations, allowing the use of  α-BTx stained ACh receptors 
to draw conclusions on the structure of  the entire NMJs. In line with the reduced 
ACh release from soleus NMJs, we found an about 22% smaller area and 19% re-
duced perimeter of  these synapses in (Table 2). In contrast, the structure of  NMJs 
in the diaphragm muscle of  mutant mice was not significantly altered (Table 2). 
The smaller size of  mutant soleus NMJs did not reflect a more immature type of  
junction because the complexity of  all NMJs as a measure of  their degree of  dif-
ferentiation was indistinguishable between genotypes (Table 2). To finally test if  the 
deletion of  α-neurexins possibly affected the elimination of  the surplus of  axonal 
branches innervating individual muscle fibers during development, we performed 
double-labelings of  NMJs (α-BTx) and axons (phosphorylated neurofilaments) (Fig-
ure 5G). Analysing the number of  NMJs per terminal nerve branch revealed no dif-
ferences between control animals and DKOs, both displaying the expected ratio of  
one NMJ/ terminal axon and muscle fiber (Table 2). 
α-Neurexins contribute to synaptic homeostasis at neuromuscular junctions
The finding that the deletion of  two α-neurexin genes had no significant effect on 
ACh release from diaphragm NMJs is surprising because reduced neurotransmis-
sion was observed at soleus NMJs (Figure 2, Table 1), and at various excitatory and 
inhibitory synapses of  the central nervous system (Missler et al., 2003; Kattenstroth 
et al., 2004; Zhang et al., 2005). Since the α-neurexin function at some but not all 
NMJs may be partially overlapping with other molecules such as laminins (Knight 
et al., 2003; Nishimune et al., 2004), we wanted to illuminate their contribution to 
release under conditions of  synaptic plasticity. Two groups of  each genotype (n = 
6 + 6 control mice, and n = 5 + 5 DKO mice) were subjected to the TIMG pro-
tocol, a chronic treatment of  intraperitoneal injections with either saline or α-BTx. 
The toxin paradigm has been previously shown to lead to a compensatory upreg-
ulation of  ACh release that is induced by a decreased sensitivity of  postsynaptic 
ACh receptors (Plomp et al., 1994). Mice were sacrified at about 10 weeks of  age 
after 4 weeks of  treatment, and phrenic nerve/ diaphragm preparations used for 
intracellular recordings as decribed above. Consistent with our basic characteriza-
tion of  neurotransmission at the diaphragm NMJ described above, the amplitude 
of  MEPPs was slightly increased in the saline-injected DKOs compared to saline-
injected control mice (control 0.93 ± 0.08 mV; DKO 1.33 ± 0.06, P<0.01; Figure 
6). Four-weeks TIMG treatment caused a robust decrease of  the MEPP amplitudes 
to almost identical levels in both genotypes (control 0.3 ± 0.01 mV; DKO 0.32 ± 
0.03, n.s.; Figure 6), indicating that the toxin treatment was similarly effective, and 
postsynaptic ACh receptor sensitivity about equal in both control and α-neurexin 
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Figure 7. Impaired upregulation of  evoked ACh release in α-neurexin-deficient NMJs.
(A) Following TIMG treatment, quantal content as a measure of  evoked ACh release from diaphragm NMJs is 
increased to 240% (control) but only to 176% (DKOs) of  saline-treated animals of  the same genotype. (B) Follow-
ing TIMG treatment, high frequency (40 Hz) stimulation of  diaphragm NMJs leads to a similar reduction of  EPP 
run-down in both control and DKO mice. (C) Diagram summarizing the electrophysiological effects of  TIMG 
treatment on control and α-neurexin DKO mice, expressed as percentage of  changes from injections with saline 
alone. In all graphs and panels, statistical significance is indicated above the bars. Data shown are means ± SEM.
89
Neurexin
much less pronounced in α-neurexin DKO NMJs (about 176%; quantal content in 
DKO mice/saline-injected 34.9 ± 2.3, DKO mice/α-BTx-injected 61.3 ± 5.4, Fig-
ure 7A) as compared to control mice (about 240%; quantal content in control mice/
saline 40.6 ± 4.5, control mice/α-BTx 97.4 ± 6.9; Figure 7A). The impaired upregu-
lation of  presynaptic release following postsynaptic reduction of  functional ACh 
receptors was also reflected by a more pronounced reduction of  EPP amplitudes in 
mutant mice (about 50%; EPP amplitude in DKO mice/saline-injected 29.7 ± 1.4 
mV, DKO mice/α-BTx-injected 14.9 ± 2.7) as compared to controls (about 15%; 
EPP amplitude in control mice/saline 24.6 ± 0.9 mV, control mice/α-BTx 21 ± 
1.0). The change in high-rate (40 Hz) stimulated EPP amplitude rundown following 
α-BTx treatment, however, was indistinguishable between the genotypes (control 61 
± 2.7%, DKO 61 ± 2.5%, Fig 7B). The TIMG experiment suggests that α-neurexins 
perform an important role in the regulation of  presynaptic release under conditions 
of  synaptic plasticity (for summary of  the effects see Figure 7C), and are possibly 
involved in translating the retrograde signals from muscle fibers with reduced post-
synaptic ACh receptors to the presynaptic release machinery.
Discussion
Neurexins are neuron-specific cell-surface molecules that were proposed to have a 
function at synapses (Missler et al., 1998a; Missler, 2003; Scheiffele, 2003) because (i) 
their structure resembles that of  a receptor (Ushkaryov et al., 1992; Ushkaryov and 
Südhof, 1993; Ushkaryov et al., 1994), (ii) they bind to postsynaptic cell-surface pro-
teins, e.g. neuroligins (Ichtchenko et al., 1995) and dystroglycan (Sugita et al., 2001), 
(iii) they are receptors for α-latrotoxin which induces massive neurotransmitter re-
lease (Geppert et al., 1998; Sugita et al., 1999), and (iv) they are highly polymorphic 
in their extracellular sequences due to extensive alternative splicing which appears 
to be functionally relevant (Ullrich et al., 1995; Tabuchi and Sudhof, 2002). Most 
importantly, deletion of  α-neurexins strongly points towards a specifically synaptic 
function because their absence severely impairs both excitatory and inhibitory neu-
rotransmitter release at synapses of  the central nervous system, presumably due to 
impaired Ca2+-channel function, whilst unaffecting brain architecture and synaptic 
ultrastructure (Missler et al., 2003).
Here, we have investigated the contribution of  α-neurexins to neurotransmission 
at NMJs by analysing the phenotype of  surviving adult DKO mice. Our findings on 
reduced spontaneous and evoked ACh release in the soleus muscle (Figure 2, Table 
1) are in line with the data on impaired physical exercise and tetanic contraction 
(Figure 1C-E), and are consistent with previous results on reduced spontaneous 
and evoked release from central synapses (Missler et al., 2003). In fact, the degree 
of  consistency between our current analysis of  peripheral synapses (i.e., NMJs) and 
the earlier data on central synapses underscores the ubiquitous importance of  the 
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molecules, and the validity of  our conclusions. However, there are also important 
differences between the analyses of  central and peripheral synapses in α-neurexin-
deficient mice as shown in this study, leading to novel insights into the function of  
α-neurexin as regulators of  neurotransmitter release.
The reduction of  transmitter release at the soleus DKO NMJ (about 25% com-
pared to controls) was much less than that found at central synapses (between 50-
95% at different synapses of  newborn TKOs). Several reasons may contribute 
to this discrepancy. (i) The NMJs investigated here are derived from DKO mice 
that represent “survivors” of  a population with high mortality, since only 40% of  
DKO2/3 and 10% of  DKO1/2 live beyond 3 weeks of  age (Missler et al., 2003). 
Therefore, the NMJ data obtained here from mice aged 4-6 weeks may be biased to-
wards a milder synaptic phenotype. (ii) The possiblity exists that the developmental 
switch from CaV1 and CaV2.2 to almost exclusively CaV2.1 channels at NMJs during 
the early postnatal period (Rosato Siri and Uchitel, 1999) prevents development of  
the full extent of  the phenotype. Although CaV2.1 channels can be regulated by 
α-neurexins (Zhang et al., 2005), both populations of  central synapses characterized 
in the newborn TKOs contain a significant proportion of  CaV2.2 channels (Missler 
et al., 2003) which may be affected more severely by the mutations. (iii) The more 
subdued role of  α-neurexins in basal transmitter release at the NMJ, compared to 
central synapses, may be due to a partially overlapping function with other cell-
adhesion molecules that are not at all present or less active at central synapses. For 
example, neural cell adhesion molecule (NCAM) is present at NMJs and affects 
morphology and function, as evidenced by smaller NMJ size and reduced high-rate 
ACh release in NCAM knockout mice (Rafuse et al., 2000). Another candidate for 
functional overlap with α-neurexin at the NMJ is laminin-β2 that binds to an extra-
cellular loop of  the CaV2.1 pore-forming subunit, thereby influencing aggregation 
of  components at ACh release sites, and consequently, the level of  neurotransmis-
sion (Noakes et al., 1995; Knight et al., 2003; Nishimune et al., 2004). 
Evidence for an additional role of  α-neurexins in synaptic homeostasis followed 
from the experiments in which we forced a homeostatic response at NMJs by lower-
ing the functional ACh receptor number by chronic treament with α-BTx. (Figure 
6-7). The normal response to this TIMG treatment is a compensatory increase of  
the quantal content, most likely via retrograde transsynaptic signaling (Plomp et al., 
1992). Diaphragm NMJs of  DKO mice were much less able to respond to the treat-
ment compared to control animals, suggesting that α-neurexins are involved in the 
mechanism of  synaptic homeostasis. Such an hypothesis is supported by the pro-
posed function of  α-neurexins in coupling calcium channels to transmitter release 
(Missler et al., 2003) because the homeostatic increase in quantal content depends 
on calcium influx (Plomp et al., 1994). In line with such an interpretation, it has 
recently been hypothesized that ACh release sites at mouse NMJs have “slots” that 
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are preferentially filled with CaV2.1 channels (Urbano et al., 2003). The scaffolding 
molecules forming these proposed “slots” may include CASK and Mint1, both of  
which can bind to the C-terminus of  CaV2.1 channels (Maximov et al., 1999) as well 
as to the cytoplasmic portion of  neurexins (Hata et al., 1996; Biederer and Südhof, 
2000), suggesting a possible way to regulate the amount of  CaV2.1 channels at ACh 
release sites. Further experiments are needed, however, to elucidate the nature of  the 
interaction between α-neurexins and the various calcium channel subtypes. Unfor-
tunately, we were not able to determine the TIMG response at NMJs of  the soleus 
muscle as the α-BTx treatment lowered the already small MEPP amplitudes at this 
NMJ to values below the detection limit (about 0.15 mV, data not shown), preclud-
ing reliable calculation of  quantal content. However, the link between α-neurexins 
and presynaptic Ca2+ influx may provide an explanation why both reduced basal 
transmission and/or impaired synaptic homeostasis are observed as NMJ pheno-
types, albeit at different ratios in the two populations studied here.
The difference between soleus and diaphragm NMJs with respect to the influ-
ence of  α-neurexins on their basal release is interesting (Figure 2, Table 1) because 
their release properties may be related to the difference in muscle fiber types, the 
soleus being a slow-twitch and the diaphragm a muscle with mixed slow- and fast-
twitch fiber composition (Prakash et al., 1996; Bewick, 2003). NMJs on those fiber 
types differ in structure and function in a way that NMJs on slow-twitch fibers dis-
play a lower initial release level (Bewick, 2003), presumably making them more vul-
nerable to the deletion of  α-neurexins as demonstrated here. The difference was not 
due, in turn, to a differential expression in the respective motor neurons innervating 
both muscle types as shown in the in situ hybridization experiments (Figure 3). The 
finding that soleus-but not diaphragm-NMJs of  α-neurexin DKO mice were smaller 
than those from control animals (Table 2) presumably reflects the difference in neu-
rotransmission, since NMJ size and levels of  evoked and spontaneous ACh release 
are positively correlated (Harris and Ribchester, 1979; Plomp et al., 1992). Other 
knockout studies leading to decreased neurotransmitter release have reported similar 
changes of  NMJ structure (for recent examples, e.g. Knight et al., 2003; Polo-Parada 
et al., 2004; Varoqueaux et al., 2005), while the morphology of  central synapses in 
the same mutant mice was remarkably unaffected as was the case in α-neurexin KO 
animals (Missler et al., 2003). Although our hypothesis that the changes in adult 
NMJ structure at soleus NMJs are secondary to the functional defects in release 
caused by the deletion of  α-neurexins is further supported by the lack of  a structural 
phenotype in newborns, a different interpretation cannot be completely excluded 
at present: If  neurexins in some indirect way caused the mild growth retardation 
observed (DKO body weight was ~30% lower than controls) and this was the sole 
reason that muscle fibers remained smaller, one could consider the reduced evoked 
release at the α-neurexin DKO soleus NMJ as the result of  a proper functioning 
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homeostatic mechanism where the smaller muscle fiber diameter dictates a lower 
evoked and spontaneous ACh release. Muscle fiber diameter is known to be inverse-
ly related to electrical input resistance (which in turn dictates MEPP amplitude), 
and positively correlated with NMJ size and level of  evoked and spontaneous ACh 
release. However, if  the reduced ACh release at soleus α-neurexin DKO NMJs is 
regarded as the proper level for such small diameter muscle fibers, the level of  spon-
taneous and evoked ACh release at α-neurexin DKO diaphragm NMJs, which was 
similar to controls (Figure 2D–E), must be considered as too high for its small fiber 
diameter. If  this idea was true, it could be concluded that lack of  α-neurexins causes 
incorrect transmitter release homeostasis at diaphragm NMJs, rather than a direct 
reduction of  ACh release at soleus NMJs. Finally, it may also be possible that both 
effects, reduced basal neurotransmission and impaired synaptic homeostasis, coexist 
but in varying ratios at the NMJs of  the different muscles. Irrespective of  the actual 
interpretation, however, our current data on NMJ function and morphology clearly 
demonstrate that α-neurexins can perform their role as presynaptic regulators even 
in the absence of  a postsynaptic neuronal partner.  
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Rab3A deletion selectively reduces 
spontaneous neurotransmitter release 




Rab3A is a synaptic vesicle-associated GTP-binding protein thought to be involved 
in modulation of  presynaptic transmitter release through regulation of  vesicle traf-
ficking and membrane fusion. Electrophysiological studies at central nervous system 
synapses of  Rab3A null-mutant mice have indicated that nerve stimulation-evoked 
transmitter release, and its short- and long-term modulation, is partly dependent 
on Rab3A, while spontaneous uniquantal release is completely independent of  it. 
Here, we studied with intracellular microelectrode methods the acetylcholine (ACh) 
release at the neuromuscular junction (NMJ) of  diaphragm and soleus muscles from 
Rab3A deficient mice. Surprisingly, we found 20-40% reduction of  spontaneous 
ACh release, measured as miniature endplate potential frequency, but completely 
intact nerve action potential-evoked release at either high- or low-rate stimulation or 
during recovery from intense release. ACh release induced by hypertonic medium 
or α-latrotoxin was also unchanged, indicating that the pool of  vesicles that is im-
mediately available for release is unaltered at the Rab3A deficient NMJ. These results 
indicate a selective role of  Rab3A in spontaneous transmitter release at the NMJ for 
which the closely related Rab3B, -C, or -D isoforms apparently do not, or incom-
pletely, compensate when Rab3A is deleted. It has been hypothesized that Rab3A 
mutation underlies human presynaptic myasthenic syndromes, in which severely re-
duced nerve action potential-evoked ACh release at the NMJ causes paralysis. Our 
observation that Rab3A deletion does not reduce evoked ACh release at the mouse 
NMJ, argues against this hypothesis.
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Exocytosis of  neurotransmitter from synaptic vesicles involves a complex interplay 
of  many presynaptic proteins that regulate vesicle transport, docking, priming, fu-
sion, and recycling (for review, see Lin and Scheller, 2000; Sudhof, 2004). Many of  
these processes are subjected to modulation, tuning synaptic signaling to ensure 
proper neuronal network function. Rab3A seems one important modulating factor 
and is a member of  the Rab family of  GTP-binding proteins with a general func-
tion in intracellular traffic (for review, see Darchen and Goud, 2000). It is thought 
that the Rab3A, B, C and D subfamily, of  which Rab3A is the most abundant in the 
brain (Geppert et al., 1994), plays a role in mammalian exocytosis. Rab3A is a GTP/
GDP-binding protein which, in the GTP-state, is associated with the synaptic vesicle 
membrane but becomes detached upon GTP to GDP hydrolysis during or shortly 
after the exocytotic event (Fischer von Mollard et al., 1991; Fischer von Mollard et 
al., 1994; Star et al., 2005). So far, two putative GTP-Rab3 binding partners have 
been demonstrated, rabphilin (Shirataki et al., 1993) and Rab Interacting Molecule 
(RIM) 1α/2α (Wang et al., 2000).
Transgenic deletion in mice showed that Rab3A is not of  crucial importance 
for nervous system function, since these knock-out (KO) mice are viable and do 
not show overt behavioural abnormalities (Geppert et al., 1994). Detailed analyses 
of  mutant and KO Rab3A mice, however, revealed mild anomalies in exploration 
behaviour and sleep (Kapfhamer et al., 2002; D’Adamo et al., 2004). Electrophysi-
ological analyses of  cultured and brain-slice hippocampal synapses from Rab3A-
deficient mice suggested a modulatory role for Rab3A, selective for evoked but not 
spontaneous release, by showing unchanged or increased initial release, increased 
paired-pulse facilitation, and a more pronounced rundown at high-rate stimulation, 
compared to wild-type (Geppert et al., 1994; Geppert et al., 1997). Rab3A-D pro-
teins appear to act mutually compensatory since each single KO mouse is viable and 
fertile, but the Rab3A-D quadruple KO mouse shows postnatal lethality (Schluter 
et al., 2004). Analysis of  transmitter release at embryonic autaptic cultures from 
Rab3A-D quadruple deficient hippocampal neurons showed unchanged spontane-
ous release properties (Schluter et al., 2004), confirming the finding of  unchanged 
spontaneous release at Rab3A single KO synapses (Geppert et al., 1997). However, 
an about 30% decrease in evoked transmitter release was revealed, resulting from a 
decrease in release probability (Schluter et al., 2004). From K+-evoked transmitter 
release studies at Rab3A KO synaptosomes it appeared that recruitment of  synap-
tic vesicles to active zones after vigorous stimulation is impaired (Leenders et al., 
2001).
The modulatory role of  Rab3A on evoked transmitter release seems to differ 
amongst synapse types, as illustrated by different effects of  Rab3A deletion on long-
term potentiation of  synaptic strength in different types of  hippocampal excitatory 
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synapses (Geppert et al., 1994; Castillo et al., 2002). Possibly, differential expression 
of  compensatory Rab3B-D proteins is of  importance here. 
Here, we investigate a possible role of  Rab3A on the release of  ACh from mo-
tor nerve terminals at the neuromuscular junction (NMJ). It is of  importance to 
understand the roles of  neuro-exocytotic proteins at the neuromuscular junction 
(NMJ). At this peripheral synapse, transmitter release is tightly regulated, in order to 
maintain successful contraction of  muscle fibres, which is crucial for the organism. 
Defective function of  Rab3A and other presynaptic proteins may underlie human 
congenital presynaptic myasthenic syndromes, where reduced ACh release leads to 
paralysis (Maselli et al., 2001; Maselli et al., 2003a), alike the auto-immune Lambert-
Eaton myasthenic syndrome where presynaptic Cav2.1 channels are targeted by au-
to-antibodies (Kim and Neher, 1988).
Rab3A is localized at transmitter release sites of  the mammalian presynaptic 
NMJ (Mizoguchi et al., 1992), as are many other proteins that have been shown to be 
involved in exocytosis at central synapses. Previously, we demonstrated an identical 
silencing effect of  Munc18-1 deletion on central synapses and the NMJ (Verhage et 
al., 2000). However, absence of  specific presynaptic proteins does not always yields 
identical effects at central synapses and the NMJ. For instance, recent analysis of  
NMJ function in double KO Munc13-1/2 embryos contrasted the finding of  com-
pletely silenced central synapses (Varoqueaux et al., 2002). A severely reduced but 
not completely blocked evoked transmitter release was found at the NMJ, together 
with intact spontaneous release (Varoqueaux et al., 2005). 
With intracellular microelectrode methods we measured ACh release at NMJs 
of  nerve-muscle preparations from diaphragm and soleus muscles from Rab3A KO 
mice. We found 20-40% reduction of  the spontaneous ACh release, but unchanged 
nerve action potential-evoked release at low- as well as high-rate stimulation fre-
quencies, and normal release induced by hypertonic medium or α-latrotoxin. These 
results suggest a selective role of  Rab3A in spontaneous transmitter release at the 
NMJ for which Rab3B, -C, or -D do not, or incompletely, compensate when Rab3A 
is deleted. Our study shows that Rab3A deficiency does not endanger successful 
neuromuscular transmission, leaving the Rab3A gene as an unlikely mutation candi-
date for causing human congenital presynaptic myasthenic syndromes. 
Materials and methods
Mice
The generation and genotyping of  the Rab3A KO mice has been described previ-
ously (Geppert et al., 1994). Mice were housed under a 12 h light / 12 h dark regime 
and ad libitum food and water. About 3 months-old animals were killed by CO2 
inhalation, and hemi-diaphragms and soleus muscles with their nerves were rapidly 
dissected and mounted in Ringer’s solution (see below) at room temperature. All 
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animal experiments were carried out in agreement with the Dutch law and Leiden 
University guidelines.
NMJ electrophysiology
Intracellular voltage measurements were performed on diaphragm and soleus nerve/
muscle preparations from Rab3A KO mice and littermate wild-type controls, pinned 
out on the bottom of  a silicone rubber-lined dish in Ringer’s medium containing 
(mM): NaCl, 116; KCl, 4.5; MgCl2, 1; CaCl2, 2; NaH2PO4, 1; NaHCO3, 23; glucose 
11; pH 7.4, gassed with 95 % O2/5 % CO2 at 26-28°C. The nerve was electrically 
stimulated through either a bipolar electrode (diaphragm) or a suction electrode 
(soleus) with supramaximal pulses (100 μs duration) from a Master-8 programmable 
stimulus generator (AMPI, Jerusalem, Israel). Upon stimulation, the nerve termi-
nal synchronously releases a number of  ACh quanta that stimulate postsynaptic 
ACh receptors and thus cause an endplate potential (EPP). Spontaneous release of  
single quanta results in miniature EPPs (MEPPs). We recorded EPPs and MEPPs 
by impaling muscle fibres near the NMJ with a 10-20 MΩ glass capillary microelec-
trode filled with 3 M KCl and connected to a GeneClamp 500B amplifier (Axon 
Instruments/Molecular Devices, Union City, CA, USA) for amplifying and filtering 
(10 kHz low-pass) of  the signal. Signals were digitized, stored and analyzed (off-
line) using a Digidata 1200 interface, Clampex 8.0 and Clampfit 8.0 programs (all 
from Axon Instruments/Molecular Devices) and routines programmed in Matlab 
(The MathWorks Inc., Natick, MA, USA). Muscles were incubated with 3.1 µM 
µ-Conotoxin GIIIB (Scientific Marketing Associates, Herts, UK), a selective blocker 
of  muscle sodium channels, to prevent muscle action potentials. This allowed for 
the undisturbed recording of  EPPs during electrical nerve stimulation (0.3, 20, 30, 
40 and 50 Hz). The amplitudes of  EPPs and MEPPs were normalized to –75 mV, 
assuming 0 mV as the reversal potential for ACh-induced current (Magleby and 
Stevens, 1972), using the formula: EPPnormalized = EPP x (-75/Vm), where Vm is the 
measured resting membrane potential. The quantal content (i.e. the number ACh 
quanta released upon a single nerve impulse) at each NMJ at 0.3 Hz stimulation was 
calculated by dividing the normalized EPP by the normalized MEPP amplitude. The 
EPP amplitude was first corrected for non-linear summation, as described before 
(Plomp et al., 1994). During high-frequent stimulation, EPP amplitudes decrease 
to a plateau level. This rundown level was determined by calculating the average 
amplitude of  the last 10 EPPs in a 40 Hz train of  1s duration and expressing it as 
percentage of  the amplitude of  the first EPP of  the train.
MEPPs were also recorded shortly after exposure of  preparations to hypertonic 
medium (0.5 M sucrose Ringer), assessing the pool of  ACh vesicles ready for im-
mediate release (Stevens and Tsujimoto, 1995). Furthermore, MEPPs were recorded 




The data is given as mean ± S.E.M, with n representing the number of  muscles 
tested. At least 30 MEPPs and EPPs were recorded at each NMJ. From the mean 
NMJ values, a muscle mean value was calculated (at least 10 NMJs were sampled per 
muscle per experimental condition), which was used to calculated a genotype group 
mean value. Four to six mice were used per genotype, from each mouse one dia-
phragm and one soleus muscle was analyzed. Possible differences between the mean 
values of  genotype groups were tested with Student’s t-test and were considered 
statistically significant if  the p-value was <0.05. 
Results
Spontaneous ACh release is reduced at Rab3A deficient NMJs 
Spontaneous ACh release at diaphragm NMJs from Rab3A KO mice and wild-type 
littermates was electrophysiologically determined by recording MEPPs, the sponta-
neous uniquantal release events. At diaphragm NMJs, a decrease of  19% in MEPP 
frequency was observed in Rab3A KO NMJs, compared to wild-type (1.24 ± 0.06 
s-1 and 1.54 ± 0.08 s-1, respectively, n=6 mice, p<0.05, Figure 1A). The amplitude of  
the MEPPs was similar for both genotypes (0.94 ± 0.09 mV at wild-type, and 1.00 
± 0.06 mV at Rab3A KO NMJs, n=6, p=0.5, Figure 1C, D). Similarly, the MEPP 
kinetics (rise times, decay times and half-widths) were unchanged (data not shown, 
Figure 1D), indicating that there were no changes in postsynaptic ACh receptor 
function due to the Rab3A deficiency. The diaphragm muscle consists of  a mixed 
population of  fast- and slow-twitch fibres, which are known to have different NMJ 
characteristics (Bewick, 2003). To investigate whether Rab3A deletion has differen-
tial effects on slow-twitch fibres we also investigated spontaneous ACh release at 
NMJs of  the soleus muscle, which exclusively consists of  slow-twitch fibres. Again, 
we found a decreased MEPP frequency (~40%) in Rab3A KO NMJs compared 
to wild-type (1.63 ± 0.11 s-1 and 2.77 ± 0.28 s-1, respectively; n=6, p<0.001, Figure 
1A). This decrease was more pronounced than that observed at diaphragm NMJs 
(p<0.01, Figure 1B). MEPP kinetics as well as amplitudes (~0.65 mV, n=6, p=0.6, 
Figure 1C, D) were again not different from wild-type. Thus, in contrast to central 
synapses (Hughes et al., 1999), Rab3A deletion reduces spontaneous transmitter 
release at NMJs, in particular those of  slow-twitch muscles. 
Unaltered size of  readily releasable vesicle pool
The observed reduction in spontaneous ACh release may be caused by a reduction 
of  the number of  transmitter vesicles that are ready for release. In order to probe 
for this vesicle pool (Stevens and Tsujimoto, 1995) we added hypertonic medium 
(0.5 M sucrose-Ringer) and measured the resulting elevated MEPP frequency. No 
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difference between genotypes was observed (diaphragm: 53.6 ± 6.5 s-1 at wild-type 
and 58.3 ± 9.3 s-1 at Rab3A KO NMJs, n=5-6 mice, p=0.68; soleus: 53.9 ± 6.9 s-1 at 


































































































Figure 1. Deletion of  Rab3A reduces spontaneous transmitter release at mouse diaphragm and soleus 
NMJs. 
(A) Mean MEPP frequency at NMJs from diaphragm (DIA) and soleus (SOL) from wild-type and Rab3A KO mice. 
(B) The reduction of  MEPP frequency is more pronounced at soleus than at diaphragm Rab3A KO NMJs. (C) No 
difference in MEPP amplitude between Rab3A KO and wild-type NMJs of  either diaphragm or soleus muscles. 
(D) Typical examples of  4 s recording traces of  MEPPs, at diaphragm (left) and soleus (right) NMJs. Lower traces 
are typical examples of  individual MEPPs.(E) Typical examples of  1 s recording traces of  MEPPs measured in the 
presence of  hypertonic medium (0.5 M sucrose-Ringer). (F) No difference in mean values of  MEPP frequency 
measured in the presence of  0.5 M sucrose-Ringer. 
Data obtained from n=5-6 mice, 10-15 NMJs per muscle. Error bars represent SEM. *p<0.05, and **p<0.01.
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This result suggests unaltered size of  the readily releasable vesicle pool at Rab3A 
KO NMJs.
Unchanged nerve action potential-evoked ACh release
We measured ACh release at diaphragm NMJs evoked by low-frequent (0.3 Hz) 
electrical stimulation of  the phrenic nerve (Figure 2A). EPP amplitudes of  wild-
type and Rab3A KO NMJs were similar (25.4 ± 1.4 and 26.2 ± 0.9 mV, respectively, 



















































































Figure 2. No differences in low-rate (0.3 Hz) nerve stimulation-evoked evoked ACh release between 
Rab3A KO and wild-type NMJs. 
(A) Typical examples of  EPPs recorded at diaphragm and soleus NMJs of  wild-type and Rab3A KO mice. Black 
dots indicate moment of  nerve stimulation. (B) Mean values of  EPP amplitudes recorded at diaphragm NMJs. (C) 
Mean values of  the calculated quantal contents at diaphragm NMJs. (D) Mean values of  EPP amplitudes recorded 
at soleus NMJs. (E) Mean values of  the calculated quantal contents at soleus NMJs. Data obtained from n=5-6 mice, 
10-15 NMJs per muscle. Error bars represent SEM.
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1 s stimulus interval recovery 5 s stimulus interval recovery
Figure 3. No differences in high-rate nerve stimulation-evoked ACh release between Rab3A KO and 
wild-type NMJs. 
Equal EPP rundown level (mean value of  the 21-35th EPP in the train, expressed as percentage of  the amplitude 
of  the first EPP), upon 20, 30, 40 or 50 Hz nerve stimulation at Rab3A KO and wild-type NMJs from diaphragm 
(A) or soleus (B) muscles. Data obtained from n=5-6 mice, 10-15 NMJs per muscle. Averaged 40 Hz EPP rundown 
profiles from diaphragm (C) or soleus (D) muscles, with examples of  individual EPP trains as insets. Kinetics and 
level of  recovery form EPP rundown was equal for Rab3A and wild-type NMJs of  diaphragm (E) and soleus (F) 
NMJs, as assessed with a protocol applying single nerve stimuli at 1 or 5 s intervals.
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leased upon nerve stimulation was similar (40.9 ± 2.1 at wild-type, and 38.9 ± 1.8 at 
Rab3A KO NMJs, n=6 mice, p=0.5). At soleus muscle NMJs, we found a somewhat 
decreased (23%) quantal content at Rab3A KO NMJs, but this reduction was not 
statistically significant (p=0.06, Figure2B). The EPP amplitudes were slightly smaller 
in Rab3A KO NMJs, but again this difference was not statistically significant (26.7 ± 
1.5 mV in wild-type, and 22.6 ± 1.6 mV in Rab3A KO NMJs, n=5-6 mice, p=0.09, 
Figure 2B). These results indicate that low-rate evoked release is not dependent on 
Rab3A presence.
In view of  the more pronounced rundown of  evoked transmitter release at high-
rate stimulation at central synapses (Geppert et al., 1994), we studied the ACh re-
lease at NMJs upon 1 s trains of  20, 30, 40 and 50 Hz stimulation. At all stimulation 
frequencies, EPP amplitudes ran down to a similar level in both Rab3A KO and 
wild-type diaphragm NMJs, with EPP amplitudes at the plateau phase of  the stimu-
lus train being about 80-85% of  the first EPP in the trains (p=0.48-0.70, n=6 mice, 
Figure 2C, E). Similarly, at soleus NMJs, high-rate stimulation resulted in equal EPP 
run-down level in both genotypes for all tested frequencies (to about 72-78%, of  
the first EPP in the trains, p=0.30-0.61, n=5-6 mice, Figure 3A-D). Thus, Rab3A 
deletion does not affect high-rate evoked ACh release at NMJs.
Normal recovery from high-rate ACh release
Rab3A may be important for replenishment of  the readily releasable vesicle pool 
after intense transmitter release. Therefore, we monitored the recovery of  the EPP 
amplitude after a 2 s train of  40 Hz stimuli, by giving single stimuli with intervals of  
either 1 or 5 s, starting 1 s after the end of  the 40 Hz train. No differences in recov-
ery rates were observed between Rab3A and wild-type NMJs, of  either diaphragm 
or soleus NMJs (Figure 3E) .
α-Latrotoxin-induced transmitter release
As an alternative means to evoke transmitter release, we applied 2.5 nM α-latrotoxin 
to diaphragm NMJs. This toxin binds to presynaptic receptors and evokes Ca2+-de-
pendent and -independent transmitter release by insertion of  ion-pores and stimula-
tion of  secondary messengers (Ushkaryov et al., 2004), resulting in high frequency 
MEPPs at the NMJ. However, the MEPP frequency was not statistically significantly 
different between genotypes, 120.8 ± 23.4 s-1 in wild-type NMJs, compared to 88.3 
± 13.9 s-1 in Rab3A NMJs (n=4-5 mice, p=0.25).
Discussion
We have examined the effect of  Rab3A deficiency on ACh release at the NMJ and 
found that spontaneous uniquantal release, but not the release evoked by either low- 
or high-rate electrical stimulation, hypertonic medium or α-latrotoxin, is reduced. 
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These results indicate that Rab3A has a specific role in the mechanism underlying 
spontaneous transmitter release at the NMJ, which is not compensated for by other 
Rab3 family members. The absence of  effects on evoked ACh release indicates that 
Rab3A is either not involved in the underlying mechanism, or that other Rab3 fam-
ily members fully compensate for its loss. Together these results show that Rab3A 
deletion does not endanger successful neuromuscular transmission. 
The present finding of  reduced spontaneous ACh release at NMJs due to Rab3A 
deletion is surprising in view of  the central synapse studies (on primary cultured 
Rab3A-deficient hippocampal neurons) that showed unaltered frequency of  spon-
taneous synaptic events (Geppert et al., 1997; Schluter et al., 2004). Although devel-
opmental reasons can not be ruled out (the central studies used embryonic material, 
while we studied NMJs from adult mice), the discrepancy most likely follows from 
more fundamental differences between hippocampal synapses and NMJs. It may be 
that expression of  Rab3B, C, and D isoforms is lower at the NMJ, so that their com-
pensatory action upon Rab3A deletion is less pronounced. Alternatively, the specific 
composition of  the neuro-exocytotic release machinery at the NMJ may differ from 
hippocampal synapses, in that it is more dependent on Rab3A for spontaneous re-
lease. For instance, the Rab3A binding partners rabphilin and/or RIM1α may be 
relative highly expressed at NMJs. About half  of  the spontaneous uniquantal ACh 
release at the mammalian NMJ is caused by Ca2+ influx via Cav2.1 channels, which 
apparently undergo some opening at resting membrane potential (Plomp et al., 
2000; Kaja et al., 2005). Rab3A might have some (indirect) stimulatory effect on the 
opening of  such channels. In this respect it is of  interest that NMJs of  some Cav2.1-
mutant mice show altered spontaneous ACh release without having altered low-rate 
evoked ACh release (Plomp et al., 2000; Kaja et al., 2004; Kaja et al., 2005).
The similar response of  Rab3A KO and wild-type NMJs to α-latrotoxin and 
hypertonic medium application indicate that it is not likely that the reduced MEPP-
frequency in Rab3A KO NMJs results from a decrease in the number of  vesicles 
in the readily releasable vesicle pool. Unchanged vesicle pool-size was also found at 
Rab3A KO hippocampal synapses (Geppert et al., 1997).
Postsynaptic MEPPs caused by spontaneous uniquantal ACh release at NMJs 
do neither influence the postsynaptic response to nerve stimulation-evoked release 
(EPPs), nor do they trigger muscle contraction by themselves (Wood and Slater, 
2001). Thus, the selective reduction of  spontaneous uniquantal ACh release at 
Rab3A deficient NMJs does not acutely endanger the successful transmission of  
impulses at the NMJ. However, it may have indirect effects in the longer term. At 
central synapses, miniature events have recently been shown to inhibit postsynaptic 
protein synthesis (Sutton et al., 2004). If  a similar mechanism exists at the NMJ, re-
duced spontaneous release at Rab3A KO NMJs would lead to upregulated postsyn-
aptic protein synthesis, possibly affecting ACh receptor expression or homeostatic 
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mechanisms regulating presynaptic transmitter release via retrograde messengers 
(Plomp et al., 1992). For hippocampal synapses it has been hypothesized that trans-
mitter quanta for spontaneous and nerve stimulation-evoked release originate from 
functionally distinct vesicle pools (Sara et al., 2005), although findings at another 
synapse seem not in agreement (Lou et al., 2005). If, however, such separate pools 
would also exist at NMJs, it might be speculated on the basis of  the present results 
that Rab3A is selectively involved in trafficking of  the vesicle pool that fuels spon-
taneous ACh release at the NMJ. 
The reduction of  spontaneous ACh release in Rab3A KO mice was more pro-
nounced at soleus than at diaphragm NMJs. This may be related to the difference 
in muscle fibre types: the soleus is a slow-twitch muscle, while the diaphragm is a 
muscle with mixed slow- and fast-twitch fibre composition (Prakash et al., 1996; 
Bewick, 2003). NMJs on slow- and fast-twitch fibres differ in structure and func-
tion, those on slow fibers being less elongated, more fatigue-resistant, and having a 
lower initial ACh release level (Bewick, 2003). These differences are probably related 
to differences in stimulation frequency and history of  use, possibly affecting local 
expression of  neuro-exocytotic proteins. It may be that Rab3A (as well as Rab3B, C, 
and D) expression level is differentially regulated at motor nerve terminals on differ-
ent muscle fibre types, leading to the observed difference in magnitude of  the reduc-
tion of  spontaneous ACh release. In a recent study we showed that neuro-exocytotic 
proteins other than Rab3A also have differential roles at NMJs of  different fibre 
types: in mice deficient for α-neurexins we found differential reducing effects on 
ACh release at soleus and diaphragm NMJs (Sons et al., 2006). 
Low-rate nerve stimulation-evoked ACh release was unaltered at Rab3A deficient 
NMJs. Again, as for spontaneous release, this finding seems at variance with data 
obtained from central synapses from Rab3A KO mice. In hippocampal synapses, 
basal electrical stimulation-evoked release was found unchanged (brain slices, Gep-
pert et al., 1994) or increased (cultured neurons, Geppert et al., 1997). Furthermore, 
at the Rab3A KO NMJ we did not observe increased rundown of  transmitter release 
upon repetitive stimulation as observed at hippocampal synapses (Geppert et al., 
1994). We excluded a role for Rab3A in recovery from high-rate evoked release by 
showing that EPP amplitudes of  wild-type and Rab3A NMJs returned with simi-
lar time-course to similar levels after a 2 s 40 Hz stimulus train. Similarly, recovery 
from hypertonic stimulation-induced transmitter release was shown unchanged at 
hippocampal synapses (Geppert et al., 1997), indicating that Rab3A is not gener-
ally involved in recovery of  the readily releasable vesicle pool and evoked transmit-
ter release. However, a role of  Rab3A in vesicle trafficking upon recovery of  K+ 
depolarization-evoked transmitter release has been proposed in a study of  Rab3A 
deficient forebrain synaptosomes (Leenders et al., 2001).
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ACh release at diaphragm NMJs from Rab3A KO mice has been studied to some 
extent by Hirsh and colleagues (Hirsh et al., 2002). In that study, spontaneous ACh 
release was found reduced by ~30%, although this change was not statistically signifi-
cant. Furthermore, it was reported that low-rate evoked ACh release was unchanged, 
which we confirmed in the present study. However, a less pronounced rundown of  
EPPs was shown at 50 Hz nerve stimulation at Rab3A deficient NMJs, which we 
could not reproduce at any of  the high-rate stimulation frequencies used in the cur-
rent study. One reason for this apparent discrepancy may be that Hirsh et al. in their 
experiments used d-tubocurarine to reduce the EPPs to subthreshold levels in order 
to prevent the triggering of  muscle action potentials. Besides blocking postsynaptic 
ACh receptors, d-tubocurarine is known to have a presynaptic effect, possibly medi-
ated by nicotinergic autoreceptors, resulting in increased EPP rundown (Glavinovic, 
1979). The reduced EPP rundown at Rab3A deficient NMJs, compared to wild-type, 
in the presence of  d-tubocurarine in the experiments of  Hirsh et al. may indicate 
that Rab3A is in some way involved in the mechanism underlying this presynaptic 
effect of  d-tubocurarine. However, in our experiments using μ-conotoxin as a tool 
to eliminate muscle action potentials (which has no presynaptic effects and does not 
interfere with ACh receptors) we failed to observe any effect of  Rab3A deletion on 
EPP rundown. This indicates that increased EPP rundown is not a physiological 
feature of  the Rab3A deficient NMJ.
The present study argues against the hypothesis that Rab3A mutation could un-
derlie paralysis in human congenital presynaptic myasthenic syndromes. Rab3A mice 
do not show symptoms of  muscle weakness, which is in agreement with the lack 
of  effects we observed on nerve stimulation-evoked ACh release at their NMJs. 
Furthermore, mutational analyses have not yielded any mutation or polymorphism 
in the Rab3A gene in patients with congenital presynaptic myasthenic syndromes 
(Maselli et al., 2001; Maselli et al., 2003a). Thus far, only some episodic ataxia type-2 
associated mutations in CACNA1A, the gene encoding presynaptic Cav2.1 chan-
nels, have been shown to cause presynaptic dysfunction at human NMJs (Maselli et 
al., 2003b).
Taken together, the present study shows that the synaptic phenotype resulting 
from Rab3A deletion at the NMJ clearly differs from that observed at central syn-
apses, especially with respect to spontaneous transmitter release, adding further evi-
dence to the view that Rab3A has distinct roles at different synapse types (Castillo 
et al., 2002; Sudhof, 2004).
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Munc18-1 expression levels control 





Prompt recovery after intense activity is an essential feature of  most mammalian 
synapses. Here we show that synapses with reduced expression of  the presynaptic 
gene munc18-1 suffer from increased depression during intense stimulation at glu-
tamatergic, GABAergic, and neuromuscular synapses. Conversely, Munc18-1 over-
expression makes these synapses recover faster. Concomitant changes in the readily 
releasable vesicle pool and its refill kinetics were found. The number of  vesicles 
docked at the active zone and the total number of  vesicles per terminal correlated 
with both Munc18-1 expression levels and the size of  the releasable vesicle pool. 
These data show that varying expression of  a single gene controls synaptic recovery 
by modulating the number of  docked, release-ready vesicles and thereby replenish-
ment of  the secretion capacity.
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Reliable and sustainable neurotransmitter release is essential for effective neuronal 
communication. However, neurons only have a limited number of  fusion-ready 
vesicles that reside in a vesicle pool at the membrane of  the presynaptic terminal 
(Rizzoli and Betz, 2005). During periods of  increased activity, this vesicle pool is de-
pleted, resulting in a decreased reliability of  neurotransmission. To ensure efficient 
neurotransmission, neurons need to be able to increase the initial number of  fusion-
ready vesicles [the so-called readily releasable pool (RRP)] and/or the rate at which 
this pool is replenished during activity. However, surprisingly little is known about 
the molecular mechanisms that control the size of  the RRP and the way vesicles are 
recruited to this pool.
The Sec1/Munc18-like (SM) protein Munc18-1 has emerged as a key compo-
nent for calcium-dependent neurotransmitter release (Rizo and Sudhof, 2002). SM 
proteins function in all intracellular membrane trafficking pathways across species. 
Genetic deletion of  munc18-1 and most other SM genes involved in synaptic-vesicle 
release across species results in a complete block of  neurotransmitter release (Harri-
son et al., 1994; Verhage et al., 2000; Weimer et al., 2003), which shows that Munc18-
1 and probably all SM proteins are indispensable factors that promote vesicle secre-
tion (Rizo and Sudhof, 2002; Toonen and Verhage, 2003; Sudhof, 2004). However, 
identifying where SM proteins act in the cascade of  events leading to the release of  
neurotransmitter has proven to be difficult and has generated apparently conflicting 
data (Schulze et al., 1994; Dresbach et al., 1998; Scott et al., 2004).
Here, we analyzed the effect of  different Munc18-1 expression levels on synaptic 
function in autaptic synapses of  GABAergic and glutamatergic central neurons, as 
well as in the peripheral neuromuscular junction (NMJ). We combined electrophysi-
ological and optical measurements to show that Munc18-1 controls synapse efficacy 




Two independent null-mutant mouse lines were produced for the munc18-1 gene 
as described (Verhage et al., 2000). Mice were bred as heterozygotes by using stan-
dard mouse husbandry and back-crossed for at least six generations to a C57BL/6 
background.
Transgenic Munc18-overexpressing mice. 
The genotypes of  all offspring were analyzed by Southern blot or PCR. The pro-
moter of  the neuron specific enolase (NSE) gene from rat (Forss-Petter et al., 1990) 
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was used to create Munc18-1 overexpressing transgenic mice. The Munc18-1 cDNA 
containing its endogenous Kozak sequence was inserted into the HindIII site of  the 
pNSE-Ex4 minigene consisting of  2.8 kb 5’ flanking DNA, exon I (50 bp), intron 
I (1.2 kb), and 6 bp of  exon II of  the rat NSE gene followed by a 1.0-kb SV40 
polyadenylation signal (Figure 10 A and B). Transgenic mice were generated by pro-
nuclear injection of  the linearized minigene into zygotes of  a C57BL/6 x CBA 
background. Five independent lines were analyzed, and two lines showed expression 
in spinal cord motoneurons. Motoneurons at the C1-C3 level of  the spinal cord, the 
level innervating the diaphragm, showed transgene expression that colocalized with 
staining for the motoneuron marker choline acetyltransferase (Figure 10C). All ani-
mal experiments were performed according to the Dutch law and ethical guidelines 
of  the Vrije Universiteit Amsterdam and the Leiden University.
Neuromuscular synapse electrophysiology.
Measurements were performed on nerve/muscle preparations from the diaphragm 
of  2- to 5-month-old WT, munc18-1+/-, and munc18OE mice. We recorded EPPs and 
MEPPs at the NMJ using 10-20 MΩ glass capillary microelectrodes and standard 
recording equipment at 26-28°C (1) in Ringer’s medium (116 mM NaCl; 4.5 mM 
KCl; 1 mM MgCl2; 2 mM CaCl2; 1mM NaH2PO4; 23 mM NaHCO3; 11 mM glucose, 
pH7.4, gassed with 95% O2/5% CO2). Hemidiaphragms were treated with 3.1 μM 
μ-conotoxin (Scientific Marketing Associates, Herts, U.K.), a selective blocker of  
muscle sodium channels, to prevent action potentials. This allowed the undisturbed 
recording of  EPPs during electrical nerve stimulation (0.3 and 40 Hz) of  the phrenic 
nerve. Spontaneous MEPPs were recorded during a period without nerve stimula-
tion. The quantal content at each endplate was calculated from EPP and MEPP 
amplitudes as described before (Plomp et al., 1994). Binomial parameters n and p 
were calculated from EPP and MEPP data according to the method of  Miyamoto 
(Miyamoto, 1975). MEPPs also were recorded in preparations shortly after addition 
of  hypertonic medium (0.5 M sucrose added to the standard Ringer’s solution)
Cell culture and viral transduction.
Microisland cultures were prepared from munc18-1+/-and WT littermate embryos at 
embryonic day 18 (see Rosenmund and Stevens, 1996). Lenti viral particles contain-
ing Munc18-1 cDNA coupled to enhanced GFP (EGFP) via an internal ribosomal 
entry site (IRES), and particles containing IRES-EGFP as control were prepared 
according to (Naldini et al., 1996) and Semliki Forest particles were prepared as de-
scribed in (Voets et al., 2001). Neurons were infected at DIV 1 with Lenti virus or 




Neurons were plated at 6,000 per cm2 on microislands of  glia cells and cultured in 
Neurobasal medium (Invitrogen, Carlsbad, CA) supplemented with 2% B-27 (In-
vitrogen), 0.5 mM glutamax (Invitrogen), 0.1% penicillin/streptomycin, and 25 μM 
2-mercaptoethanol. Receptor blockers bicuculline (GABA, 20 μM) and CNQX (glu-
tamate, 10 μM) were used to characterize autaptic neurons. Whole-cell voltage-clamp 
recordings (holding potential, -70 mV) were performed on individual GABAergic 
(cultured from neocortex) or glutamatergic (cultured from hippocampus) autaptic 
neurons. The patch pipette contained the following solution: 125 mM K+-gluconic 
acid, 10 mM NaCl, 4.6 mM MgCl2, 4 mM K2-ATP, 15 mM creatine phosphate, 1 
mM EGTA, and 20 units/ml phospocreatine kinase (pH 7.30). External medium 
contained 140 mM NaCl, 2.4 mM KCl, 4 mM CaCl2, 4 mM MgCl2, 10 mM Hepes, 
and 10 mM glucose (pH 7.30). Spontaneous release was mostly recorded in the pres-
ence of  TTX (200 nM). Compared to recordings without TTX, this did not change 
amplitude or frequency, indicating that we recorded only miniature (nonevoked) in-
put. Because TTX did not have an effect on basic electrophysiology, we pooled data 
sets recorded with and without TTX. For hyperosmotic sucrose applications, 500 or 
200 mM sucrose was applied to the external medium for 3-4 seconds via a double-
barrel application pipette that ensured instant application and rapid clearance of  
the sucrose medium. Axopatch 200A (Axon Instruments, Union City, USA) was 
used for whole-cell recordings and signals were acquired using Digidata 1322A and 
Clampex 8.1 (Axon Instruments). Clampfit 8.0 was used for offline analysis.
Fluorscence imaging. 
To selectively label the RRP in WT and SFVM18 overexpressing neurons, cells were 
loaded with FM4-64 in calcium free Tyrode’s containing 500 mM sucrose for 3-4 
seconds (16 µM FM4-64, 500 mM sucrose, 0 mM CaCl2, 2.5 mM KCl, 119 mM 
NaCl, 3 mM MgCl2, 30 mM glucose, 25 mM HEPES, pH 7.4). The 500 mM sucrose 
containing solution was replaced by calcium free Tyrode’s containing 16 μM FM4-
64 for an additional 60 seconds to ensure labeling of  all exocytosed vesicles. Cells 
were washed for 10 minutes with calcium free Tyrode’s. All solution changes were 
made using a fast microperfusion system (SF77B, Warner Instruments). Images were 
acquired with a Coolsnap CCD camera (Roper Scientific) with constant and identical 
camera settings between coverslips. To ensure that identified puncta were synapses, 
calcium containing Tyrode’s with a high concentration of  potassium (2 mM CaCl2, 
60 mM KCl, 61.5 mM NaCl, 2 mM MgCl2, 30 mM glucose, 25 mM HEPES, pH 7.4) 
was applied to the neurons for 60 seconds and loss of  fluorescence was observed 
by comparing puncta before and after the high potassium application. Images were 
analyzed using fixed region sizes of  1 µm2. Fluorescent intensity was obtained by 
averaging these regions. Background fluorescence was measured after four times 
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of  60 s application of  high potassium and subtracted from all frames to give total 
releasable fluorescence.
Microscopy 
Microisland cultures at DIV 14 were fixed in 4% PFA, permeabilized with 0.2% 
Triton X-100, and blocked with 2% goat serum. Cells were stained with monoclonal 
anti-MAP2 (Chemicon) and polyclonal anti-synapsin (E028) antibodies using goat 
anti-mouse Alexa 546 and goat anti-rabbit Cy5 secondary antibodies. Images were 
acquired on a Zeiss LSM510, and total synapse number (synapsin positive) and den-
drite length (MAP2) were calculated with custom written routines in Matlab (written 
by Dr. W. Veldkamp, Leiden University Medical Centre).
Diaphragm muscles of  Munc18-1 heterozygote (munc18-1+/-), wild-type (WT), 
and Munc18-1 overexpressing (munc18OE) littermates at postnatal day 16 (PN16) 
were dissected and fixed in 2% PFA for 1-2 h. Muscles were rinsed thoroughly with 
PBS and incubated with Texas red-conjugated α-bungarotoxin (Molecular Probes, 
Eugene, OR) for 2-3 h at room temperature. After extensive washes in PBS, tissues 
were mounted and examined with a Zeiss confocal fluorescent microscope (LSM510) 
with filter sets and optics selective for rhodamine, and images were processed with 
Adobe Photoshop. For analysis of  endplate diameter, images of  α-bungarotoxin-
positive neuromuscular junctions were taken at three confocal depths resulting in an 
average diameter per endplate.
Electron microscopy.
Hippocampal islands cultures of  munc18-1+/- or littermate WT mice (embryonic 
day 18) obtained from four different litters were grown on BELLCO photo-etched 
grid coverslips (BELLCO Glass Inc., Vineland, NJ). WT hippocampal neurons were 
infected (DIV 14) with SFV munc18-1-IRES-EGFP or SFV IRES-EGFP as control 
and observed under a fluorescence microscope 6 h after infection to map the loca-
tion of  infected cells.
As for electrophysiology, only glia islands containing a single neuron were used 
for analysis. Cells were fixed for 45 min at room temperature with 2.5% glutaral-
dehyde in 0.1 M cacodylate buffer (pH 7.4). After fixation cells were washed three 
times for 5 min with 0.1 M cacodylate buffer (pH 7.4), postfixed for 2 h at room 
temperature with 1% OsO4 in bidest, washed, and stained with 1% uranyl acetate 
for 40 min in the dark. After dehydration through a series of  increasing ethanol 
concentrations, cells were embedded in Epon and polymerized for 24 h at 60°C 
After polymerization of  the Epon, the coverslip was removed by alternately dip-
ping it in liquid nitrogen and hot water. Cells of  interest were selected by observing 
the flat Epon embedded cell monolayer (containing the BELLCO grid) under the 
light microscope and mounted on prepolymerized Epon blocks for thin sectioning. 
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Ultrathin sections (~90 nm) were cut parallel to the cell monolayer and collected 
on single-slot, formvar-coated copper grids, and stained in uranyl acetate and lead 
citrate. Autaptic synapses were selected in serial ultrathin sections at low magnifica-
tion by using a JEOL (Tokyo, Japan) 1010 electron microscope, and high-resolution 
images were acquired at x100,000 magnification.
The distribution of  synaptic vesicles, total vesicle number, size of  the vesicle 
cluster, post synaptic density, and active zone length were measured on digital im-
ages taken at x100.000 magnification using analySIS software (Soft Imaging System, 
Germany). The observer was blinded for the genotype. No difference was observed 
in any of  the parameters measured between WT synapses expressing SFV IRES-
EGFP and noninfected WT synapses, these synapse were therefore pooled.
Statistical analysis.
Data shown are mean values ± SEM. Statistical significance was determined by using 
Student’s t-test, and overall group differences were analyzed by using ANOVA.
Northern blot, in situ hybridization, and protein analysis. 
Total RNA was prepared from mouse brain at different postnatal days using TRI-
zol (Invitrogen). Ten micrograms was loaded on denaturing formaldehyde gels and 
transferred to Hybond N+ (Amersham Pharmacia). A 1.0-kb fragment of  the SV40 
polyadenylation signal labeled with 32P was used as a transgene specific probe. For in 
situ hybridization, brains and cervical spinal cord sections were quickly removed and 
frozen on dry ice. Sagittal sections (16 μm) were prepared on a cryostat and mount-
ed on poly(L)lysine coated glass slides. Sections were dried and kept at -80°C until 
used. Antisense digoxygenin-labeled RNA probe was transcribed from the vector 
pGEM4SV40 containing the 1.0-kb SV40 polyadenylation signal of  the pNSE-Ex4 
Protein Level
Munc18-1 49 ± 12%
Hexokinase 100%
GDP dissociation inhibitor (GDI) 97 ± 13%
Calmodulin 103 ± 12%
Syntaxin 1A 97 ± 5%
Syntaxin 1B 90 ± 8%
SNAP25 (A+B) 105 ± 15%
Synaptobrevin/VAMP-2 104 ± 6%
Synaptophysin 114 ± 20%
Doc2A 97 ± 5%
Doc2B 99 ± 8%
Rab3A 100 ± 3%
Rabphilin3A 89 ± 11%
Table 1. Quantification of  syn-
aptic protein levels in munc18-1 
heterozygous null mutant mice.
Table shows the quantification 
of  a number of  synaptic proteins 
in brain homogenates from E18 
mouse embryos. Immunoblots were 
loaded with three different amounts 
of  brain protein from heterozygote 
and WT littermates and signals were 
normalized for the WT hexokinase 
level as a general marker. Data are 
averages ± SEM, n = 4 to 8. Only 
the Munc18-1 level differed sig-
nificantly between heterozygote and 
WT mice (P < 0.001).
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construct. Hybridization, color reaction, and double labeling with choline acetyl-
transferase antibodies were performed according to standard procedures. Mouse 
brains were solubilized, and equal amounts of  protein were subjected to 8-15% 
SDS/PAGE. Depending on the size of  the investigated protein, the following in-
ternal standards were used: calmodulin (17 kDa), GDI (54 kDa), and hexokinase 
(96 kDa). Monoclonal antibodies (Synaptic Systems, Göttingen, Germany; except 
Munc18-1 from Transduction Labs, Lexington) against the following proteins were 
used (code names given in brackets when applicable): Munc18-1, synaptobrevin II 
(Cl69.1); Rab3A/C (Cl42.1). Polyclonal antibodies against the following proteins 
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Figure 1 Basal synaptic transmission in munc18-1 heterozygous, wildtype and Semliki Forest virus 
Munc18 overexpressing glutamatergic autaptic neurons.
(A) Examples of  MAP2 (red) and Synapsin (white) immunostaining of  glutamatergic autaptic neurons and 
quantification of  the amount of  Synapsin positive synapses/μm MAP2 positive dendrite length. No difference was 
observed between WT and munc18-1+/-  neurons. (WT total dendritic length 3288 ± 86.3 μm, total synapse number 
118 ± 4.8 and 0.036 ± 0.003 synapses/μm dendrite, n = 19; munc18-1+/-  total dendritc length 3588 ± 97.67 μm, 
total synapse number 122 ± 8.9 and 0.034 ± 0.004 synapses/μm dendrite, n = 17, p > 0.05 for all parameters). Bars 
are 20 μm. (B) EPSC amplitude and decay time are similar in WT and munc18-1+/-   neurons (WT 2471 ± 286 pA, 
3.9 ± 0.2 msec, n = 27; munc18-1+/-  2473 ± 432 pA, 3.4 ± 0.2 msec, n = 17, p > 0.05 for both parameters). Inset 
shows representative traces of  WT and munc18-1+/-  EPSCs. (C) Example traces of  spontaneous glutamatergic 
release (mEPSCs) in WT and munc18-1+/-  neurons. (D) Average mEPSC amplitude, decay time and frequency do 
not differ between WT and munc18-1+/-  neurons (WT 28.5 ± 3.4 pA, 2.28 ± 0.12 msec, 20.3 ± 4.0 Hz, n = 11 cells, 
2200 events; munc18-1+/-  31.4 ± 2.9 pA, 2.67 ± 0.21 msec, 16 ± 2.1 Hz, n = 10 cells, 2000 events, p > 0.05 for 
all parameters tested). (E) Example MAP2 and Synapsin immunostaining. Quantification in WT and Semliki forest 
virus overexpressing Munc18-1 (SFVM18) glutamatergic autaptic neurons shows no significant difference between 
the two genotypes (WT total dendritic length 3285 ± 101.2 μm, total synapse number 115 ± 6.3 and 0.035 ± 0.005 
synapses/µm dendrite, n = 21; SFVM18 total dendritic length 3184 ± 104.2 μm, total number of  synapses 121.5 ± 
5.7 and 0.038 ± 0.004 synapses/µm dendrite, n = 17, p > 0.05 for all parameters). Bars are 20 μm. Semi-quantitative 
immuno fluorescence analysis showed that SFVM18 infection led to a 2.8 ± 0.3 times higher Munc18-1 protein level 
after 7 hours (WT n = 11 and SFVM18 n = 10).(F) No difference in EPSC amplitude and decay time between WT 
and Semliki Forest mediated overexpression of  Munc18-1 (WT amplitude 2471 ± 286 pA, decay 3.86 ± 0.15 msec, 
n = 27; SFVM18 amplitude 2894 ± 303 pA, decay 4.37 ± 0.33 msec, n = 20, p > 0.05 for both parameters). Inset 
shows example EPSC of  WT and SFVM18 neuron.
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(I374); Doc2A/B (I734 and N321), and choline acetyltransferase (AB114P, Chemi-
con).
Results
In homozygous munc18-1-null mutant mice, synapses are silent (Verhage et al., 
2000), identifying munc18-1 as an essential gene but providing little information 
on its molecular function. Heterozygous mice (munc18-1+/-) had a 50% reduction 
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Figure 2. GABAergic transmission in Munc18-1 heterozygote autaptic neurons. 
(A) Spontaneous GABAergic release is unaffected in munc18-1+/-  autaptic neurons. Average mIPSC amplitude, 
decay time, and frequency are identical in WT and munc18-1+/-  neurons (WT 32.5± 3.1 pA, 14.4 ± 0.4 ms, 1.7 ± 0.5 
Hz, n = 10 cells, 2,100 events; munc18-1+/-  37.2 ± 10.0 pA, 14.8 ± 0.9 ms, 1.6 ± 0.5 Hz, n = 6 cells, 1,200 events, 
P > 0.05 for all parameters). (B) Example traces of  mIPSCs in WT and munc18-1+/-  neurons. (C) IPSC amplitude 
and decay time are similar in WT and munc18-1+/-  neurons (WT 1,403 ± 203 pA, 14.7 ± 1.5 ms, n = 27; munc18-
1+/-  1,209 ± 206 pA, 16.1 ± 1.3 ms, n = 21, P > 0.05 for both parameters). (Inset) Representative traces of  WT and 
munc18-1+/-  IPSCs. (D) Synaptic rundown of  GABAergic IPSCs during 10-Hz stimulation is faster in munc18-
1+/-  compared to WT and reaches a lower steady-state plateau. Shown are averaged τs of  mono-exponential fits (** 
P < 0.01). Biexponential fitting of  the same data shows a significantly reduced τ slow for munc18-1+/-  neurons, in 
line with glutamatergic neurons (Fig. 1A). (Inset) Example traces of  the first and last IPSC from WT and munc18-
1+/-  neurons. For clarity, the stimulus artifact (see C Inset) was removed from the traces. (E) Synaptic rundown 
of  GABAergic IPSCs during high-frequency stimulation (40 Hz, 2.5 s) is faster in munc18-1+/-  compared to WT. 
Monoexponential fits revealed a significant increase in synaptic rundown in munc18-1+/-  neurons (WT τ = 0.25 ± 
0.05 s, n = 14; munc18-1+/-  τ = 0.07 ± 0.02 s, n = 14, P < 0.01). (F) Activity- and calcium-dependent refill kinetics 
of  the RRP after depletion of  the pool by 2.5-s stimulation at 40 Hz are similar between WT and munc18-1+/- 
neurons (WT recovery τ = 5.2 ± 0.7 s, n = 13; munc18-1+/-  recovery τ = 5.0 ± 0.9 s, n = 14, P > 0.05).
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binding partners or 22 other synaptic proteins (Table 1) (Toonen et al., 2005). Au-
taptic cultures from these mice had similar dendrite length and number of  synapses 
as cultures from WT littermates (Figure 1).
Munc18-1 heterozygous autapses contain a smaller pool of  readily releasable vesicles.
Whole-cell recordings of  autaptic glutamatergic or GABAergic munc18-1+/- and WT 
littermate neurons showed similar excitatory and inhibitory postsynaptic currents 
(EPSCs and IPSCs) upon single depolarizations (Figures. 1B and 2C). The charac-
teristics of  spontaneous miniature (m) excitatory and inhibitory postsynaptic events 
(amplitude, frequency, and decay time) also did not differ between munc18-1+/- and 
WT neurons (Figures 1 C and D and 2 A and B). Thus, a reduction of  Munc18-1 
protein level does not affect synaptic physiology under basal conditions nor does it 
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Figure 3. Synaptic transmission in munc18-1 heterozygous autaptic neurons. 
(A) Synaptic rundown of  glutamatergic EPSCs during 10-Hz stimulation is faster in munc18-1+/-  compared with 
WT. Rundown kinetics were best characterized with biexponential fits and revealed that the slow component of  
the rundown was decreased in munc18-1+/-  neurons. EPSC τfast = 0.12 ± 0.03, τslow = 3.93 ± 0.87 for munc18-
1+/-  neurons, and τfast = 0.12 ± 0.01, τslow = 6.86 ± 1.11 for WT (n =11 and n = 20, P< 0.05 for τslow). Averaged 
weights of  τfast and τslow were not different between WT and munc18-1+/- . (Insets) The first and last EPSC of  the 
10-Hz stimulation. For clarity, the stimulus artifact (see B Inset) was blanked from the traces. (B) Hypertonic sucrose 
(500 mM) application shows a 36% decrease in RRP size in munc18-1+/-  neurons compared with WT neurons 
(WT: 1.06 ± 0.1 nC, n = 30; munc18-1+/- : 0.67 ± 0.09 nC, n = 30, P < 0.01). (Inset) Example traces duration 500 
mM sucrose application. (C) Activity-and calcium-dependent refill kinetics of  the RRP after depletion of  the pool 
by 2.5-s stimulation at 40 Hz are similar between WT and munc18-1+/-  neurons (WT recovery: τ = 2.9 ± 0.4 s, n 
= 20; munc18-1+/-  recovery: τ = 2.6 ± 0.3 s, n = 21, P> 0.05). (Insets) Individual WT traces during the paradigm. 
(D) Activity- and calcium-independent refill kinetics of  the RRP tested by paired sucrose application with different 
interstimulus intervals are not different between WT and munc18-1+/-  neurons (number of  cells is in brackets, no 
significant difference at each of  the different time points tested). The response of  the second stimulus is plotted 
as a percentage of  the first stimulus. (Inset) Typical responses to two sucrose applications with 4-s interval for WT 
and munc18-1+/-  neurons.
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However, repeated stimulation produced a more pronounced rundown of  
evoked responses (synaptic depression) in munc18-1+/- neurons compared with WT 
neurons. This increased synaptic depression was observed both in glutamatergic and 
in GABAergic synapses and was most pronounced at 10-Hz stimulation (Figure 3 
A and Figure 2 D). The rundown kinetics of  glutamatergic synapses at 10 Hz were 
best characterized by biexponential curve fits (Pyott and Rosenmund, 2002), which 
revealed an increased rundown especially of  the slow phase (τslow) in munc18-1
+/- 
neurons. At 40-Hz stimulation, 80% depression was reached within 1 s in all groups, 
and a significant increase in depression in munc18-1+/- neurons was observed in 
GABAergic (Figure 2E) but not in glutamatergic neurons (Figure 4). Differences in 
synaptic release probability, RRP size, and replenishment rate all may contribute to 
the observed increase in synaptic depression. To test RRP size, we applied hyper-
tonic sucrose solution to empty the RRP via a Ca2+-independent mechanism (Ste-
vens and Tsujimoto, 1995; Rosenmund and Stevens, 1996). The sucrose response in 
munc18-1+/-  neurons was significantly smaller (0.67 ± 0.1 nC, n = 30) compared 
with WT neurons (1.06 ± 0.1 nC, n = 30, P < 0.01; Figure 3B). To test whether a re-
duction of  Munc18-1 also affected the RRP refilling, we used two approaches. First, 
we depleted the RRP with 40-Hz stimulation and measured the recovery by using 
0.5-Hz stimulations (Rhee et al., 2002). The 40-Hz stimulation resulted in similar 
depletion of  the RRP in both genotypes (see also Figure 4), and recovery from RRP 
depletion was not significantly slower in munc18-1+/- neurons (Figure 3C). Second, 
we applied paired pulses of  hypertonic sucrose with different time intervals between 
pulses (Rosenmund et al., 2002). Again, no difference in RRP recovery was observed 
between WT and munc18-1+/- neurons (Figure 3D).
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Supporting Figure 5 Toonen et al.
Figure 4. Synaptic rundown during high-
frequency stimulation in glutamatergic WT and 
munc18-1+/-  autaptic neurons.
Synaptic rundown during high frequency stimulation 
(40 Hz, 2.5 s) is similar for WT and munc18-1+/- .
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Thus, Munc18-1 levels are rate-limiting during high-frequency neurotransmis-
sion. A 50% reduction in protein levels results in a reduction of  the RRP size with-
out affecting the rate by which this (smaller) pool is replenished.
Munc18-1 heterozygous mice have impaired neuromuscular synaptic function.
Studies on SM proteins in Drosophila and Caenorhabditis elegans have been conducted 
on neuromuscular synapses (Wu et al., 1998; Weimer et al., 2003). To be able to 
directly compare our results, we performed electrophysiological recordings on dia-
phragm NMJs of  munc18-1+/- mice and WT littermates. To test whether munc18-
1+/- NMJs, like the autaptic cultures, were impaired in sustaining vesicle release dur-
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Figure 5. Synaptic transmission at NMJs of  
munc18-1 heterozygote, WT, and Munc18-1-
overexpressing littermates. 
(A) munc18-1+/-  mice are less able to sustain high-
frequency evoked transmitter release at neuromuscular 
synapses. Indicated are the amplitudes of  synaptic 
responses (EPPs) to each individual stimulus for 
40 stimuli delivered to the phrenic nerve at 40 Hz, 
expressed as percentage of  the first response. Data 
represent means ± SEM of  five animals per group 
and 15 NMJs sampled per animal. (Inset) A typical 
example of  the 40-Hz EPP rundown. No gross 
morphological differences were observed between 
NMJs of  the two genotypes (Figure 7 E and D). (B) 
Typical examples of  MEPP frequency recordings in 
WT and munc18-1+/-  NMJs. (C) Several physiological 
parameters in munc18-1+/-  and WT NMJs. WT value 
was set at 100%. Where applicable, absolute values 
are indicated. Data represent means ± SEM of  eight 
to nine animals per group and 10-15 NMJs sampled 
per animal. Differences between the groups were 
statistically significant for quantal content (P < 0.01), 
MEPP frequency (P < 0.05), sucrose response (P 
< 0.05), and statistical releasable pool n (P < 0.01). 
(D) Spontaneous MEPPs in munc18OE and WT mice 
(Upper, 10 s). The amplitude and kinetics of  MEPPs 
were similar at WT and munc18OE NMJs (Lower). (E) 
Physiological parameters at NMJs of  munc18OE and 
WT mice. WT value was set at 100%. Where applicable, 
absolute values are indicated. Data represent means 
± SEM of  10-11 animals per group and 10-15 NMJs 
sampled per animal. Differences between groups were 
significant for quantal content (P < 0.05), MEPP 
frequency (P < 0.001), and statistical releasable pool 
n (P < 0.05).
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col. Munc18-1+/- NMJs displayed a significantly larger rundown of  evoked endplate 
potential (EPP) amplitudes (to 67% of  the first EPP compared with 78% for WT, 
P < 0.01; Figure 5A).
A B
Supporting Fig. 3 Toonen et al
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Figure 6. Munc18-1 overexpression does not increase quantal content during evoked release nor activity-
independent RRP recovery. 
(A) We used the competitive AMPA/NMDA channel blocker kynurenic acid to unmask possible receptor saturation 
during single evoked release. Application of  200 μM kynurenic acid reduced EPSC amplitude to the same extent in 
WT neurons as compared to neurons overexpressing Munc18-1. (Relative reduction of  EPSC amplitudes in 200 μM 
kynurenic acid, WT 64.81 ± 2.03%, n = 20; SFVM18 70.31 ± 2.83%, n = 19, P = 0.12). (B) Absolute effect of  200 
μM kynurenic acid on EPSC amplitude (WT 3,511.47 ± 414.71 pA, n = 20; WT + kynurenic acid 2,213.48 ± 257.50 
pA, n = 20; SFVM18 3,474.60 ± 449.30 pA, n = 19; SFVM18 + kynurenic acid 2,563.59 ± 389.36 pA, n = 19). 
Reduction in EPSC amplitude due to kynurenic acid application was indistinguishable between WT and Munc18-1-
overexpressing neurons. Thus, Munc18-1 overexpression does not increase the amount of  glutamate released during 
single evoked release. Note that these experiments were conducted paired with the sucrose applications in Fig. 8E 
showing that 500 mM sucrose application does result in receptor saturation in SFVM18-overexpressing neurons. 
(C) In the absence of  the 200 μM kynurenic acid, SFVM18-overexpressing neurons show an apparent increase in 
activity independent recovery of  the RRP as probed with dual 500 mM sucrose applications with 1-, 2-, 4-, 7-, and 
30-s intervals. The response of  the second stimulus is plotted as a percentage of  the first stimulus (number of  cells 
in brackets, ** P < 0.01). (D) In the presence of  200 μM kynurenic acid, which prevents postsynaptic receptor 
saturation, no effect of  SFVM18 overexpression on activity independent recovery is observed. Thus, 500 mM 
sucrose application in SFVM18-overexpressing neurons leads to receptor saturation (see Fig. 6C), this clips the 
initial sucrose response when kynurenic acid is not present in the bathing solution, thereby introducing an apparent 
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Figure 7. GABAergic transmission in Munc18-1-overexpressing autaptic neurons. 
(A) No difference in IPSC amplitude and decay time between WT, Semliki Forest (SFVM18) and Lenti virus (Lenti)-
mediated overexpression of  Munc18-1. (WT amplitude 1,403 ±203 pA, decay 14.7 ± 1.5 ms, n = 23; LentiM18 
amplitude 1,724 ± 168 pA, decay 15.8 ± 1.2 ms, n = 24; SFVM18 am litude 1,287 ± 143 pA, d cay 14.1 ± 0.8 
ms, n = 32, P > 0.05 for both parameters). (Inset) Typical example of  IPSC of  WT, Semliki, and Lenti-mediated 
overexpression of  Munc18-1. Semiquantitative immunofluorescence analysis showed that SFVM18 infection led to 
a 2.8 ± 0.3 times higher Munc18-1 protein level after 7 h (WT n = 11 and SFVM18 n = 10). Infection with Lenti 
virus resulted in a milder overexpression (1.86 ± 0.4, n = 11). Neurons were stained with a polyclonal antibody 
specific for Munc18-1, and fluorescence intensity was compared between transfected and nontransfected cells using 
identical settings (regions of  interest placed on three different positions in the cell soma). (B) Munc18-1 overexpres-
sion results in faster activity dependent refilling of  the RRP in GABAergic neurons. IPSC amplitude was sampled 
at a frequency of  0.5 Hz after depletion of  the RRP with a 40-Hz stimulation train for 2.5 s. (Insets) Individual 
WT (black) and SFVM18 (gray) traces during the paradigm. (C) Quantification of  the RRP recovery kinetics in 
GABAergic autaptic neurons overexpressing Munc18-1 either via Semliki Forest or Lenti virus-mediated infection. 
(SFV M18 τ= 2.56 ± 0.40 s, n = 8; Lenti τ = 3.29 ± 0.3s, n = 10; WT τ = 5.24 ± 0.71 s, n = 13, P < 0.05 for WT 
versus SFV or Lenti). (D) Example traces of  spontaneous release (mIPSCs) in WT, Lenti virus, Munc18-1, and 
SFVM18-overexpressing neurons. (E) Spontaneous release (mIPSCs) frequency is increased upon SFVM18 and 
Lenti virus-mediated Munc18-1 (Lenti) overexpression (WT 1.7± 0.6 Hz, n = 10 cells, 2,100 events; SFVM18 6.5 
± 2.0 Hz, n = 6 cells, 800 events; Lenti 5.8 ± 1.3 Hz, n = 19, 3,700 events P < 0.001 for SFVM18 and Lenti versus 
WT). mIPSC amplitude and decay time are not affected by Munc18-1 overexpression (WT 32.5± 3.1 pA, 14.4 ± 





(n) sem n P value
WT 53.87 2.85 8 0.0047
Munc18-1+/- 42.43 2.04 9  
WT 45.78 1.96 13 0.024
Munc18OE 51.60 1.20 11  
 Release probability (p)
WT 0.91 0.004 8 0.6
Munc18-1+/- 0.91 0.004 9  
WT 0.89 0.006 13 0.3
Munc18OE 0.90 0.005 11  
Table 2. Calculated release probability and vesicle 
pool in WT, munc18-1+/-, and Munc18OE NMJs
Table shows the data obtained from calculating release 
probability (p) and statistical vesicle pool (n) in NMJs ac-
cording to the method of  Miyamoto (Miyamoto, 1975) 
versus WT). (F) Similar to glutamatergic neurons (Fig. 7), synaptic rundown during 10-Hz stimulation is not differ-
ent between WT and SFVM18-overexpressing GABAergic neurons. Rundown kinetics were best characterized with 
biexponential fits. IPSC τ fast = 0.15 ± 0.3, τ slow = 4.1 ± 0.6 for WT neurons and τ fast = 0.12 ± 0.4, τ slow = 4.3 
± 0.4 for SFVM18 (n = 32 and n = 15). (G) Synaptic rundown during high-frequency stimulation (40 Hz, 2.5 s) in 
SFVM18 and WT GABAergic neurons. SFVM18-overexpressing neurons appear to depress more slowly although 
averaged rundown τs are not significantly different.
As in autapses, we tested whether the 
EPP rundown could be explained by a 
reduction in RRP size by applying 500 
mM sucrose. The response, measured 
as miniature endplate potential (MEPP) 
frequency, was 31% lower at munc18-1+/- 
endplates (P < 0.05; Figure 5C). As an 
alternative approach, we used the calcu-
lation method of  Miyamoto (Miyamoto, 
1975) to estimate RRP size and release 
probability from our EPP data. This 
method showed that the release probabil-
ity was unchanged at munc18-1+/- NMJs, 
whereas the RRP size was reduced by 
21% (P < 0.01; Figure 5C and Table 2). In 
addition, in munc18-1+/- NMJs, the fre-
quency of  spontaneous uniquantal acetyl-
choline release events (measured as MEPP frequency) and the 0.3-Hz evoked release 
(quantal content) were reduced by 20-25% (P < 0.05 and < 0.01, respectively; Figure 
5C). These single synapse recordings reveal a reduction in the RRP size as well as 
a concomitant decrease in evoked release (quantal content). Given that the quantal 
content is the product of  the size of  the RRP and the probability that a vesicle is 
released upon stimulation (Del Castillo and Katz, 1954), these data suggest that 
Munc18-1 does not substantially influence vesicular release probability.
Munc18-1 overexpression results in a larger RRP and enhances activity-dependent RRP 
replenishment.
To investigate the effect of  Munc18-1 overexpression on synaptic-vesicle release, 
we applied two viral-expression systems in autaptic cultures. We tested the effect of  
acute, high overexpression of  Munc18-1 with the Semliki Forest virus system, 6 to 
8 h postinfection (Ashery et al., 1999). In addition, we used a Lenti viral system to 
investigate the effect of  long-term, moderate overexpression of  Munc18-1, 10 to 14 
days postinfection (Naldini et al., 1996). Munc18-1 overexpression with either Sem-
liki (SFVM18) or Lenti virus did not affect neuronal morphology or total synapse 
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Figure 8. Synaptic transmission in Munc18-1-overexpressing autaptic neurons. 
(A) Single 500 mM sucrose response is not significantly different between WT and SFVM18 overexpression (WT: 
1.1 ± 0.1 nC, n = 39; SFVM18: 1.3 ± 0.2 nC, n = 35, P = 0.4). (B) Single 200 mM sucrose application reveals an 
increased RRP size in SFVM18-overexpressing neurons (V T: 0.074 ± 0.011 nC, n =11; munc18-1+/- : 0.035 ± 0.011 
nC, n =11; SFVM18: 0.17 ± 0.041 nC, n =16, P< 0.05 between V T and SFVM18 and P < 0.01 between SFVM18 
and munc18-1+/-  neurons). (Inset) Typical responses to 200 mM sucrose application for the three genotypes tested. 
(C) Single 500 mM sucrose application in the presence of  200 µM of  the NMDA/α-amino-3-hydroxy-5-methy1-
4-isoxazolepropionic acid (AMPA) receptor blocker kynurenic acid results in an expected decreased response in 
WT neurons, whereas the response of  SFVM18-overexpressing neurons is unaffected (WT minus kynurenic acid: 
0.95 ± 0.14 nC, n = 15 and WT plus kynurenic acid: 0.63 ± 0.1 nC, n =15, P < 0.05; SFVM18 minus kynurenic 
acid:1.04 ± 0.1 nC, n =15 and SFVM18 plus kynurenic acid: 0.96 ± 0.08, n = 15, P = 0.5). This finding shows that 
the increased release of  glutamate in SFVM18-overexpressing neurons leads to receptor saturation and indicates 
that the RRP is increased on Munc18-1 overexpression. (D) Direct labeling of  the RRP by using 500 mM sucrose 
solution containing 16 μM FM4-64 reveals a 2-fold larger RRP in SFVM18-overexpressing neurons compared 
with WT. Shown are average arbitrary fluorescent units (a.u.) from 769 synapses on 18 neurons for WT and 960 
synapses on 18 neurons for SFVM18 from four independent experiments (WT: 91 ± 7.6 a.u., SFVM18: 191 ± 
10.8 a.u., P < 0.01 with n = 4). (Insets) Examples of  VUT and SFVM18-overexpressing presynaptic terminals 
labeled with FM4-64 (red) by using 500 mM sucrose on EGFP (green)-filled dendrites. (Bar: 5 μm.) (E) Munc18-1 
overexpression increases the recovery rate after activity-dependent RRP depletion. EPSC amplitude was sampled 
at a frequency of  0.5 Hz after depletion of  the RRP with a 40-Hz stimulation train for 2.5 s. (Insets) Individual 
WT and SFVM18 traces during the paradigm. (F) Single exponential fits of  RRP recovery show a significant faster 
replenishment in neurons overexpressing Munc18-1 (SFV Munc18-1: τ =1.8 ± 0.2 s, n =15; WT: τ = 2.9 ± 0.4 s, 
n = 20, P < 0.05). (G) Munc18-1 overexpression decreases synaptic rundown during high-frequency stimulation 
(40-Hz, 2.5 s). (H) Single exponential fits of  the synaptic rundown show significant decrease in synaptic rundown 
in neurons overexpressing Munc18-1 (SFV Munc18-1: τ = 0.57 ± 0.1 s, n =15, WT: τ = 0.27 ± 0.04 s, n = 20, P 
= 0.003). (I) mEPSC frequency is significantly increased on Munc18-1 overexpression (WT: 20.3 ± 3.9 Hz, n =11 
cells, .2,300 events; SFVM18: 51.6 ± 7.0 Hz, n =12 cells, 2,000 events, P < 0.001). Miniature amplitude and decay 
time are not affected by Munc18-1 overexpression (WT: 28.5 ± 3.4 pA, 2.28 ± 0.12 ms; SFVM18: 35.7 ± 3.5 pA, 




responses in SFVM18-overexpressing glutamatergic neurons did not differ from 
WT responses (Figure 1F, EPSC). Effects of  Munc18-1 overexpression on evoked 
responses may be masked by postsynaptic receptor saturation. Therefore, evoked 
responses were measured in the presence of  the competitive NMDA/α-amino-3-
hydroxy-5-methy1-4-isoxazolepropionic acid (AMPA) receptor blocker kynurenic 
acid (Meyer et al., 2001). In the presence of  200 µM kynurenic acid, the EPSC 
amplitude in WT and SFVM18 neurons was reduced to the same extent, indicating 
that saturation of  postsynaptic receptors did not mask an effect in SFVM18 neu-
rons (Figure 6 A and B). Evoked responses after SFVM18- or Lenti virus-mediated 
Munc18-1 overexpression in GABAergic neurons also were similar to WT (IPSC, 
Figure 7A). Thus, acute as well as chronic overexpression of  Munc18-1 does not af-
fect basal synaptic strength or synapse formation in autaptic cultures.
To test whether overexpression of  Munc18-1 increases RRP size, we applied 
hypertonic sucrose (500 mM). The response from SFVM18-overexpressing neu-
rons was not significantly different from WT neurons (SFVM18: 1.3 ± 0.2 nC, n 
= 26; WT: 1.1 ± 0.1 nC, n = 30, P = 0.4; Figure 8A). Again, postsynaptic receptor 
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Figure 9. Receptor desensitization does not 
explain decreased 40-Hz rundown in Munc18-
overexpressing neurons. 
(A) To confirm that postsynaptic receptor 
desensitization did not contribute to the synaptic 
rundown, WT and SFVMunc18-overexpressing 
neurons were stimulated with 100 action potentials at 
40 Hz in the presence of  50 μM cyclothiazide, a drug 
that blocks glutamatergic receptor desensitization. 
(B) Single exponential fits of  the synaptic rundown 
show a significant decrease in synaptic rundown in 
neurons overexpressing Munc18-1 (SFV Munc18-1 τ 
= 0.74 ± 0.11 s, n = 6, WT τ = 0.38 ± 0.07 s, n = 7, 
P = 0.003). (C) Relative residual amplitudes are similar 
indicating that the stimulus train emptied the RRP in 
both genotypes. (D) Decay of  single EPSCs in the 
absence and presence of  50 μM cyclothiazide show 
the typical increase upon cyclothiazide application but 
this increase does not differ between WT and Munc18-overexpressing neurons. (E) In contrast to 40 Hz stimulation 




saturation could mask potential effects of  Munc18-1 overexpression. Therefore, we 
conducted three additional experiments. First, we applied a milder osmotic stimu-
lus (200 mM sucrose) known to result in submaximal RRP depletion (Rosenmund 
and Stevens, 1996) to WT, munc18-1+/-, and SFVM18-overexpressing neurons. This 
stimulus resulted in a >2-fold higher response in Munc18-overexpressing neurons 
compared with WT, and, consistent with the data in Figure 3, munc18-1+/-neurons 
showed a significantly smaller response (SFVM18: 0.17 ± 0.041 nC, n =16; munc18-
1+/-: 0.035 ± 0.011 nC, n =11; and WT: 0.074 ± 0.011 nC, n =11, P < 0.05 between 
WT and SFVM18; Figure 8B). This result suggests that application of  500 mM 
sucrose indeed saturated postsynaptic receptors, masking an increase in RRP size. 
Second, we applied 500 mM sucrose in the presence of  200 µM kynurenic acid (see 
above). Consistent with the first experiment, an almost 2-fold difference in RRP 
size now became evident (WT: 0.95 ± 0.14 nC; and WT plus kynurenic acid: 0.63 ± 
0.1 nC, P < 0.05; SFVM18: 1.04 ± 0.10 nC; and SFVM18 plus kynurenic acid: 0.96 
± 0.08, P = 0.5; Figure 8C). Third, we directly labeled the RRP by using the styryl 
dye FM4-64 in combination with 500 mM sucrose application (Pyle et al., 2000; 
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Figure 10. Generation of  Munc18-
1-overexpressing mice and 
NMJ morphology of  munc18-1 
heterozygote, overexpressing, and 
WT littermates. 
(A) Schematic diagram of  the NSE-
Munc18-1 minigene. Four kilobases of  
rat NSE promoter sequence precedes the 
Munc18-1 cDNA, which is followed by 
the SV40 polyadenylation signal. PCR 
primers for genotyping are depicted as 
arrows, and Northern blot and in situ 
probe are depicted as solid black bar. 
(B) The PN04 line expresses Munc18-
1 mRNA in whole-brain lysate at 
postnatal day 5 (P5) and expression 
increases with age (A, 3-month-old 
adults). A 32P-labeled probe specific 
for the transgenic Munc18-1 was used, 
which does not recognize endogenous 
Munc18-1 (see Materials and Methods). 
(C) Colocalization with an antibody 
staining for the motoneuron marker 
choline acetyltransferase at the C1-C3 
level of  the spinal cord shows that a high 
percentage of  motoneurons do express 
the transgene. (Bar: 250 μm.) (D) NMJs 
in whole-mount diaphragms were stained 
with Texas red-labeled α-bungarotoxin to 
label acetylcholine receptors on the postsynaptic muscle membrane. No morphological changes were observed 
between the different genotypes (representative NMJs for the different genotypes are shown). Fluorescence 
intensity was identical for all genotypes indicating that the amount of  acetylcholine receptors at the endplate was 
not altered as a result of  different Munc18-1 protein levels. (Bars: 10 μm.) (E) Endplate diameter measured at three 
confocal depths at random intervals throughout the entire diaphragms off  all genotypes. No significant change 
in mean endplate diameter was observed: WT (24.01 ± 1.1 μm, n = 48), munc18OE (24.6 ± 0.8 μm, n = 79), and 
munc18-1+/-   (23.50 ± 0.6 μm, n = 67). Data are mean ± SEM.
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higher fluorescence intensity on Munc18-1 overexpression (Figure 8D) Together, 
these independent lines of  evidence confirm that Munc18-1 overexpression indeed 
leads to a larger initial RRP size.
Next, we examined whether Munc18-1 overexpression also resulted in a smaller 
rundown and faster RRP replenishment. Indeed, synapses overexpressing Munc18-
1 showed less synaptic depression during high-frequency stimulation (Figure 8 G 
and H, EPSC rundown; 40 Hz) and an accelerated refilling of  the RRP after high-
rate (40-Hz) electrical stimulation (Figure 8E; SFV Munc18-1: τ = 1.8 ± 0.2 s and 
WT: τ = 2.9 ± 0.4 s, P < 0.05). The same effect was observed in GABAergic neu-
rons infected with either SFVM18 or Lenti virus Munc18-1 (Figure 7 B and C). We 
ruled out any contribution of  postsynaptic receptor desensitization by repeating the 
experiment in the presence of  50 µM cyclothiazide, a drug that blocks glutamate 
receptor desensitization (Figure 9). In contrast to the faster RRP replenishment af-
ter activity-dependent depletion, paired sucrose application did not reveal an effect 
of  Munc18-1 overexpression on the rate of  RRP replenishment when tested in the 
presence of  200 µM kynurenic acid (Figure 6 C and D). Thus, Munc18-1 overex-
pression increases the RRP size and its replenishment, probably by activity- and/or 
Ca2+-dependent mechanisms. As a result, synapses recover faster. Consistent with 
an increase in RRP size, Munc18-1 overexpression also led to a >2-fold increase in 
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Figure 11. Munc18 protein levels 
control the number of  docked 
synaptic vesicles. 
(A) Electron micrographs of  typical 
asymmetrical glutamatergic synapses 
from munc18-1+/- , WT, and SFVM18-
overexpressing autaptic neurons. 
Hippocampal autaptic neurons were 
analyzed after 14 days in culture and 6 
h after infection with SFV. (Scale bar: 
200 nm.) (B) The number of  vesicles 
docked at the active zone increases 
with increasing amounts of  munc18-
1 (munc18-1+/- : 3.1 ± 0.6, n=26;WT: 
4.8 ± 0.3, n = 62; and SFVM18: 7.0 
± 0.4, n = 45; P<0.05 for munc18-
1+/-  vs. WT and P < 0.001 for WT 
vs. SFVM18), whereas the size of  
the active zone and the vesicle cluster 
perimeter do not significantly change 
(ANOVA, P> 0.05). The number of  
vesicles within 150 nm from the active 
zone (WT: 24.4 ± 0.9; SFVM18: 41.9 
± 2.6, P < 0.001) and total number of  
vesicles per synapse is higher in SFV 
Munc18-1-overexpressing synapses 
compared with WT (WT: 62.6 ± 3.8; 
SFVM18: 90.1 ± 7.2, P < 0.001) but 
not in munc18-1+/-  neurons.
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neurons, without affecting postsynaptic receptor sensitivity and/or numbers (Figure 
8 I and J, mEPSCs, and Figure 7 D and L, mIPSCs).
Munc18-1-overexpressing mice have enhanced synaptic function in NMJs. 
We analyzed diaphragm NMJs of  Munc18-1-overexpressing mice (munc18OE, Fig-
ure 10). We first assessed RRP size with 500 mM sucrose. The sucrose-induced 
MEPP frequency was not significantly different between munc18OE and WT NMJs 
(P = 0.16; Figure 5E). Both spontaneous uniquantal acetylcholine release (MEPP 
frequency) and evoked release (quantal content at 0.3-Hz stimulation) were in-
creased compared with WT controls, by 53% and 14%, respectively (P < 0.001 and 
P < 0.05; Figure 5D and E). As in munc18-1+/- mice, no differences were seen in 
resting membrane potential, quantal size (MEPP amplitude), upward or downward 
slopes of  spontaneous events, and evoked response latency (Figure 5D and data not 
shown). Hence, in accordance with autaptic neurons and in contrast to the robust 
decrease of  EPP responses in Drosophila NMJs on overexpression of  Rop (Schulze 
et al., 1994), increased levels of  Munc18-1 lead to an increase in synaptic efficacy of  
the NMJ without affecting the fusion process.
Munc18-1 proteins levels control the number of  docked synaptic vesicles.
In autaptic neurons, the RRP size correlates with the number of  docked vesicles 
(Schikorski and Stevens, 2001). Therefore, we performed quantitative electron mi-
croscopy on glutamatergic synapses at 14 days in vitro (DIV). At low magnification, 
the general appearance of  autaptic cultures from munc18-1+/-, WT littermates, and 
WT neurons infected with SFV Munc18-1 was similar, and asymmetrical synapses 
with a clear active zone and postsynaptic density were present in comparable num-
bers (Figure 11A). The size of  the active zone, postsynaptic density, and synaptic 
vesicle cluster perimeter did not differ between genotypes (Figure 11B), indicat-
ing that Munc18-1 levels do not influence general synapse morphology or size. 
However, the number of  vesicles in immediate contact with the presynaptic active 
zone membrane increased significantly with increasing Munc18-1 expression levels 
(munc18-1+/-: 3.1 ± 0.6, n = 26; WT: 4.8 ± 0.3, n = 62; and SFVM18: 7.0 ± 0.4, n 
= 45; P < 0.05 for munc18-1+/- versus WT and P < 0.001 for WT versus SFVM18). 
Hence, these morphometric data show that Munc18-1 expression levels correlate 
with the number of  docked synaptic vesicles per active zone area, which parallels 
the observed physiological changes in RRP size. We also quantified the number of  
vesicles within 150 nm (approximately three times the synaptic vesicle size) from the 
active zone. Again, a positive correlation between the number of  vesicles present in 
this pool and Munc18-1 expression levels was found (Figure 11B), which may ex-
plain the faster RRP replenishment. Finally, the total number of  vesicles present in 




In the present study we show that the efficacy of  synaptic transmission at both excit-
atory and inhibitory synapses depends on Munc18-1 levels, and we identify changes 
in RRP size and replenishment as the primary underlying mechanism. This mecha-
nism may be related to the way in which protein kinase C (Stevens and Sullivan, 
1998; Virmani et al., 2005) and ras GTPases (Kushner et al., 2005) modulate synaptic 
transmission, but it is distinct from the two other major mechanisms to control syn-
aptic efficacy in nerve terminals, which rely on changes in vesicle-release probability 
(Geppert et al., 1997; Augustin et al., 1999; Reim et al., 2001) or connectivity changes 
[changes in the number of  synapses that connect two neurons and/or the size of  
the terminals (Tyler and Pozzo-Miller, 2001)]. Although all three mechanisms can in-
crease presynaptic output, only an increase in RRP size and replenishment warrants 
a sustained enhancement in synaptic efficacy.
Munc18-1-dependent changes in RRP size can be explained by the observed 
bidirectional changes in docked vesicles (fewer in munc18-1+/- neurons and more on 
Munc18-1 overexpression). These observations are in line with our previous obser-
vations in Munc18-1 null mutant chromaffin cells (Voets et al., 2001) and neocortex 
at late embryonic stages (Bouwman et al., 2004) as well as with studies in C. elegans 
(Weimer et al., 2003). Earlier in development, a docking defect was not observed in 
mouse neocortex (Verhage et al., 2000). The docking phenotype suggests a role for 
Munc18-1 that is distinct from other presynaptic proteins like Munc13-1, Rab3s, 
complexins, and Rim1α, which all influence synaptic efficacy through modulation 
of  the release probability without affecting vesicle docking and number or their 
localization (Augustin et al., 1999; Reim et al., 2001; Calakos et al., 2004). The in-
crease in docked vesicles on Munc18-1 overexpression may be a consequence of  
the increased total number of  vesicles in the terminal. However, in previous studies, 
changes in total vesicle number did not lead to concomitant changes in the number 
of  docked vesicles (Weimer et al., 2003; Gitler et al., 2004), and Munc18-1 overex-
pression in chromaffin cells also increased docking but without affecting total vesicle 
numbers (Toonen et al., 2006). Hence, often docking does not correlate with the 
total number of  available vesicles, presumably because of  the limited availability of  
docking sites. Therefore, we conclude that Munc18-1 specifically regulates the dock-
ing step, maybe by establishing such sites. In addition, Munc18-1 overexpression 
apparently influences the total number of  vesicles in the synapse by an unknown 
mechanism. The increased total number of  vesicles may contribute to the faster 
RRP replenishment, especially the increased number of  vesicles within 150 nm from 
the membrane (Figure 11B). Because the cluster perimeter and active zone area were 
unchanged (Figure 11B), the vesicle concentration within the cluster must be higher, 
which may promote faster reloading and greater occupancy of  docking sites. The 
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unaltered responses to paired hypertonic shocks suggest that Munc18-1 overexpres-
sion increases replenishment in a calcium-dependent manner.
The conclusion that Munc18-1 regulates the docking step, together with the un-
altered kinetics of  spontaneous and evoked fusion events, both in autapses and 
NMJs, argue for a role of  Munc18-1 upstream of  the synaptic vesicle fusion process 
itself. A large body of  evidence suggests that the interaction of  soluble N-ethyl-
maleimide-sensitive factor attachment protein receptors (SNARE) proteins from 
vesicular and target membranes drives this fusion reaction (Chen et al., 1999; Schoch 
et al., 2001; Washbourne et al., 2002). Deletion of  SNAP-25 or synaptobrevin, two 
members of  the SNARE complex involved in synaptic-vesicle release, results in a 
severe impairment of  neurotransmission without affecting vesicle docking (Chen 
et al., 1999; Schoch et al., 2001). Hence, our data suggest that Munc18-1 functions 
upstream of  SNARE complex formation. In vitro, Munc18-1 interacts tightly with 
the SNARE protein syntaxin 1 (Hata et al., 1993; Pevsner et al., 1994). As Munc18-1 
has no membrane interacting domains, the interaction with syntaxin 1 at the plasma 
membrane may be important for vesicle docking. Therefore, it seems plausible that 
the Munc18-1/syntaxin 1 dimer is involved in initial steps preceding vesicle fusion, 
the docking step, and that Munc18-1 subsequently is displaced to allow syntaxin to 
initiate SNARE complex formation and vesicle fusion.
Most of  the effects of  altered Munc18-1 expression described here can be ex-
plained by changes in the RRP size only (sucrose response, FM-dye loading, and 
vesicle distribution in electron micrographs). The increase in miniature frequency 
in Munc18-1 overexpressing neurons and the decrease in the munc18-1+/- NMJ are 
consistent with this conclusion. However, miniature frequency was not significantly 
different in munc18-1+/- autaptic neurons, as expected given the smaller RRP size 
in these cells, which is probably because of  the fact that this frequency is rather 
variable in autapses. There is a trend between the groups (27% difference in group 
average; Figure 1D), in fact, this is rather similar to the NMJ (29% difference; Figure 
5C). Increasing the release rate by using 200 mM sucrose (Figure 8B) did result in 
the expected Munc18-1-dependent changes. Secondly, single evoked responses were 
normal in munc18+/- and Munc18-1-overexpressing neurons (Figures 1B and F, 2C, 
and 7A) despite differences in RRP size. This finding suggests that the release prob-
ability of  the vesicles released during these single stimuli is altered. The observed 
differences in synaptic depression upon repetitive stimulation (Figures 3A, 5A, 8G, 
2 D and E, and 7F and G) are consistent with such an explanation, although in this 
case changes in RRP size may still contribute. On the other hand, the fact that, at the 
monosynaptic NMJ, changes in RRP size do correlate with changes in EPP ampli-
tude and miniature frequency strengthens the explanation that Munc18-1 does not 
directly control release probability but primarily RRP size. It is becoming evident 
that synaptic transmission in central synapses cannot be described accurately unless 
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heterogeneity of  vesicular release probability is taken into account. The fact that 
single evoked responses are unaltered in autapses despite differences in RRP size 
also may be attributable to such heterogeneous release probability. The initial release 
probability per synapse may be adjusted to the optimal dynamic range (Burrone and 
Murthy, 2003) despite differences in RRP size and the release probability of  the 
first vesicle, released on a single stimulus, may be different from other releasable 
vesicles.
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Munc18-1 is involved in homeostatic 
upregulation of  transmitter release at 





Homeostatic upregulation of  presynaptic neurotransmitter release in response to a 
reduction of  postsynaptic transmitter sensitivity has been observed at brain synapses 
and neuromuscular junctions (NMJs). This phenomenon allows synapses to adapt to 
(patho-)physiological changes. Compensatory upregulation of  ACh release has been 
observed at NMJs of  patients with myasthenia gravis and in experimental animal 
models for this paralytic auto-immune disease, in which postsynaptic ACh receptors 
at NMJs are reduced by autoantibodies. This form of  synaptic plasticity presum-
ably involves local retrograde signaling from post- to presynapse. Ultimate targets 
of  such signaling pathway may be the protein components of  the neuro-exocytotic 
machinery or proteins that modulate its function. One candidate is Munc18-1, a 
presynaptic protein which is essential for neurotransmitter release and presumably 
acts as positive regulator of  transmitter release at mouse NMJs. Munc18-1 is known 
to interact with the protein complex that regulates membrane fusion of  transmit-
ter vesicles. Here, we have investigated Munc18-1 involvement in homeostatic up-
regulation of  transmitter release at NMJs. To this end, we induced an experimental 
form of  myasthenia gravis to Munc18-1 heterozygous null-mutant mice, Munc18-1 
overexpressing transgenic mice, and wild type controls. Neurotransmitter release 
was measured with in vitro electrophysiological methods. Myasthenic Munc18-1 
heterozygous null-mutant mice were impaired in their ability to upregulate acetyl-
choline release at their NMJs. On the other hand, Munc18-1 overexpressing NMJs 
did not show additional upregulation, compared to wild-type controls. We conclude 
that Munc18-1 is involved in homeostatic upregulation of  transmitter release, and 
that other factors become limiting when Munc18-1 is present at elevated level.
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Successful synaptic transmission between a neuron and its target cell relies on mu-
tual tuning of  pre- and postsynaptic structure and function. This is of  particular 
importance during embryonic development when the physical properties of  cells, 
e.g. cell input resistance, change drastically as a result of  their growth. Throughout 
later stages in life there are also further (patho-)physiological changes that require 
structural and/or functional synaptic adaptation to ensure appropriate signal trans-
mission. The molecular mechanisms by which neuronal cells monitor and adapt 
their synaptic strength are not well understood yet (Davis and Bezprozvanny, 2001; 
Davis, 2006; for review, see Turrigiano et al., 1998; Regehr et al., 2009).
One form of  synaptic adaptation is the increase of  presynaptic neurotransmitter 
release following a reduction in postsynaptic sensitivity for the transmitter. It has 
been suggested that a retrograde messenger is involved, signaling from the postsyn-
aptic cell to the presynaptic cell. Although synaptic adaptation has been observed 
at CNS synapses (Bacci et al., 2001), this apparent homeostatic adaptive change 
has been best characterized at vertebrate and invertebrate neuromuscular junctions 
(NMJs).  For example, increase of  glutamate release from motor nerve terminals 
has been observed at the Drosophila NMJ, either upon lowering the number of  post-
synaptic glutamate receptors or inhibiting their function with transgenetic methods 
(Davis et al., 1998; Petersen et al., 1997). In transgenic mice with reduced expression 
of  neuregulin and a consequently impairment  of  acetylcholine receptor (AChR) 
synthesis, the reduction of  functional postsynaptic AChRs leads to compensatory 
increase in presynaptic ACh release at the NMJ (Sandrock, Jr. et al., 1997).
Similarly, compensatory increase of  ACh release has been found at NMJs of  
patients suffering from myasthenia gravis (MG), in which autoantibodies against 
the AChR cause a reduction of  receptor density resulting in muscle weakness (Vin-
cent et al., 2001). In vitro electrophysiological analysis of  NMJ function in muscle 
biopsies from MG patients revealed (partial) compensatory upregulation of  ACh 
release (Cull-Candy et al., 1980; Plomp et al., 1995). MG has been studied using 
experimental models in rat, where the AChR function has been decreased by the use 
of  antibodies or by chronic in vivo application of  the AChR blocker α-bungarotoxin. 
In these models, a similar upregulation of  ACh relase was demonstrated (Plomp et 
al., 1992; Plomp et al., 1995). Detailed electrophysiological studies showed that the 
amount of  this upregulation at each individual (experimental) myasthenic NMJ was 
depending on the amount of  reduction of  postsynaptic AChRs at that NMJ (Plomp 
et al., 1992; Plomp et al., 1995). This strongly suggests that local postsynaptic fac-
tors are signaling in a retrograde fashion to the presynaptic cell, as also suggested 
for Drosophila NMJs (Aberle et al., 2002; Davis et al., 1998; McCabe et al., 2003; 
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Petersen et al., 1997), cricket CNS synapses (Davis and Murphey, 1993) and rat hip-
pocampal synapses (Micheva et al., 2003). 
The molecular mechanism underlying retrograde signaling in the homeostatic 
control of  ACh release at myasthenic NMJs is largely unknown. Retrograde signal-
ing is accomplished either by diffusible retrograde messenger or through a transsyn-
aptic protein complex (Regehr et al., 2009). Neurotrophic factors are candidates for 
diffusible messengers, since in vitro pharmacological block of  the tyrosine kinases re-
ceptors reduces the increased ACh release levels at experimental MG NMJs to nor-
mal values (Plomp and Molenaar, 1996). Furthermore, nitric oxide has been shown 
to act as retrograde messenger in hippocampal synapses (Micheva et al., 2003). In-
teresting candidates for forming a transsynaptic signalling protein complex are e.g. 
neuroligins and neurexins (Futai et al., 2007; Scheiffele, 2003).
The ultimate target of  the retrograde signaling cascade leading to increased re-
lease is likely to be the presynaptic exocytotic machinery, dedicated to fast and pre-
cisely timed fusion of  synaptic vesicles with the plasma membrane. A vast number of  
proteins is involved in exocytosis (see for reviews (Rosenmund et al., 2003; Sudhof, 
2004; Verhage and Toonen, 2007; Toonen and Verhage, 2007), but the key event in 
synaptic vesicle fusion is the formation of  the so-called SNARE complex (Poirier 
et al., 1998; Sutton et al., 1998). This is a parallel four-helix bundle formed by the 
SNARE motifs of  the three neuronal SNARE proteins (syntaxin-1 and SNAP25 
on the plasma membrane, and vesicle membrane-associated synaptobrevin). The 
energy released by the formation of  this complex catalyzes the fusion reaction that 
leads to transmitter release (Finley et al., 2002; Hanson et al., 1997; Lin and Scheller, 
1997).
The protein family Sec-Munc18 is necessary for exocytosis in yeast (Aalto et al., 
1992; Novick et al., 1981), C. elegans (Hosono et al., 1992), Drosophila (Harrison et 
al., 1994) and mice (Verhage et al., 2000) and was initially discovered as a binding to 
syntaxin (Hata et al., 1993). Munc18 can either bind to the to the ‘closed’ form of  
syntaxin, or to syntaxin participating in the SNARE complex. In the ‘closed’ form 
of  syntaxin, the N-terminus folds back onto the Habc domain forming a four helical 
structure which prevents participation of  the protein in the SNARE complex (Du-
lubova et al., 1999; Misura et al., 2000). The arch-like structure of  Munc18 binds as 
a clasp to the four helical syntaxin structure. The other mode of  binding involves 
association of  the N-terminus of  Munc18 with the N-terminus of  syntaxin while 
assembled in the SNARE complex, leaving the arch-shape structure of  Munc18 free 
to clasp the four helices of  the SNARE complex (Dulubova et al., 2007; Shen et 
al., 2007; Yamaguchi et al., 2002). How exactly Munc18 is involved in secretion is 
not clear yet, but most likely Munc18 is a catalyst for SNARE complex formation, 
which in turn drives membrane fusion (Sudhof  and Rothman, 2009; see for reviews 
Toonen and Verhage, 2007).
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Based on fact that Munc18-1 is a key player in exocytosis, the protein could be 
involved in the release-increasing retrograde signaling cascade at myasthenic NMJs. 
In a previous paper we have described the effect of  varying the levels of  Munc18-1 
on transmitter release in mice by the use of  heterozygous Munc18-1 null-mutant 
mice (Munc18-1+/-) and mice overexpressing Munc18-1 (Munc18-1OE) (Toonen 
et al., 2006b). A clear positive correlation between release parameters in the NMJ 
and the level of  Munc18-1 was described. In the present study, we investigated the 
role of  Munc18-1 in homeostatic upregulation of  transmitter release in the NMJ. 
Heterozygous Munc18-1 null-mutant mice and mice overexpressing Munc18-1 were 
subjected to an experimental form of  MG involving chronic in vivo application of  
the AChR blocker α-bungarotoxin and it was investigated whether compensatory 
increase of  ACh release occurred at their NMJs. Our results indicate that Munc18-1 
is indeed involved in this form of  synaptic adaptation.
Materials and Methods
Mice
Munc18-1+/- mice were bred by means of  standard mouse husbandry and back-
crossed for at least 6 generations to a C57Bl/6 background (Verhage et al., 2000). 
These mice had 50% reduced Munc18-1 protein level in brain, as determined by 
Western blot analysis (Toonen et al., 2006b). 
Munc18-1OE mice were generated as described (Toonen et al., 2006b). The linear-
ized pNSE-Ex4 minigene containing the promoter of  neuron specific enolase from 
rat (Forss-Petter et al., 1990) and Munc18-1 cDNA was injected into zygotes with a 
C57Bl/6 x CBA background. The transgenic mice were viable and fertile. Histologi-
cal analysis of  brain and spinal cord sections at C1-C3 level, from which the innerva-
tion of  the diaphragm muscle originates, showed transgene expression. In the spinal 
cord, the transgene staining was co-localized with staining for the motor neuronal 
marker choline-acetyltransferase.
Genotypes were analyzed using Southern blot or polymerase chain reaction 
methods. The mice were housed under a 12 h light / 12 h dark regime with ad libitum 
food and water. The animals were euthanized by CO2 inhalation. Hemi-diaphragms 
with their phrenic nerves were rapidly dissected and pinned out in Ringer’s solution 
(see below) at room temperature.
All animal experiments were carried out according to the Dutch law and local 
University guidelines (DEC#99029).
Toxin-induced myasthenia gravis
We used an experimental animal model for MG that was originally developed in 
rats and is termed toxin-induced MG (TIMG) (Molenaar et al., 1991). The model 
involves repeated injections with small doses of  α-bungarotoxin (Biotoxins Incor-
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porated, ST. Cloud, FA, USA), a highly potent and selective blocker of  AChRs at 
NMJs. We adjusted and re-evaluated the model for use with mice (data not shown). 
During a period of  four weeks, mice of  about 4 months of  age (body weights of  
about 20 g) were injected intraperitoneally every 48 hour during the work week (i.e. 
on Mondays, Wednesdays and Fridays) with a low dose of  α-bungarotoxin. Control 
groups received physiological saline (0.9% NaCl) injections. As a first dose, 1.2 µg 
α-bungarotoxin was injected. Thereafter, doses of  0.8 μg were given. Three hours 
after an injection the mice showed slightly invaginated flanks, indicating mild muscle 
weakness. There were no apparent breathing problems. In general, these symptoms 
had disappeared by the next, toxin-free, day. If  the symptoms of  weakness (scored 
in individual mice) were too severe, the dose of  α-bungarotoxin was lowered. The 
mice were well able to feed and drink. At the end of  the TIMG treatment, body 
weights of  the TIMG and saline-injected control mice were similar.
Neuromuscular synapse electrophysiology
Measurements were performed on nerve/muscle preparations from right and left 
hemi-diaphragms of  wild type, Munc18-1+/-, and Munc18-1OE mice. Upon stimula-
tion of  the phrenic nerve, the nerve terminal releases a number of  ACh quanta. 
Part of  the transmitter binds postsynaptic ACh receptors and causes them to open. 
The resulting ion current gives rise to an endplate potential (EPP). Spontaneous 
release of  single quanta results in miniature EPPs (MEPPs). We recorded EPPs 
and MEPPs by impaling muscle fibers near the NMJ with a 10-20 MΩ glass capil-
lary microelectrode filled with 3 M KCl and standard recording equipment at 26-
28°C (Plomp et al., 1994) in Ringer’s medium containing (mM): NaCl, 116; KCl, 4.5; 
MgCl2, 1; CaCl2, 2; NaH2PO4, 1; NaHCO3, 23; glucose 11; pH 7.4, gassed with 95 
% O2/5 % CO2. Hemi-diaphragms were incubated with 3.1 µM µ-Conotoxin GIIIB 
(Scientific Marketing Associates, Herts, UK), a selective blocker of  muscle sodium 
channels, to prevent action potentials. This allowed for the undisturbed recording of  
EPPs during electrical nerve stimulation (0.3 and 40 Hz) of  the phrenic nerve with 
a bipolar stimulation electrode. The quantal content (i.e. the number ACh quanta 
released upon a single nerve impulse) at each NMJ was calculated from EPP and 
MEPP amplitudes, normalized to -75 mV membrane potential. The EPP amplitude 
was corrected for non-linear summation, as described before (Plomp et al., 1994). 
During high-frequent stimulation (1 s, 40 Hz), EPP amplitudes decrease to a plateau 
level. The rundown level of  the EPP amplitude during 40 Hz stimulation for 1 s of  
the phrenic nerve was determined by averaging the amplitudes of  the last 10 EPPs 
of  the train and expressing it as percentage of  the amplitude of  the first EPP of  
the train.
A GeneClamp 500B amplifier from Axon Instruments (Union City, CA, USA) 
was used for amplifying and filtering (10 kHz low-pass) of  the signals. The record-
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ings were digitized and analyzed using a Digidata 1200 interface, Clampex 8.0 and 
Clampfit 8.0 programs (Axon Instruments) and routines programmed in Matlab 
(The MathWorks Inc., Natick, MA, USA).
Statistical analysis
The significance of  differences in mean values between genotype groups were tested 
using Student’s t-test. Differences in effect of  TIMG treatment between genotypes 
was tested with the multivariate general linear model (interaction parameter) and 
the post-hoc Tukey test by using SPSS 10.0 for Windows (SPSS Inc., Chicago, IL, 
USA).
Results
Analysis of  basic neuromuscular synaptic function in Munc18+/- mice
We performed intracellular recordings of  EPPs from muscle fibers of  diaphragm-
phrenic nerve-muscle preparations from wild type mice (N=12, 10-15 NMJs sam-
pled per animal) and Munc18-1+/- mice (N=10, 10-15 NMJs sampled per animal). 
These mice had received repeated injections with saline and served as a control for 
the TIMG group that was injected with α-bungarotoxin (see below). 
The MEPP amplitude was the same in both genotype groups (0.93 ± 0.05 and 
0.93 ± 0.05 mV, Figure 1A, G). We did not observe differences in spontaneous 
quantal ACh release between wild type and Munc18-1+/- NMJs. The mean MEPP 
frequency was 1.62 ± 0.10 and 1.52 ± 0.10 s-1, respectively (Figure 1B, G). At low-
frequency nerve stimulation (0.3 Hz), the mean amplitude of  the EPPs was 25.66 
± 1.31 mV in wild type and 25.44 ± 1.17 mV in Munc18-1+/- NMJs. The calculated 
quantal content was 41.54 ± 2.08 in wild type and 40.57 ± 2.31 in Munc18-1+/- 
NMJs (Figure 1C). Upon high-frequency (40 Hz) nerve stimulation, Munc18-1+/- 
NMJs displayed a more pronounced rundown of  EPP amplitude, to a level of  74 ± 
1.3% of  the amplitude of  the first EPP of  the stimulation train, compared to 83 ± 
0.9% at wild type NMJs (Figure 2, p<0.001). 
Thus, although low-frequency evoked ACh release as well as spontaneous re-
lease did not differ between Munc18-1+/- and wild type NMJs, a more pronounced 
rundown of  EPP amplitude was observed at Munc18-1+/- NMJs at high-frequency 
nerve stimulation. This most likely reflects a decrease in quantal content during the 
stimulus train. 
Myasthenic Munc18-1+/- neuromuscular synapses show impaired compensatory increase 
of  ACh release
Subjection of  mice to the TIMG protocol (four weeks α-bungarotoxin treatment) 

















































































































































Figure 1. Low-rate evoked and spontaneous acetylcholine release at neuromuscular synapses of  wild 
type, Munc18-1+/- and Munc18-1OE mice with toxin-induced myasthenia gravis.
Effect of  TIMG-treatment (shaded bars) on MEPP amplitude, quantal content at 0.3 Hz nerve stimulation and 
MEPP frequency at NMJs of  diaphragms from Munc18-1+/- (A-C), Munc18-1OE (D-F) mice, compared with wild 
type littermates. N=5-12 mice, 10-15 NMJs sampled per muscle, data represent grand mean group values + S.E.M. 
TIMG-treatment induced equal reductions of  MEPP amplitudes of  ~70% in either genotype. The extent of  the 
resulting increase in quantal content in the wild type group was larger than that in the Munc18-1+/- group (p<0.05). 
MEPP frequency at saline-injected control Munc18-1OE NMJs was higher than at wild type NMJs (p<0.05). TIMG 
treatment reduced the MEPP frequency at Munc18-1OE NMJs (p<0.05), to a larger extent than at wild type NMJs 
(P<0.01). (G) Typical examples of  MEPP recordings at NMJs of  the different genotype mice under TIMG- and sa-
line-injected control condition (10s traces, left and right columns). In the middle column, individual MEPPs record-
ed from control and TIMG-treated NMJs have been superimposed at enlarged time-base. *p<0.05, ***p<0.001.
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Munc18-1+/- and wild type mice, to 0.34 ± 0.01 mV (n=11) and 0.31 ± 0.02 mV 
(n=10), respectively (Figure 1A, G). This indicates that the reduction of  postsyn-
aptic sensitivity to ACh in the TIMG condition was established at a similar degree 
in both genotypes. The amplitude of  EPPs evoked by low-frequency stimulation 
(0.3 Hz) after TIMG treatment was 19.5 ± 1.43 mV in wild type and 17.8 ± 0.64 
mV in Munc18-1+/- NMJs. At wild type TIMG NMJs the quantal content was in-
creased by 126% (p<0.001) compared with the saline-treated controls (Figure 1C). 
However, the increase of  quantal content at Munc18-1+/- TIMG NMJs was only 
79% (p<0.001), statistically significantly less than the increase at wild type NMJs 
(p<0.01). Thus, although basic neuromuscular synaptic transmission seems largely 
unaltered at Munc18-1+/- NMJs, presynaptic adaptation in response to reduced post-
synaptic transmitter sensitivity is impaired.
In both wild type and Munc18-1+/- groups, rundown of  the EPP amplitude at 
40 Hz stimulation was more pronounced in TIMG than saline-injected control mice 
(Figure 2). In wild type TIMG-NMJs the rundown reached a level of  62 ± 2.4% of  
Figure 2























































































































































































































































Figure 2. High-rate evoked acetylcholine release at neuromuscular synapses of  wild type, Munc18-1+/- 
and Munc18-1OE mice with toxin-induced myasthenia gravis. 
Effect of  TIMG-treatment (shaded bars) on EPP amplitude rundown during high-rate (40 Hz) stimulation for 1 
s of  the phrenic nerve of  diaphragms from wild-type, Munc18-1+/- and Munc18-1OE mice (N=5-12 mice, 10-15 
NMJs sampled per muscle). (A) Mean rundown level of  EPP amplitude. At each NMJ the EPP amplitude rundown 
level was taken as the calculated mean amplitude of  the last 10 EPPs in the train, expressed as a percentage of  the 
first EPP of  the train. Data represent grand mean group values ± S.E.M. Average rundown profiles from (B) wild-
type, (C) Munc18-1+/- and (D) Munc18-1OE NMJs under saline-injected control condition (filled circles) and TIMG 
condition (open circles). Insets are typical examples of  40 Hz EPP train recordings. ***p<0.001.
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the first EPP in the train, which differed from the 83 ± 0.9% observed in controls 
(p<0.001). In Munc18-1+/- TIMG NMJs the rundown of  EPPs amplitude  increased 
to 59 ± 1.8%, which was significantly different from control values (74 ± 1.3%, 
p<0.001).
At TIMG-NMJs the mean MEPP frequency tended to be reduced in both wild 
type (9%) and Munc18-1+/- mice (18%), compared with their saline-injected con-
trols, but this difference was not statistically significant. At NMJs with very small 
MEPPs, as often encountered under TIMG conditions, the mean frequency may 
have been underestimated due to loss of  MEPPs that were too small to detect, i.e. 
with amplitudes smaller than about 0.1 mV. In order to substantiate this hypoth-
esis we classified the NMJs with respect to their MEPP amplitude into classes of  
0.1 mV bin-width and calculated for each class the mean MEPP frequency. In all 
overlapping MEPP amplitude classes there was no statistically significant difference 
between MEPP frequencies measured in TIMG or control NMJs, in either wild type 
or Munc18-1+/- NMJs (Figure 3). The wild type and Munc18-1+/- TIMG-NMJs in 
the 0.1-0.2 mV MEPP amplitude class (which were not encountered in saline-treated 
controls) had clearly lower MEPP frequencies than all the classes of  NMJs, with 
larger MEPP amplitude. This indicates that some loss of  MEPPs in the baseline 
noise had occurred, which may explain the small reduction of  overall mean MEPP 
frequency in the TIMG groups of  either genotype compared to their control value 
obtained in saline-injected mice. As a result the mean MEPP amplitude may have 
been overestimated at these NMJs and, consequently, the TIMG quantal contents 
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Figure 3. Relation between MEPP amplitude and MEPP frequency at neuromuscular synapses of  
Munc18-1+/- and Munc18-1OE mice with toxin-induced myasthenia gravis. 
NMJs of  (A) wild-type, (B) Munc18-1+/- and (C) Munc18-1OE mice were classified with respect to their mean MEPP 
amplitudes (normalized to -75 mV resting membrane potential) in bins of  0.1 mV width. Data points represent 
the mean MEPP frequency ± S.E.M. within a bin (open symbols, TIMG; filled symbols, saline-injected controls). 
In the lower panels of  each figure, the numbers of  NMJs in each bin are given in a histogram (filled bars, TIMG; 
open bars, saline-injected control). No statistically significant differences were found between TIMG and controls 
NMJs, when both present in a bin. 
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Thus, NMJs from Munc18-1+/- mice showed impaired synaptic plasticity in that 
they were not able to upregulate their ACh release as much as wild type control 
NMJs upon reduction of  postsynaptic transmitter sensitivity (Figure 4).
Overexpression of  Munc18-1 does not further increase the level of  homeostatic upregula-
tion of  transmitter release in TIMG 
The data obtained from Munc18-1+/- mice indicated that a reduced level of  Munc18-
1 limits the ability of  motor nerve terminals to compensate for the reduced post-
synaptic ACh sensitivity under myasthenic conditions by an increase of  ACh release. 
Consequently, we hypothesized that increased Munc18-1 protein levels might in-
crease the level of  compensatory upregulation of  ACh release. To test this hypothe-
sis we subjected Munc18-1OE mice, which overexpress Munc18-1 in motor neurons, 
to our TIMG protocol and analyzed synaptic transmission at their NMJs.
Under control (i.e. saline-injected) conditions (N=7 wild type mice and N=5 
Munc18-1OE mice, 10-15 endplates per muscle), MEPP amplitude was similar at 
wild-type and Munc18-1OE NMJs (0.99 ± 0.09 mV and 0.90 ± 0.04, respectively, 
Figure 1E, G). Munc18-1OE NMJs had a 36% increased MEPP frequency compared 
with wild type (2.21 ± 0.17 s-1 and 1.62 ± 0.14 s-1, respectively, p<0.05, Figure 1E, 
G). The mean quantal content of  Munc18-1OE NMJs was 46.6 ± 1.05, which is 18% 
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Figure 4. Normalized effects of  toxin-induced myasthenia gravis on neuromuscular synapse parameters 
of  wild type, Munc18-1+/- and Munc18-1OE mice.
Overview of  the effects of  TIMG-treatment on MEPP amplitude, MEPP frequency, quantal content and rundown 
of  40 Hz EPP amplitude in wild-type, Munc18-1+/- and Munc18-1OE NMJs. TIMG values of  the parameters of  
each genotype group were expressed as a percentage of  the mean values obtained in saline-injected control groups. 
*p<0.05, different from wild type group.
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did just not reach statistical significance (p=0.05, Figure 1F). Also, there was no 
significant change in EPP amplitude rundown upon 40 Hz stimulation at Munc18OE 
NMJs compared to wild type (rundown to 80 ± 0.7% and 82 ± 0.7% of  the first 
EPP, respectively, Figure 2).
At Munc18-1OE NMJs under TIMG conditions there was a tendency to display 
less compensatory increase of  ACh release than at TIMG/wild type NMJs (78% vs. 
121% increase, respectively, N=5 TIMG/Munc18-1OE and 5 TIMG/wild type mice, 
Figure 1F). However, this difference was not statistically significant. Under TIMG 
conditions, the EPP amplitude rundown became more pronounced, compared to 
saline-injected controls, to a similar degree in both genotypes (rundown level of  
61 ± 3.6% of  first EPP at TIMG/wild type and 65 ± 2.4% at TIMG/Munc18-
1OE NMJs, Figure 2). We observed a TIMG-induced decrease of  the overall mean 
MEPP-frequency of  44% at Munc18-1OE NMJs, which was larger (p<0.05) than the 
small TIMG-induced decrease of  ~10% at wild type NMJs (Figure 1E, G). When we 
classified the NMJs in MEPP amplitude bins of  0.1 mV it appeared that there was a 
clear tendency of  MEPP frequencies at TIMG/Munc18-1OE NMJs to be about 50% 
lower than that of  NMJs in the similar amplitude class of  saline-injected controls. 
However, these reductions were not statistically significant (Figure 3 and 4).
Thus, overexpression of  Munc18-1 did not further augment the level of  com-
pensatory increase of  ACh release upon a reduction in postsynaptic ACh sensitiv-
ity.
Discussion
At myasthenic NMJs, homeostatic upregulation of  ACh release partially compen-
sates for the loss of  postsynaptic transmitter sensitivity after reduction of  AChRs. 
Most likely, this involves retrograde signaling from muscle fibers to motor nerve ter-
minals. We hypothesized that neuro-exocytotic proteins are the final targets of  such 
a signaling pathway. The data presented here indicate that the key neuro-exocytotic 
protein Munc18-1 indeed plays a role in the mechanism underlying this form of  
functional synaptic plasticity.
Role of  Munc18-1 in neurotransmitter release at the neuromuscular synapse
Munc18-1+/- saline control group NMJs showed increased rundown of  EPP am-
plitude during high-frequent stimulation, compared to wild-type, and Munc18-1OE 
NMJs displayed an increased MEPP frequency. This is in agreement with data we 
reported previously on NMJs and hippocampal autaptic synapses of  Munc18-1+/- 
and Munc18-1OE mice (Toonen et al., 2006b), concluding a role for Munc18-1 in 
regulation of  the vesicle pool size. A smaller vesicle pool size in Munc18-1+/- NMJs 
explains the reduced MEPP frequency, since vesicle pool size is a factor that de-
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termines the level of  spontaneous transmitter release (Prange and Murphy, 1999; 
Stevens and Sullivan, 1998). Rundown of  high-rate evoked transmitter release is 
believed to represent depletion of  the readily releasable pool of  synaptic vesicles 
(Kuromi and Kidokoro, 2000), and Munc18-1 also controls the number of  docked, 
release-ready vesicles in chromaffin cells (Toonen et al., 2006a; Voets et al., 2001) 
and C. elegans (Weimer and Jorgensen, 2003). The increased rundown of  high-rate 
evoked release as observed in Munc18-1+/- is consistent with these reports.
Our earlier studies on Munc18-1+/- NMJs showed a decrease in quantal content 
and MEPP frequency, which we did not find in the present study. In addition we ob-
served an increase in quantal content in Munc18-1OE NMJs and in MEPP frequency 
in in Munc18-1OE NMJs (Toonen et al., 2006b). Although we did find the increase 
in MEPP frequeny, the increase in quantal content in this study was not statistically 
significant.The reason for this discrepancy is not clear but might stem from the dif-
ference in age of  the mice. The mice used in the present study were older due to 
the TIMG/saline treatment of  six weeks. Possibly, adaptation occurs to the changed 
Munc18-1 levels during aging.
Role of  Munc18-1 in homeostatic transsynaptic upregulation of  transmitter release at 
myasthenic neuromuscular synapses
Subjection of  Munc18-1+/- mice to an experimental model for MG showed that 
these NMJs are less capable of  compensatory increase of  transmitter release com-
pared to wild-type myasthenic NMJs. This indicates that Munc18-1 is involved in the 
homeostatic upregulation of  ACh release at myasthenic NMJs. 
It has been shown that Munc18-1 is involved in all steps leading to neurotrans-
mitter release, from tethering, docking, priming to fusion (Rizo and Rosenmund, 
2008; reviewed in: Toonen and Verhage, 2007). Munc18-1 may act as crystallization 
points for SNARE formation, so recruitment or activation of  Munc18-1 may lead to 
an increased number of  ACh quanta released following a presynaptic impulse. This 
may be the result of  an increase of  the readily releasable pool (RRP) of  vesicles. This 
is in accordance with the observed more pronounced rundown during high-frequen-
cy stimulation in TIMG and MG, since the maintenance of  a high vesicle turnover 
in such a large RRP during high-frequency stimulation will put more strain to the 
exocytotic machinery. However, one could expect a higher basal MEPP frequency in 
TIMG NMJs when the RRP is increased, which was not observed.  
Munc18-1 is a substrate for cyclin-dependent kinase 5 (Fletcher et al., 1999; Sh-
uang et al., 1998) and protein kinase C (PKC) (Barclay et al., 2003; de Vries et al., 
2000; Fujita et al., 1996). Activation of  PKC has been shown to underlie enhance-
ment of  neurotransmitter secretion in different forms of  synaptic plasticity (Brager 
et al., 2003). Phosphorylation of  Munc18-1 might be involved in the upregulation 
of  ACh release at myasthenic NMJs. This would require stimulation of  kinases at 
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motor nerve terminal by the putative retrograde messenger that is released from the 
myasthenic muscle fiber. Interestingly, stimulation of  TrkB membrane receptors by 
neurotrophins, which are candidate retrograde factors, has been shown to activate 
PKC (Zirrgiebel et al., 1995). However, other studies did not find an effect of  PKC 
inhibition on upregulated ACh release in rat TIMG NMJs in vitro (Plomp and Mole-
naar, 1996). In addition, PKC phosphorylation of  Munc18-1 is known to stimulate 
release in chromaffin cells (Barclay et al., 2003), without increasing the number of  
docked vesicles (Wierda et al., 2007).
Another mechanism by which Munc18-1 might be targeted in the signaling cas-
cade is via a transsynaptic protein complex formed by the postsynaptic scaffold-
ing protein PSD-95, and neuroligin and presynaptic β-neurexin (Futai et al., 2007). 
This signaling route was described for rat hippocampal CA1 pyramidal neurons, and 
positively influences presynaptic release. Since β-neurexin binds to the scaffolding 
protein CASK, which in turn is known to bind Mint1, a binding partner of  Munc18-
1, a role of  Munc18-1 could be envisioned here (Futai et al., 2007, and references 
herein). However, more research is necessary to elucidate the exact signaling path-
way that is employed in MG synapses.   
Surprisingly, Munc18-1OE NMJs did not show further enhanced levels of  upregu-
lation of  ACh release upon the loss of  postsynaptic ACh sensitivity induced by the 
TIMG treatment, when compared to the augmented level at wild type TIMG-treat-
ed NMJs. Upregulation of  ACh release rather tended to be lower in Munc18-1OE 
TIMG-NMJs, but the difference was not significant. Apparently, Munc18-1 protein 
at Munc18-1OE NMJs is present at a supramaximal level and under this condition 
other factors that participate in the mechanism of  upregulation of  ACh release will 
become limiting. Alternatively, Munc18-1 at this increased level may exert unknown 
inhibitory actions on such factors.
TIMG treatment reduced MEPP frequency at Munc18-1OE NMJs but not at wild 
type controls. The reasons for this difference are not clear. One possible explanation 
is that a larger proportion of  MEPPs remained undetected due to a larger reduction 
of  MEPP amplitude at Munc18-1OE NMJs by the TIMG treatment. However, this 
was not observed. It is possible that due to the already elevated ACh release level 
at Munc18-1OE NMJs, compared to wild type controls, a further increase of  evoked 
release induced by the TIMG treatment prevents full replenishment of  the transmit-
ter vesicle pool so that MEPP frequency becomes reduced.
TIMG induced a more pronounced rundown of  ACh release at high-rate nerve 
stimulation at NMJs of  all three studied Munc18-1 genotypes, compared to that at 
NMJs of  saline-injected control mice. As the quantal content is increased under 
TIMG conditions, the most likely explanation is that the readily releasable vesicle 
pool becomes exhausted at a faster rate. A similar association between increased 
quantal content and a more pronounced rundown at high-rate nerve stimulation 
159
Munc18-1 TIMG
was shown at NMJs of  mice overexpressing acetylcholinesterase (Farchi et al., 2003). 
However, increased exhaustion of  the vesicle pool due to the high level of  ACh re-
lease may not be the only explanation because an increased rundown of  release has 
been observed as soon as 3 hours after the first α-bungarotoxin injection in TIMG 
rats, when MEPP amplitude is decreased but quantal content not yet increased (J.J. 
Plomp, unpublished results). Furthermore, it was expected that increased levels of  
Munc18-1 at Munc18-1OE NMJs would have counteracted more pronounced run-
down of  ACh release during high-rate nerve stimulation through facilitation of  the 
replenishment rate of  the vesicle pool. However, this was not observed;  apparently 
Munc18-1 is not the rate-limiting factor in this process.
In conclusion, we have shown that Munc18-1 is involved in homeostatic upregu-
lation of  ACh release at mouse NMJs in response to a lowered postsynaptic sensitiv-
ity for ACh. From a clinical point of  view, elucidation of  the molecular mechanism 
of  upregulation of  ACh release at myasthenic NMJs is important. New drug targets 
can be identified and their activation should boost the process of  synaptic adapta-
tion in order to counteract or prevent muscle weakness. Unfortunately, Munc18-1 
appears to be a poor candidate in view of  the observed lack of  enhanced compensa-
tory upregulation of  ACh release at myasthenic Munc18-1OE NMJs.
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Rab interacting molecule 1α (RIM1α) is a large, multidomain protein thought to be 
implicated in neurotransmitter release and several forms of  synaptic plasticity in the 
central nervous system. We investigated the role of  RIM1α at the peripheral neuro-
muscular junction (NMJ) by performing electrophysiological recordings of  synaptic 
signals at ex vivo NMJs of  homozygous RIM1α knockout mice. Furthermore, to 
assess whether RIM1α plays a role in synaptic plasticity at the NMJ, we induced an 
experimental form of  myasthenia gravis by injecting mice with α-bungarotoxin, a 
blocker of  postsynaptic acetylcholine receptors. This procedure is known to induce 
compensatory upregulation of  acetylcholine release from the presynaptic motor 
nerve terminal at the NMJ. No effect of  the deletion of  RIM1α in the NMJ was 
found, neither on the basic neurotransmitter release parameters, nor on the homeo-
static increase of  transmitter release under experimental myasthenic condition. This 
leads to the conclusion that RIM1α is redundant for synaptic function at the mouse 
NMJ.
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Rab3 Interacting Molecule (RIM) proteins are localized to presynaptic zones and are 
believed to play a scaffolding role in synaptic vesicle docking or priming (Wang et al., 
1997). Originally discovered as a Rab3a interacting protein, it has been established 
that RIM interacts with other active zone proteins as well (e.g. Munc13, liprin, and 
calcium channels) (Schoch et al., 2002; Kiyonaka et al., 2007).
In vertebrates, the RIM protein family is encoded by four genes expressed in a 
variety splice variants. α-RIMs (RIM1α and RIM2α) are full length proteins, con-
sisting of  an N-terminal Rab3-binding sequence and a Munc13-binding sequence, a 
central PDZ-domain and two C-terminal C2-domains (Wang et al., 2000). In contrast 
to this, β-RIM (RIM2β) does not contain the Rab3- and Munc13-binding sequence. 
Furthermore, there are three γ-RIMs (RIM2γ, RIM3γ, and RIM4γ), consisting only 
of  the C-terminal C2-domains and a short flanking sequence (Wang et al., 2000; 
Wang and Sudhof, 2003). In C. elegans RIM is encoded by one gene, unc10 (Koushika 
et al., 2001).
RIM1α KO mice are viable and fertile but show alterations in memory and learn-
ing and an impairment of  vesicle priming (Powell et al., 2004). Several forms of  syn-
aptic plasticity (mossy fiber long term potentiation (LTP), short term potentiation 
(STP)) were shown to be altered (Castillo et al., 2002; Schoch et al., 2002; Calakos 
et al., 2004). The RIM1α /RIM2α double KO mouse (Schoch et al., 2006a) is not 
viable, and analysis of  E18.5 embryos showed a strongly impaired calcium regulated 
neurotransmitter release in the NMJ. Deletion of  unc10 in C. elegans RIM (Koushika 
et al., 2001) results in impaired neurotransmitter release with a defect in priming.
RIM1α most likely participates in vesicle priming by its N-terminal interaction 
with Munc13, a large active zone protein that is crucial for priming (Betz et al., 2001; 
Dulubova et al., 2005). Munc13 forms homodimers, and α-RIM competes with the 
Munc13-Munc13 interaction to form Munc13-RIM heterodimers (Lu et al., 2006). 
The N-terminal of  α-RIM can simultaneously bind GTP-bound Rab3A on syn-
aptic vesicles (Dulubova et al., 2005); this Rab3/RIM/Munc13 tripartite complex 
approximates synaptic vesicles to the priming machinery. RIM1α may also stimulate 
neurotransmitter release in a more direct way through an interaction with presynap-
tic voltage-dependent calcium channels which inhibits their inactivation (Kiyonaka 
et al., 2007), although a recent publication failed to show this (Wong and Stanley, 
2010).
Many proteins that have been shown to participate in exocytosis in central syn-
apses are also present at neuromuscular junctions (NMJs), such as the SNARE 
proteins, and Munc18 (reviewed by Lin and Scheller, 2000; Sudhof, 2004; Sudhof  
and Rothman, 2009). Previously, we demonstrated an identical silencing effect of  
Munc18-1 deletion on central synapses and the NMJ (Verhage et al., 2000). Howev-
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er, absence of  specific presynaptic proteins does not always lead to identical effects 
at central synapses and the NMJ. Analysis of  Munc13-1/2 deficient mice showed 
severely reduced (but not absent) evoked transmitter release and unaltered sponta-
neous release at the NMJ (Varoqueaux et al., 2005). In contrast, central synapses of  
these mice were completely silenced  (Varoqueaux et al., 2002).
Here, we evaluated the role of  RIM1α in neuromuscular synaptic function. 
Electrophysiological recordings of  postsynaptic response in the muscle fiber from 
diaphragm nerve-muscle preparations of  RIM1α KO mice allow to quantify the 
acetylcholine (ACh) release at NMJs. Surprisingly, all basic ACh release parameters 
were unaltered compared to those recorded in the wild-type control NMJs. Since 
RIM1α has been implicated in synaptic plasticity at CNS synapses (Castillo et al., 
2002; Schoch et al., 2002; Calakos et al., 2004), we also tested for a possible role of  
RIM1α in synaptic homeostasis at the NMJ. In the condition of  myasthenia gravis 
(MG), where auto-antibodies reduce the number of  functional postsynaptic ACh re-
ceptors (AChRs), NMJs up-regulate presynaptic ACh release to compensate for the 
loss of  postsynaptic sensitivity (Plomp et al., 1995). We investigated this in a toxin-
induced myasthenia gravis (TIMG) mouse model, where the functional density of  
AChRs is reduced by application of  α-bungarotoxin (Plomp et al., 1992). In order 
to elucidate a possible role for RIM1α in this form of  synaptic plasticity at the NMJ 
we subjected both RIM1α KO and wild type mice to the TIMG model. Both groups 
displayed a similar compensatory increase of  neurotransmitter release, implicating 
that RIM1α is not playing a role in this form of  synaptic plasticity. 
Taken together, our results indicate that RIM1α is redundant for basal neu-




RIM1α KO mice (Schoch et al., 2002) were housed under a 12 h light / 12 h dark re-
gime with ad libitum food and water. The animals were euthanized by CO2 inhalation. 
Hemi-diaphragms with their phrenic nerves were rapidly dissected and mounted in 
Ringer’s solution (see below) at room temperature.
All animal experiments were carried out according to the Dutch law and guide-
lines of  the Leiden University.
Toxin-induced myasthenia gravis
We used an experimental animal model for myasthenia gravis that was originally 
developed in rats and is termed toxin-induced myasthenia gravis (TIMG) (Molenaar 
et al., 1991). The model involves repeated injections with α-bungarotoxin (Biotoxins 
Incorporated, FA, USA), a highly potent and selective blocker of  AChRs at NMJs. 
We adjusted and re-evaluated the model for use with mice (data not shown). During 
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a period of  four weeks, mice of  about 4 months of  age were injected intraperitone-
ally every 48 hour with α-bungarotoxin. Control groups received physiological saline 
injections. As a first dose, 1.2 μg α-bungarotoxin was injected. Thereafter, doses 
of  0.8 μg of  the toxin were administered. Three hours after an injection the mice 
showed slightly invaginated flanks, indicating mild muscle weakness. There were no 
apparent breathing problems. In general, these symptoms had disappeared by the 
next, toxin-free, day. If  the symptoms of  weakness (scored visually in individual 
mice) were too severe, the following dose of  α-bungarotoxin was lowered by 0.2 µg. 
The mice were well able to feed and drink.
Neuromuscular synapse electrophysiology
Measurements were performed on nerve/muscle preparations from right and left 
hemi-diaphragms of  wild type and RIM1α KO mice. Upon electrical stimulation 
of  the phrenic nerve, the nerve terminal releases a number of  ACh quanta. Part of  
the transmitter binds postsynaptic AChRs and causes them to open. The resulting 
ion current gives rise to an endplate potential (EPP). Spontaneous release of  single 
quanta results in miniature EPPs (MEPPs). We recorded EPPs and MEPPs by im-
paling muscle fibers near the NMJ with a 10-20 MΩ glass capillary microelectrode 
filled with 3 M KCl and standard recording equipment at 26-28° C (Plomp et al., 
1994) in Ringer's medium containing (mM): NaCl, 116; KCl, 4.5; MgCl2, 1; CaCl2, 
2; NaH2PO4, 1; NaHCO3, 23; glucose 11; pH 7.4, gassed with 95 % O2/5 % CO2. 
Hemi-diaphragms were incubated with 3.1 µM µ-Conotoxin GIIIB (Scientific Mar-
keting Associates, Herts, UK), a selective blocker of  muscle sodium channels, to 
prevent action potentials. This allowed for the undisturbed recording of  EPPs dur-
ing electrical nerve stimulation (0.3 and 40 Hz) of  the phrenic nerve with a bipolar 
stimulation electrode. The quantal content (i.e. the number ACh quanta released 
upon a single nerve impulse) at each NMJ was calculated from EPP and MEPP am-
plitudes, normalized to -75 mV membrane potential. The EPP amplitude was cor-
rected for non-linear summation. During high-frequency stimulation (1 s, 40 Hz), 
EPP amplitudes have the tendency to decrease to a plateau level. The degree of  
run-down of  EPP amplitudes was determined by averaging the amplitudes of  the 
last 10 EPPs in the train and has been expressed as percentage of  the amplitude of  
the first EPP in the train.
MEPPs were also recorded shortly after exposure of  preparations to hypertonic 
medium (0.5 M sucrose Ringer), assessing the pool of  ACh vesicles ready for im-
mediate release (Stevens and Tsujimoto, 1995).
A GeneClamp 500B amplifier from Axon Instruments (Union City, CA, USA) 
was used for amplifying and filtering (10 kHz low-pass) of  the signals. The record-
ings were digitized and analyzed using a Digidata 1200 interface, Clampex 8.0 and 
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Clampfit 8.0 programs (Axon Instruments) and routines programmed in Matlab 
(The MathWorks Inc., Natick, MA, USA).
Statistical analysis
The significance of  differences in grand mean values between genotype groups were 
tested using Student’s t-test, and differences in effect of  TIMG treatment between 
genotypes was tested with the multivariate general linear model (interaction param-
eter) and the post-hoc Tukey test by using SPSS 10.0 for Windows (SPSS Inc., Chi-
cago, IL, USA).
Results
Unaltered basic ACh release properties of  RIM1α KO NMJs 
To investigate whether deletion of  RIM1α had an effect on transmitter release prop-
erties we analyzed basic NMJ function in RIM1α KO mice. It appeared that both 
spontaneous as well as evoked release parameters were indistinguishable between 
wild-type and KO mice (Figure 1, 2). EPP amplitudes were 26.8 ± 1.17 mV in wild-
type NMJs, and 28.5 ± 2.0 mV in RIM1α KO NMJs (n = 6, p = 0.516). MEPP am-
plitudes were 1.02 ± 0.08 mV in wild-type NMJs and 1.02 ± 0.08 mV in RIM1α KO 
NJMs (n = 6, p = 0.769), MEPP frequency was 2.30 ± 0.24 MEPP s-1 in wild-type, 


















































Figures Chapter 7: Redundancy of RIM1α in neuromuscular function
Figure 1. Spontaneous ACh re-
lease parameters are unchanged 
in RIM1α KO and wild-type 
NMJs. 
(A) Mean values of  MEPP ampli-
tudes measured in wild-type and 
RIM1α KO NMJs (n = 6 mice, 10-
15 NMJs measured per muscle). In 
TIMG, the MEPP amplitude was 
reduced equally (~ 70 %) in both 
genotypes (n = 7 wild-type mice, n 
= 8 RIM1α KO mice, 10-15 NMJs 
measured per muscle). (B) Mean 
values of  MEPP frequency were 
similar in both genotypes and were 
similarly decreased in TIMG, pre-
sumably due to some loss MEPPs 
in background noise. (C) Repre-
sentative examples of  MEPPs for 
both genotypes under control and 
TIMG conditions. 
Data is presented as means ± 
S.E.M.; * p< 0.05, ** p<0.01, and 




the run-down profiles of  EPPs during high-frequency (40 Hz) stimulation were 
similar as well (Figure 3), 81.8 ± 1.05 %, compared to 82.05 ± 0.63 % in RIM1α 
KO NMJs (n = 6, p = 0.949). We also found no difference in the number of  ready 
releasable vesicles tested by addition of  0.5 M sucrose solution (Figure 4), in wild-
type NMJs 87.6 ± 12.2 MEPPs s-1 were recorded, against 75.43 ± 11.4 MEPPs s-1 in 
RIM1α KO NMJs (n = 6, p = 0.488).
Appropriate synaptic homeostasis at RIM1α KO NMJs
Next, we assessed whether RIM1α deficiency impedes or prevents the compensa-
tory mechanism in the NMJ in response to a reduced postsynaptic sensitivity in the 
TIMG model. In both RIM1α KO as well as wild-type NMJs, the MEPP amplitude 
was decreased by 68% (Figure 1), to wild-type values of  0.33 ± 0.03 mV, and 0.34 
± 0.03 mV in RIM1α KO NMJs (n = 7 wild-type, n = 8 RIM1α KO mice, p = 
0.769). The compensatory up-regulation of  the quantal content was similar in both 
genotypes (Figure 2B), namely 175% of  control wild-type NMJ values and 185% 
of  control RIM1α KO values (wild-type 79.1 ± 3.4, n= 7, RIM1α 79.8 ± 3.8, n = 
8, p = 0.535). The TIMG treatment caused a more pronounced run-down of  EPP 
Figure 2 ACh release evoked by 
0.3 Hz nerve stimulation is similar 
in both RIM1α KO and wild-type 
NMJs.
(A) Mean values of  EPP amplitudes in 
both genotypes in the control and TIMG 
condition. TIMG treatment induced 
32% reduction of  the EPP amplitude 
in wild-type NMJs, and 34% in RIM1α 
KO NMJs (n = 6 wild-type control and 
RIM1α KO mice, n = 7 wild-type TIMG 
mice, n = 8 RIM1α KO mice, 10-15 
NMJs measured per muscle). (B) Mean 
values of  quantal content. In both geno-
types, the quantal content was increased 
by ~80 %. (C) Representative examples 
of  EPPs for both genotypes under con-
trol and TIMG conditions. Data is pre-
sented as means ± S.E.M.; * p< 0.05, ** 
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amplitudes during high-frequent stimulation, which was comparable in both geno-
types  (Figure 3; rundown level of  66.5 ± 1.8 %, n = 7 in wild-type, and 65.9 ± 2.0 
% in RIM1α KO, n = 8, p = 0.638). We probed for the number of  readily releasable 
vesicles by application of  sucrose solution, and found that the induction of  TIMG 
had no statistically significant influence on the resulting increased MEPP frequency 
(88.7 ± 15 MEPPs s-1, n = 5 in wild-type, and 73.3 ± 14.7 MEPPs s-1 in RIM1α KO 
NMJs, p = 0.492 (Figure 4). Summarizing, RIM1α KO mice do not show any defect 
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Figure 3. EPP amplitudes during high 
frequent (40 Hz) nerve stimulation for 1 
s show similar rundown profiles in both 
genotypes. 
TIMG NMJs show an increased EPP rundown 
compared to control NMJs. (A) Typical exam-
ples of  40 Hz EPPs are shown. (B) Mean val-
ues of  rundown of  EPP amplitudes. Displayed 
is the average amplitude of  the last ten EPPs in 
the train, expressed as percentage of  the first 
EPP in the train (n = 6 wild-type control and 
RIM1α KO mice, n = 7 wild-type TIMG mice, 
n = 8 RIM1α KO mice, 10-15 NMJs measured 
per muscle) Data is presented as means ± 





Our experiments performed on NMJs from mice lacking the active zone protein 
RIM1α did not reveal any synaptic defects. The ACh release evoked by either low- 
or high-rate electrical stimulation or hypertonic medium was not different from the 
wild-type control NMJs. Even when challenging the NMJ by subjection of  the mice 
to a model of  myasthenia gravis, which causes a compensatory up-regulation of  
transmitter release, no differences were observed between RIM1α KO NMJs and 
wild-type. This can be explained in two ways: 1) either RIM does not play a role in 
NMJ electrophysiology, or 2) the protein is redundant and its absence is functionally 
compensated for by the highly homologous RIM2α. The presence of  RIM1α has 
been demonstrated in the diaphragm (personal communication, S. Schoch), leav-
ing the latter explanation the most likely one. Indeed, a recent publication on the 
RIM1α/2α double KO (DKO) mouse (Schoch et al., 2006b) further supported the 
presumed redundancy of  RIM1α in the NMJ. The RIM1α/2α DKO is, in contrast 
to mice KO for the single genes, not viable and dies immediately after birth due to 
respiration failure. Analysis of  embryonic RIM1α/2α DKO NMJs in diaphragm 
showed that evoked neurotransmitter release was dramatically impaired. EPPs were 
10-fold smaller and exhibited failures during repetitive stimulation. Spontaneous re-
lease was unaltered but was no longer calcium dependent. These data show that 
RIM1α and RIM2α are functionally redundant in the NMJ, thereby explaining the 
lack of  effect we observed here in RIM1α KO NMJs.
NMJs from mice that were subjected to the TIMG model showed a similar re-






























Figures Chapter 7: Redundancy of RIM1α in neuromuscular function
Figure 4. Unaltered size of  the readily releasable synaptic vesicle pool. 
(A) Mean values of  MEPP frequency measured in the presence of  hypertonic (0.5 M) sucrose-Ringer’s medium 
(n = 5 wild-type control and RIM1α KO mice, n = 5 wild-type TIMG mice, n = 6 RIM1α KO mice, 10-15 NMJs 
measured per muscle). (B) Typical examples of  200 ms recordings of  MEPPs measured in the presence of  0.5 M 
sucrose-Ringer’s medium. Data is presented as means ± S.E.M.
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that the pool of  readily releasable vesicles was not changed in TIMG. This indicates 
that the compensatory increase of  quantal content (by ~80 %) in TIMG is not 
achieved by increasing the readily releasable pool. The underlying mechanism is still 
unclear but may involve an increase in Ca2+ sensitivity of  the release machinery.
The TIMG treatment clearly induced in both RIM1α KO and wild-type mice 
the phenomenon of  compensatory increase of  transmitter release at the NMJ. Al-
though we were unable to demonstrate a role for RIM1α in this phenomenon of  
synaptic homeostasis, it is still likely that α-RIMs are involved since the protein has 
been implicated in synaptic plasticity in the CNS (Castillo et al., 2002; Schoch et al., 
2002; Calakos et al., 2004). In view of  this, it would be interesting to investigate NMJ 
function in mice that are homozygous null-mutant for RIM1α in combination and 
heterozygous RIM2α null-mutation (one single allele of  RIM2 α), since these mice 
are viable but may be less well able to respond to decreased ACh sensitivity with a 
compensatory increase of  presynaptic transmitter release at the NMJ.
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The aim of  the studies described in this thesis was to elucidate the roles of  several 
neuro-exocytotic proteins at the motor nerve terminal in neuromuscular synaptic 
transmission, making use of  genetic knockout (KO) mice, each missing one (or 
more) neuro-exocytotic proteins. In addition, it was investigated in a pharmacologi-
cal mouse model for myasthenia gravis (MG) whether some of  these proteins play 
a role in the phenomenon of  compensatory upregulation of  acetylcholine (ACh) 
release at the neuromuscular junction (NMJ) in this disease. 
This chapter briefly summarizes the major findings of  this thesis and addresses some 
of  the remaining questions. In addition, suggestions for future research are made. 
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Summary and General Discussion
Summary of  experimental chapters 
Chapter 2 describes the electrophysiological and morphological analysis of  NMJs 
from mice lacking Munc13-1 and Munc13-2. Munc13 has been implicated in the 
priming of  synaptic vesicles. In contrast to Munc13-1 and Munc13-2 single KOs, 
the double KO mice are not viable and die upon birth. Therefore, NMJs of  these 
mice were investigated at embryonic day 18.5. Although evoked release was strongly 
reduced in the NMJ of  Munc13-1/ 2 deficient mice, miniature endplate potentials 
(MEPPs, i.e. spontaneous ACh release) were observed at more than 2-fold higher 
frequency, compared to wild-type. This was surprising, because hippocampal syn-
apses in these mice have been reported to be completely silenced. The current find-
ing thus suggests that vesicle priming at the NMJ is partly Munc13 independent. 
Morphological analysis of  the diaphragm showed a highly disorganized muscle fibre 
orientation and endplates that were no longer organized in the typical mid-line end-
plate-band as observed in wild-type diaphragms. This phenotype closely resembled 
that of  the choline acetyltransferase KO mice (Brandon et al., 2003), at which NMJs 
are completely silenced, indicating that action potential evoked ACh release is neces-
sary for normal muscle development. The current findings at Munc13-1/2 double 
KO mice indicate that the presence of  spontaneous ACh release (MEPPs) alone is 
not sufficient for normal muscle development.
In chapter 3, the role of  α-neurexins in the NMJ was investigated. There are 
three isoforms, α-neurexin 1, -2, and -3 (for review, see Missler and Sudhof, 1998). 
α-Neurexins are transmembrane proteins with an intracellular domain enabling in-
teraction with components of  the release machinery, and an extracellular domain 
that can participate in a transsynaptic protein complex. Deleting α-neurexins in 
mice results in strongly reduced neurotransmitter release in CNS (Missler et al., 
2003). α-Neurexins presumably regulate release through interaction with the Cav2.2 
and Cav2.1 voltage gated Ca
2+ channels (Zhang et al., 2005). Mice lacking all three 
α-neurexin isoforms die at birth, but a subset of  mice lacking two isoforms survives 
to adulthood. We used these mice to analyze NMJ function in two different muscle 
types (the slow-twitch fiber soleus muscle, and the diaphragm with a mixture of  slow 
and fast twitch fibers). Neuromuscular synapse function in the soleus muscle was 
slightly impaired, showing a decrease in both MEPP frequency and quantal content 
of  about 30%. In diaphragm NMJs, however, no effect was observed. To investigate 
the release characteristics of  a NMJ without any α-neurexin present, we examined 
the embryonic diaphragm NMJ of  triple KO mice and found undisturbed transmit-
ter release, too. To determine a possible role of  α-neurexins in synapse homeostasis, 
we investigated α-neurexin double KO mice under the condition of  toxin-induced 
MG (TIMG), a model for MG using α-bungarotoxin. This condition normally re-
sults in ~2-fold upregulation of  evoked ACh release at the NMJ, partially com-
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pensating the reduced density of  functional ACh receptors. Indeed, compensatory 
upregulation of  quantal content at the α-neurexin double KO NMJ was much less 
pronounced than in the wild-type controls. These findings show that α-neurexins 
are important for efficient neurotransmitter release at some types of  NMJs and that 
they play a role in the mechanism of  synaptic homeostasis at NMJ under myasthenic 
condition. 
Rab3A is one of  a family of  small GTP-binding proteins associated with syn-
aptic vesicles, which have been implicated in modulating evoked neurotransmitter 
release in brain synapses (Fischer von Mollard et al., 1991; Geppert et al., 1994; Fis-
cher et al., 1994; Star et al., 2005). Compound KO mice for Rab3A, Rab3B, Rab3C, 
and Rab3D are not viable (Schluter et al., 2004). Chapter 4 describes the NMJ 
function in soleus and diaphragm of  Rab3A deficient mice.  We found 20-40% re-
duction in spontaneous ACh release (MEPP frequency) but unaltered nerve action 
potential-evoked release and recovery from release induced by high-frequent stimu-
lation. This indicates a selective role of  Rab3A in spontaneous transmitter release 
at the NMJ that cannot or only partially be taken over by the closely related Rab3B, 
-C, or -D isoforms. It has been hypothesized that Rab3A mutation underlies ACh 
release deficits in human presynaptic myasthenic syndromes. Our observation of  a 
normal level of  evoked ACh release at the Rab3A KO NMJ, however, argues against 
this hypothesis. 
Chapter 5 describes the effect of  varying Munc18-1 protein levels in cultures of  
hippocampal neurons and the NMJ. Munc18-1 is the only protein described in this 
thesis whose deletion is lethal and causes a total arrest of  neurotransmitter release 
in CNS and PNS (Verhage et al., 2000). Heterozygous Munc18-1 KO (Munc18+/-) 
mice are viable and have a 50% reduction of  Munc18-1 protein level in the brain, 
making them a suitable model to study the effect of  decreased Munc18-1 level. In 
addition, the effect of  increased level of  the protein on exocytosis was studied in 
Munc18-1 overexpressing mouse (Munc18OE) and in hippocampal cell cultures over-
expressing the protein after viral transfection.
NMJ function was analyzed in wild-type mice, Munc18+/-, and Munc18OE  mice. 
A clear ‘gene-dosage’ effect of  Munc18-1 was observed on MEPP frequency and 
quantal content. In Munc18+/- NMJs, increased run-down of  ACh release upon 
high-frequency stimulation was observed as well, and a decreased response to a 
hypertonic shock, used to probe for the size of  the readily releasable pool of  synap-
tic vesicles.  Electrophysiological synaptic analysis of  hippocampal neuron cultures 
from Munc18-1+/- mice showed a similar increased run-down of  transmitter release 
during high-frequency stimulation and decreased response to hypertonic stimula-
tion. Viral overexpression of  Munc18-1 in these cultured hipocampal synapses, on 
the other hand, increased the response to hypertonic shock and resulted in less pro-
nounced run-down during high-frequency stimulation. Electron microscopic analy-
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sis showed a clear difference in the number of  morphologically docked vesicles. 
These data led to the conclusion that Munc18-1 is involved in modulating the num-
ber of  docked, release-ready synaptic vesicles at nerve terminals. 
Chapter 6 describes a study where Munc18-1OE, Munc18-1+/-, and wild-type 
mice were subjected to the TIMG model. It appeared that Munc18-1+/- NMJs were 
less able to increase the quantal content than wild-type NMJs. Overexpression of  
Munc18-1 on the other hand failed to increase the compensatory response. These 
results indicate that Munc18-1 is involved in the signaling cascade leading to in-
creased quantal content in TIMG but that other factors may become rate-limiting in 
the Munc18-1OE NMJ.
RIM1α is a known binding partner of  Rab3A (Wang et al., 2000) and has been 
suggested to play a role in synaptic vesicle priming. Mice in which RIM1α is deleted 
are viable and show minor behavioral defects (Castillo et al., 2002; Schoch et al., 
2002; Powell et al., 2004; Calakos et al., 2004). Chapter 7 describes that deleting 
RIM1α in mice does not affect NMJ function, neither under basal conditions, nor 
in the condition of  TIMG. Most likely, RIM1α is redundant and RIM2α assumes 
its function. Indeed, recent data show that RIM1α/2α double KO mice (Schoch et 
al., 2006) die upon birth and their embryonic NMJs show strongly impaired evoked 
ACh release.
Phenotypic differences between central and neuromuscular  
synapses of  neuro-exocytotic protein knockout mice
This thesis has contributed to the knowledge on the role of  Munc18-1, Munc13s, 
Rab3A, Neurexins and RIM1α in neuromuscular synaptic transmission. When com-
paring the function of  these proteins in NMJ and CNS, it is interesting that usually 
the synaptic phenotype in the NMJ is much milder compared to that in synapses 
of  the CNS. The strongest example is Munc13, deletion of  which results in com-
plete ablation of  neurotransmitter release in CNS (Varoqueaux et al., 2002) while 
the NMJ still exhibits MEPPs and even, to some extent, retains nerve-stimulated 
release. Deleting Rab3A and α-neurexin also has a much milder effect on release 
properties of  the NMJ compared to CNS, while deleting RIM1α failed to elicit any 
effect. For Munc18-1, the overall similarity between CNS and NMJ phenotype was 
the strongest. Munc18-1 is the only protein among the ones investigated here whose 
deletion in mice results in lethality; the two remaining isoforms are apparently not 
able to take over its functions. Thus, Munc18-1 is essential for neurotransmission 
at the NMJ, while the other proteins fulfill a more regulatory function, or can be 
compensated for by isoforms or other proteins.
The NMJ is different from synapses in the CNS both in function and morphol-
ogy, and therefore it may not be surprising that this is reflected in the molecular 
organization of  the secretion machinery. In contrast to CNS synapses, the post-
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synaptic cell is not another neuron, the number of  vesicles that is released in an ac-
tion potential dependent manner is much higher (diaphragm NMJ: around 30; CNS 
synapses: around 3), the probability of  release in the NMJ is approximately 100% 
and there is only one type of  neurotransmitter. In addition, although plasticity is em-
ployed to ensure successful muscle contraction, plasticity in the CNS plays a much 
more crucial role and forms the basis of  many of  the brain’s functions like learning 
and memory. Concluding, the role of  a certain protein in the process of  secretion is 
depending on the cellular context in which it is exerting its role. 
Role of  the studied neuro-exocytotic proteins in synaptic 
homeostasis and relevance to myasthenia gravis
One of  the goals of  this thesis was to investigate the role of  specific presynaptic 
proteins in the homeostatic upregulation of  ACh release as observed in NMJs of  
muscle biopsies from MG patients, by applying the TIMG model in mice genetically 
lacking these proteins. The phenomenon of  compensatory increase of  transmitter 
release has been described in several other experimental systems (see Introduction). 
The decreased sensitivity to ACh due to a lowered density of  postsynaptic ACh 
receptors leads via a largely unknown mechanism to increased ACh release from 
the presynaptic nerve terminal. Proteins that are playing a role in transmitter release 
are likely targets of  this signaling mechanism. We investigated the effect of  deleting 
Munc18-1, Neurexins and RIM1α on the homeostatic response at the myasthenic 
NMJ. 
Munc18-1
In NMJs with only 50% Munc18-1 expression level, the compensatory response in 
TIMG was less pronounced arguing for the implication of  this protein somewhere 
in the signaling pathway. Munc18-1 has been implied in regulating the readily releas-
able pool of  vesicles, which may be the mechanism of  increase of  ACh release in 
TIMG. However, when we exposed NMJs from TIMG muscles to high-sucrose 
medium to probe for the size of  the pool we failed to see an increase, rendering it 
unlikely that it is this specific function of  Munc18-1 that is modulated for increase 
in ACh release. This raises the possibility that instead of  being an active player in 
the signaling cascade, Munc18-1 is present in rate-limiting amounts in the strained 
exocytotic machinery in NMJs of  Munc18-1 heterozygous mice. In line with this, 
increasing Munc18-1 levels in NMJs had no effect on the homeostatic performance 
of  the synapse under TIMG conditions. 
α-Neurexins
Mice lacking two of  the three isoforms of  α-neurexin showed impaired upregula-
tion of  transmitter release at the TIMG NMJ. Interestingly, diaphragm NMJs from 
185
Summary and General Discussion
neurexin double KO mice did not differ in ACh release characteristics from wild-
type under basal conditions. Even the release properties of  NMJs from (embryonic) 
mice lacking all three isoforms of  neurexin were unchanged, indicating that this 
protein is not involved in basic neurotransmitter exocytosis at the NMJ. The de-
creased upregulation observed in TIMG neurexin double KO NMJs thus indicates 
that neurexin is specifically involved in plasticity of  the diaphragm NMJ, possibly 
quite far upstream the exocytotic processes, because neurexin has been suggested to 
participate in trans-cellular signaling processes. Alternatively, neurexin’s role in the 
homeostatic response may lay in modulation of  the coupling of  calcium channels 
with the exocytotic machinery, as observed in central synapses.
RIM1α
Although we did not observe functional changes in NMJs lacking RIM1α (neither 
under basal nor TIMG conditions) we cannot exclude a role of  RIM proteins in 
homeostasis at the NMJ, because RIM1/2α double KO mice have impaired ACh re-
lease at the NMJ, and die perinatally (Schoch et al., 2006). This indicates that Rim2α 
takes on the role of  RIM1α in the RIM1α KO mouse. To further investigate RIM 
protein involved in synaptic homeostasis at the NMJ, it would be interesting to apply 
the TIMG model on mice homozygous for RIM1α and heterozygous for RIM2α. 
One can wonder whether it is possible to really pinpoint essential factors in the 
signaling cascade that leads to increased neurotransmitter release in TIMG NMJs. 
Homeostatic processes are crucial to the survival of  the organism, and it is not un-
thinkable that evolution has produced many parallel pathways and players to ensure 
NMJ transmission.
The clinical relevance for MG of  this rather fundamental neurobiological study 
is yet unclear. It may be that myasthenic patients exist with a certain polymorphism/
splice variant for munc18-1 or neurexin, causing them to have less compensatory 
upregulation of  transmitter release. These patients may have more severe paralytic 
symptoms.  More research into the details of  pathways leading to the NMJ’s ability 
to counteract threats to signal transmission may be beneficial for many more dis-
eases in which successful neurotransmission is compromised, like Lambert Eaton 
myasthenic syndrome and congenital myasthenic syndromes (see for review Boony-
apisit et al., 1999). Furthermore, such studies may reveal new pharmacological tar-
gets that may be exploited to increase ACh release to overcome or prevent block of  
neuromuscular transmission.
Considerations on the use of  knockout mice
Experiments described in this thesis have been carried out on genetically modified 
mice (mostly KO mice, and one mouse overexpressing the Munc18-1 gene). Careful 
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consideration of  genetic background, compensatory mechanisms, homeostasis, and 
developmental differences is necessary when characterizing synaptic transmission in 
genetically engineered animals. 
It is known that genes fulfill different roles during development (in utero and 
postnatally) and in adulthood (e.g. the dependence of  NMJ synaptic transmission on 
different types of   Ca2+ channels (Urbano et al., 2003)). 
Developmental changes due to the absence of  the gene of  interest may in itself  
cause (subtle) changes in the mechanism of  synaptic homeostasis. Further activa-
tion of  synaptic homeostatic mechanisms by the TIMG treatment might show an 
abnormal result, what could be attributed to a direct functional consequence of  the 
absence of  the KO-gene product. However, the mechism of  synaptic homeostatis 
might already have been altered in itself. 
Furthermore, the genetic background of  the mouse strain can significantly al-
ter a neurological or musculoskeletal phenotype of  transgenic animals (Yoshiki 
and Moriwaki, 2006). For instance, the genetic background alters the outcome of  
anxiety related tasks, likely due to changes in GABAergic transmission (Robertson, 
1979; Chapouthier et al., 1991; Griebel et al., 2000; Rodgers et al., 2002). Geneti-
cally deleting proteins participating in synaptic transmission may also have different 
effects depending on the genetic background of  the mouse, as demonstrated with 
the serotonin-transporter (Holmes et al., 2002; Holmes et al., 2003) and serotonin 
receptor 5-HT1A deletions (Lesch et al., 2003), when expressed in different inbred 
mouse strains. 
Alternatives for conventional knockout mice
In the studies of  this thesis, ‘first generation’ knockout mice were used, generated 
by gene targeting through homologous recombination (Capecchi, 1989). One of  
the disadvantages of  this technique is that the gene is deleted in every cell and 
throughout the development and lifetime of  the mouse, as described above. New 
techniques have become available that enable temporal and spatial control of  ge-
netic manipulations: the Cre/LoxP recombinase system (Tsien et al., 1996a; Tsien et 
al., 1996b), and the tetracycline-inducible system (Gossen and Bujard, 1992; Furth 
et al., 1994). The Cre-LoxP system uses mice with LoxP sites flanking the gene of  
interest (floxed mice), which are bred with transgenic mice expressing Cre recom-
binase under the control of  a selected promoter (Cre mice). Once expressed, Cre 
recombines the floxed gene and produces gene KO (reviewed in Gaveriaux-Ruff  
and Kieffer, 2007). In this system, the choice of  the promoter determines the time 
and location of  Cre expression. One possibly underestimated worry is the potential 
cellular toxicity of  Cre recombinase (Schmidt-Supprian and Rajewsky, 2007). The 
tetracycline-inducible system is similar to the Cre-LoxP in that both systems make 
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use of  homologous recombination and embryonic stem cells, and both require the 
generation of  two sets of  transgenic mice. 
Another, fundamentally different approach is RNA interference (RNAi), which 
can selectively down-regulate gene expression (reviewed in Gao and Zhang, 2007). 
The silencing of  a gene is accomplished posttranscriptionally.  Due to variation in 
the degree of  silencing, the term ‘knock-down’ has been introduced. The method 
has been used in cell cultures and whole organisms, and the methods of  delivery 
can be as simple as feeding double stranded RNA to worms (Kamath and Ahring-
er, 2003), and by injecting RNA constructs into pronuclei. Moreover, stable RNAi 
knock-down mouse have been engineered (Peng et al., 2006) although it is yet to be 
confirmed that the transgenic RNAi effect is permanent (Gao and Zhang, 2007). 
One drawback of  the RNAi method is that there may be residual expression of  
RNAi-targeted genes. In addition, there is a difference in the competency of  cells to 
carry out RNAi (Gao and Zhang, 2007). 
RNAi has been successfully used in mammalian muscle tissue by Kong and co-
workers (Kong et al., 2004), decreasing the levels of  MuSK and rapsyn. However, to 
my knowledge, the method has not been used to target presynaptic proteins in the 
NMJ as the the small size of  the nerve terminal precludes RNAi injection. 
Outlook
Future research on elucidating the roles of  synaptic proteins in the mammalian NMJ 
certainly will most likely involve the further analysis of  the still growing number of  
KO mice, both conventional and inducible, like described above. Subjecting these 
animals to TIMG will help to gain insight into the mechanism of  homeostatic in-
crease of  transmitter release. It would be very helpful to induce gene KO after es-
tablishment of  the TIMG situation, to avoid pre-existing homeostatic mechanisms 
counteracting the effects of  the protein’s absence. 
A publication by Das and coworkers described a co-culture of  vertebrate embry-
onic motoneuron and skeletal muscle cells, which formed neuromuscular synapses 
(Das et al., 2007). Although the functional aspects of  these synapses were not de-
scribed in much detail in this paper, it may be interesting to use such a system to 
induce TIMG. This may allow for a controlled, ex vivo experimental set-up in which 
blockers can be used to investigate the homeostatic signaling cascade in detail.
RNAi sounds like a promising method as soon as it possible to knock down 
genes in the nerve ending, although this method is only useful for genes that are 
expressed locally. 
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Dit proefschrift heeft als vraagstelling wat de rol van een aantal specifieke eiwitten 
is bij de afgifte van neurotransmitter in de neuromusculaire junctie (NMJ). Tevens is 
voor een aantal van deze eiwitten onderzocht of  ze een rol spelen in het fenomeen 
van compensatoire verhoging van neurotransmitter afgifte zoals dat waargenomen 
wordt in de NMJs van patiënten met de spierziekte myasthenia gravis (MG). 
Neuromusculaire junctie
De NMJ vormt het contact tussen de spiervezel en het motorneuron. Het uiteinde 
van de zenuw maakt hier nauw contact met de spier. De elektrische prikkel die vanuit 
het cellichaam van het neuron in het ruggenmerg naar het zenuwuiteinde is gereisd, 
wordt hier overgedragen naar de spiervezel waarna via een aantal stappen de vezel 
contraheert en er beweging tot stand komt.
Exocytose 
In het zenuwuiteinde bevinden zich blaasjes, gevuld met acetylcholine (in het geval 
van skeletspieren van zoogdieren).  Acetylcholine (ACh) is een zgn. neurotransmitter, 
een stof  die gebruikt wordt bij de overdracht van prikkels binnen het zenuwstelsel. 
Op het moment dat een elektrische prikkel het zenuwuiteinde bereikt, wordt dit 
waargenomen door calciumdoorlaatbare kanalen in het celmembraan. Deze kanalen 
gaan kortstondig open, waardoor calcium de cel binnenstroomt. Dit calciumsignaal 
resulteert via aan aantal stappen in de fusie van een aantal van tevoren klaargelegde 
synaptische blaasjes met het celmembraan. Hierdoor wordt  acetylcholine afgegeven 
aan de extracellulaire ruimte. De spiercel heeft op de plek van de NMJ ACh 
receptoren (AChR)  in het celmembraan, dit zijn ionkanalen die uitsluitend openen 
wanneer acetylcholine zich bindt aan het kanaal. Tijdens de korte opening van 
de AChR loopt er een netto positieve stroom, waardoor de membraanpotentiaal 
stijgt. Wanneer deze potentiaal een drempel overschrijdt, gaan voltageafhankelijke 
natriumkanalen in de spiercel open en stijgt de membraanpotentiaal nog verder. 
Deze potentiaalverandering wordt de ‘spier actiepotentiaal’ genoemd. Een spier 
actiepotentiaal leidt tot de opening van voltageafhankelijke calciumkanalen in het 
membraan van de spiervezel, waarop calciumionen de cel binnenstromen. Deze 
calcium instroom resulteert in bulk calcium afgifte uit het sarcoplasmatisch reticulum 
(een onderdeel van de cel), dit zorgt voor contractie van de spiervezel en dus voor 
de mogelijkheid tot beweging. Naast de hierboven beschreven gestimuleerde afgifte 
waarbij een aantal blaasjes tegelijkertijd fuseert met het plasmamembraan bestaat 
spontane afgifte, waarbij ongeveer één keer per seconde één blaasje fuseert met het 




MG is een autoimmuun ziekte.  20-500 op de miljoen mensen krijgen MG, waarbij 
er in het bloed van de patiënt antilichamen tegen de AChR aangetroffen worden. De 
ziekte kenmerkt zich door spierzwakte die verergert na inspanning. Tegenwoordig 
zijn er behandelingen waardoor de ziekte  onder controle gehouden kan worden. 
Wanneer een spiermonster van een patiënt met MG met behulp van 
elektrofysiologische technieken (zie hieronder) onderzocht wordt, ziet men dat 
de gevoeligheid voor ACh van het postsynaptische element sterk verminderd is. 
Eén van de oorzaken hiervan is dat er, na binding van de auto-antilichamen tegen 
de AChR  een immuunsysteem-aanval op de cel plaatsvindt, waardoor deze cel 
schade oploopt. Er is gebleken dat de zenuwcel probeert te compenseren voor 
de verminderde gevoeligheid van ACh van de spiercel, door de afgifte van meer 
blaasjes ACh dan normaal. Deze (gedeeltelijke) compensatie van het systeem zorgt 
ervoor dat de drempel van de spier actiepotentiaal iets beter gehaald wordt, maar de 
zenuwcel houdt het niet lang vol om veel meer blaasjes dan normaal af  te geven. Na 
inspanning neemt de spierzwakte dus sneller toe.
Het fenomeen van de compensatie van neurotransmitterafgifte is heel interessant. 
De postsynaptische cel geeft kennelijk feedback aan de presynaptische cel over de 
mate waarin de signaalstofafgifte effectief  is, waarop de presynaptische cel het aantal 
blaasjes met neurotransmitter aanpast aan de gevoeligheid  van de postsynaptische 
cel. Deze feedback wordt ‘retrograde signalering’ genoemd (‘retro’ aangezien de 
postsynaptische cel de presynaptische cel informeert). Waaruit dit signaal precies 
bestaat is in dit specifieke geval niet bekend, net zo goed als niet bekend is via 
welke route de toename van neurotransmitterafgifte tot stand komt. Wanneer dit 
mechanisme opgehelderd wordt, kan dit potentieel belangrijk zijn voor klinisch 
onderzoek. Voor ziekten waarbij een toename van synaptische ‘kracht’ wenselijk is 
(bijvoorbeeld bij spierzwakte) zouden farmaca die een dergelijk mechanisme kunnen 
stimuleren een onderdeel van de behandeling kunnen uitmaken.
Om het fenomeen van synaptische compensatie zoals gezien in spierbiopten 
van patiënten met MG te onderzoeken zijn verschillende diermodellen ontwikkeld. 
Eén model bestaat uit het herhaaldelijk injecteren van muizen met het toxine 
α-Bungarotoxine (toxin-induced myasthenia gravis, TIMG). Dit toxine wordt 
opgezuiverd uit het gif  van de ‘banded krait’, een dodelijk giftige slang die o.a. in 
China en Thailand voorkomt. Het gif  bindt specifiek aan de AChR en blokkeert deze. 
Herhaaldelijk injecteren zorgt ervoor dat een deel van de receptoren in de NMJ van 
de muizen geblokkeerd wordt. Hiermee wordt het effect dat de antilichamen tegen 
de ACh in MG patiënten teweeg brengen nagebootst. 
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Door gebruik te maken van elektrofysiologische technieken kan het proces van 
neurotransmitterafgifte in de NMJ onderzocht worden. Voor de experimenten 
die beschreven staan in dit proefschrift is voornamelijk gebruik gemaakt van een 
preparaat van het middenrif  met de bijbehorende phrenische zenuw. Het preparaat 
wordt daarbij vastgezet in een schaaltje met fysiologische zoutoplossing en in de 
opstelling gebracht. Een glaselektrode  met een zeer fijn uiteinde (gekoppeld aan een 
versterker) wordt in de spiervezel gebracht ter hoogte van de NMJ, hiermee wordt 
de membraanpotentiaal geregistreerd (normaal ligt deze rond de -75 mV). Spontane 
afgifte van een blaasje met neurotransmitter wordt gezien als een kleine piek met een 
amplitude van ongeveer 1 mV, de miniatuur eindplaat potentiaal (MEPP). Wanneer 
de zenuw gestimuleerd wordt fuseren meerdere blaasjes, het signaal dat dit tot gevolg 
heeft heet de eindplaatpotentiaal (EPP). Normaal gesproken leidt een EPP direct 
tot een spieractiepotentiaal en dus tot contractie van de spier, dit is niet wenselijk 
aangezien contractie de meting ernstig verstoort. Door toediening van een specifiek 
toxine (µ-conotoxine) worden de voltagegevoelige natriumkanalen geblokkeerd en 
zodoende treedt er geen spieractiepotentiaal en dus contractie op. De EPP bestaat uit 
de sommatie van MEPPs, wanneer de amplitude van de EPP gedeeld wordt door de 
amplitude van de MEPP binnen één eindplaat wordt de ‘quantal content’ verkregen. 
Dit is het aantal afgegeven blaasjes per zenuwstimulatie. Voor uit uitvoeren van deze 
berekening worden de amplitudes eerst genormaliseerd naar -75 mV en wordt er 
gecorrigeerd voor de niet-lineaire sommatie van MEPPs.
Door het bepalen van de EPP amplitude, de MEPP amplitude, de ‘quantal 
content’, de frequentie van de MEPPs en nog andere waarden kunnen uitspraken 
worden gedaan over het functioneren van de NMJ. Wanneer bijvoorbeeld NMJs van 
muizen die een TIMG behandeling hebben ondergaan geanalyseerd worden, ziet 
men hele kleine MEPPs. Wanneer de ‘quantal content’ berekend wordt van deze 
NMJs ligt deze rond de 100, terwijl in controle dieren de waarde rond de 30 ligt. 
Synaptische eiwitten
Het fusieproces van de blaasjes met acetylcholine is complex. Het is van groot belang 
dat dit strak geregisseerd wordt, er moet op de juiste tijd en op de juiste locatie 
genoeg (maar niet teveel) ACh vrijkomen. Deze specifieke regulatie wordt verzorgd 
door een groot aantal eiwitten, de zgn. synaptische eiwitten. De SNARE eiwitfamilie 
is van cruciaal belang: Syntaxine en Synaptotagmine aan het plasmamembraan 
en Synaptobrevine aan het blaasje. Deze drie eiwitten binden en vormen zo het 
SNARE complex. Bij de vorming van dit complex komt de energie vrij die nodig is 
om het membraan van het blaasje te laten fuseren met het celmembraan. Naast de 
SNARE eiwitten bestaan er vele andere eiwitten die verschillende functies hebben in 
synaptische exocytose. Van veel van deze eiwitten is de rol in neurotransmitter afgifte 
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in synapsen in het brein onderzocht maar nog niet in de NMJ. In dit proefschrift 
is de rol van vijf  eiwitten (Munc13, Munc18, α-Neurexine, Rim1α en Rab3A) in de 
NMJ onderzocht.  Dit is gedaan door het analyseren van NMJs van knock-out (KO) 
muizen. Een KO muis is een muis die genetisch gemodificeerd is zodat het het gen 
dat codeert voor een eiwit afwezig is. Om te onderzoeken of  een eiwit betrokken is 
bij het compensatie-effect in MG is bij drie typen KO muizen ook het TIMG model 
toegepast.
Munc13 is een groot eiwit met verschillende domeinen en lijkt betrokken 
te zijn bij het primingsproces, waarbij het blaasje klaargemaakt wordt om na het 
calciumsignaal direct te fuseren met het celmembraan. In hoofdstuk 2 worden NMJs 
van muizen geanalyseerd die zowel Munc13-1 en Munc13-2 missen, zgn. dubbel KO 
muizen. Aangezien deze muizen niet levensvatbaar zijn worden embryonale spieren 
geanalyseerd. Het blijkt dat gestimuleerde afgifte sterk verminderd is in de dubbel 
KO NMJs, terwijl de spontane afgifte is verdubbeld. Dit suggereert dat priming in 
de NMJ niet uitsluitend geregeld wordt door Munc13. Een morfologische analyse 
laat zien dat de eindplaten niet zoals in controle muizen gerangschikt zijn in één 
band maar chaotisch verdeeld zijn.
Neurexine1α is transmembraaneiwit, waarvan een deel buiten en een deel binnen 
de cel uitsteekt. Het is ontdekt als de bindingsplaats van het gif  van de zwarte 
weduwe spin: α-latrotoxine. Dit gif  heeft tot gevolg dat er een massieve exocytose 
plaatsvindt. Eerdere experimenten hebben uitgewezen dat Neurexine interacteert 
met een calciumkanaal en op deze manier waarschijnlijk een regulerend effect heeft 
op exocytose. In zoogdieren bestaan drie verschillende vormen van het eiwit. Muizen 
die alle drie de vormen missen sterven bij de geboorte, van muizen die nog één 
vorm hebben bereikt een aantal de volwassen leeftijd. In hoofdstuk 3 beschrijven 
wij de analyse van muizen die twee vormen van Neurexine missen.  Ondanks het 
feit dat deze dieren duidelijk minder sterk waren dan controle muizen,  bleken de 
NMJs van het diafragma normaal. In een kuitspier, die samengesteld is uit een ander 
type spiervezels) zagen wij een geringe afname van exocytose.  Om de NMJ in 
totale afwezigheid van Neurexine te onderzoeken, hebben wij  embryonale spieren 
onderzocht van muizen die triple-knock out waren. De kuitspier was te klein om te 
onderzoeken en in het diafragma bleek de afgifte onveranderd. 
We hebben onderzocht of  Neurexine een rol speelt in de synaptische homeostase 
door het TIMG model toe te passen op muizen die twee vormen van Neurexine 
missen. Het bleek dat deze muizen minder in staat waren tot het compenseren van 
het verlies van gevoeligheid voor ACh. Neurexine is dus in sommige NMJs  van 
belang voor efficiente neurotransmissie en blijkt een rol te spelen in het mechanisme 
van synaptische homeostase.
Rab3A is een klein GTP-bindend eiwit dat in de GTP-gebonden vorm bindt aan 
synaptische blaasjes en na (of  tijdens) fusie weer vrijkomt van het blaasje wanneer 
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GTP tot GDP gehydrolyseerd wordt. De transitie tussen de GTP- en GDP-
gebonden vorm kan als een moleculaire schakelaar functioneren waardoor interactie 
met bindingpartners gereguleerd kan worden.  Het eiwit is betrokken bij plasticiteit 
waardoor een modulatoire rol verondersteld wordt. Hoofdstuk 4 beschrijft de 
analyse van NMJs in het diafragma en een kuitspier van de Rab3A KO muis. Het 
blijkt dat de afwezigheid van Rab3A alleen een effect heeft op de MEPP frequentie, 
deze is zo’n 20-40% verlaagd. Kennelijk speelt het eiwit een rol bij de spontane 
afgifte van neurotransmitter, welke niet overgenomen wordt door één van de drie 
andere Rab3 vormen (Rab3B, -C, en-D).
 Munc18-1 is een bindingspartner van het SNARE eiwit Syntaxine en essentieel 
voor neurotransmitter afgifte. Muizen zonder Munc18-1 gaan dood bij de geboorte 
en hebben geen exocytose. In hoofdstuk 5 is gekeken naar het effect van het 
variëren van de hoeveelheid Munc18-1 in celculturen en in de NMJ. Hierbij is 
gebruik gemaakt van muizen die heterozygoot KO zijn, deze hebben nog 50% 
Munc18-1 en zijn levensvatbaar. Tevens is gekeken naar muizen die Munc18-1 tot 
overexpressie brengen, deze groepen zijn met elkaar vergeleken.  Het blijkt dat de 
MEPP frequentie na een hypertone schok verlaagd is in NMJs van heterozygote 
muizen, en de NMJs zijn minder goed in staat om tijdens hoogfrequente stimulatie 
de EPP amplitude op niveau te houden. Deze bevindingen werden ook gezien in 
celculturen van hippocampusneuronen van deze muizen. Samen met de resultaten 
van morfologische analyse lijkt het aannemelijk dat Munc18-1 betrokken is in het 
moduleren van het aantal gedockte en geprimede blaasjes in zenuwuiteinden.
In hoofdstuk 6 wordt beschreven wat TIMG voor effect heeft op muizen die 
heterozygoot voor Munc18-1 zijn en muizen die het eiwit tot overexpressie brengen. 
Het blijkt dat heterozygote muizen minder in staat zijn om te compenseren voor 
het verlies van ACh gevoeligheid. Muizen die Munc18-1 tot overexpressie brengen 
bleken niet beter te zijn in het compenseren voor het verlies van ACh gevoeligheid. 
Munc18-1 is kennelijk betrokken bij de signaalroute die leidt tot de upregulatie 
van afgifte in TIMG maar andere factoren zijn beperkend zodat extra Munc18-1 
ineffectief  is.
Rab interacting molecule-1 α (RIM1α) is een groot eiwit dat een belangrijke rol 
speelt in neurotransmissie, waarschijnlijk bij het klaarmaken van blaasjes voor de 
fusie. Het eiwit bindt o.a. aan Rab3A en aan Munc13. Naast RIM1α bestaat RIM2α, 
muizen die beide eiwitten missen zijn niet levensvatbaar. Hoofdstuk 7 beschrijft de 
elektrofysiologische analyse van de neurotransmitter afgifte in  NMJs van RIM1α 
KO muizen, zowel onder controle omstandigheden als met TIMG. Het blijkt 
dat de afwezigheid van RIM1α geen effect heeft op de neurotransmitterafgifte. 
Waarschijnlijk neemt RIM2α de rol van RIM1α over.  
Het werk dat beschreven staat in dit proefschrift heeft bijgedragen aan de kennis 
die bestaat over de rol die bepaalde synaptische eiwitten (Munc13, Neurexine, 
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Munc18-1, Rab3A en RIM1α) spelen bij neurotranmsitter afgifte in de NMJ van 
muizen. Verder is aangetoond dat Munc18-1 en Neurexine naar alle waarschijnlijkheid 
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